RESULT_COUNT: 709,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
MNK,MNK:US,BBG002BHBHM1,See what the IHS Markit Score report has to say about Mallinckrodt Plc.,2017-10-20 12:06:40 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120207387.html?.tsrc=rss,Short interest is high for MNK with between 15 and 20% of shares on loan.  This means that investors who seek to profit from falling equity prices are currently targeting MNK.  ETFs that hold MNK had net inflows of $7.39 billion over the last one-month.
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt To Present At The Stifel 2017 Healthcare Conference,2017-10-18 21:00:00 +0000,https://finance.yahoo.com/news/mallinckrodt-present-stifel-2017-healthcare-210000000.html?.tsrc=rss,"STAINES-UPON-THAMES, England , Oct. 18, 2017 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Tuesday, Nov. 14, 2017 , at the ..."
MNK,MNK:US,BBG002BHBHM1,"ETFs with exposure to Mallinckrodt Plc : October 18, 2017",2017-10-18 13:52:28 +0000,http://finance.yahoo.com/r/711fd318-6d79-31d6-b5a5-2a47e92bb09f/etfs-with-exposure-to-mallinckrodt-plc-october-18-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Mallinckrodt Plc Here are 5 ETFs with the largest exposure to MNK-US. Comparing the performance and risk of Mallinckrodt Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
MNK,MNK:US,BBG002BHBHM1,See what the IHS Markit Score report has to say about Mallinckrodt Plc.,2017-10-17 12:05:19 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120519461.html?.tsrc=rss,"Short interest is high for MNK with between 15 and 20% of shares on loan.  This means that investors who seek to profit from falling equity prices are currently targeting MNK.  Over the last one-month, outflows of investor capital in ETFs holding MNK totaled $3.09 billion."
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Opens Specialty Brands Office In New Jersey, Announces $100,000 Donation To Princeton University Program For High Achieving, Low-Income High School Students",2017-10-16 17:15:00 +0000,https://finance.yahoo.com/news/mallinckrodt-opens-specialty-brands-office-171500913.html?.tsrc=rss,"BEDMINSTER, N.J., Oct. 16, 2017 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (MNK), a leading global specialty pharmaceutical company, today joined U.S. Rep. Leonard Lance, R-N.J., to mark the official opening of its Specialty Brands office campus in New Jersey.  The new space at 1425 U.S. Route 206, in Bedminster, N.J. is home to a workforce of nearly 500 that supports marketed and development products in the company's hospital therapies and autoimmune and rare diseases businesses."
MNK,MNK:US,BBG002BHBHM1,See what the IHS Markit Score report has to say about Mallinckrodt Plc.,2017-10-13 12:03:39 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120339053.html?.tsrc=rss,"Short interest is moderately high for MNK with between 10 and 15% of shares outstanding currently on loan.  Over the last one-month, outflows of investor capital in ETFs holding MNK totaled $9.15 billion."
MNK,MNK:US,BBG002BHBHM1,See what the IHS Markit Score report has to say about Mallinckrodt Plc.,2017-10-12 12:08:33 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120258929.html?.tsrc=rss,"Short interest is high for MNK with between 15 and 20% of shares on loan.  This means that investors who seek to profit from falling equity prices are currently targeting MNK.  Over the last one-month, outflows of investor capital in ETFs holding MNK totaled $7.00 billion."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt plc to Report Earnings Results for Third Quarter of Fiscal 2017,2017-10-10 20:57:00 +0000,https://finance.yahoo.com/news/mallinckrodt-plc-report-earnings-results-205700813.html?.tsrc=rss,"STAINES-UPON-THAMES, United Kingdom , Oct. 10, 2017 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, announced today it will report fiscal 2017 third quarter ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt to Begin Sarcoidosis Study on Acthar Gel,2017-10-10 20:50:08 +0000,https://finance.yahoo.com/news/mallinckrodt-begin-sarcoidosis-study-acthar-205008189.html?.tsrc=rss,Mallinckrodt plc (MNK) announced that it will initiate a new phase IV study on H.P. Acthar Gel as a therapy option in patients with symptomatic sarcoidosis.
MNK,MNK:US,BBG002BHBHM1,Surprising Analyst 12-Month Target For IHE,2017-10-09 14:50:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2eAZwKvjCGg/surprising-analyst-12-month-target-for-ihe-cm856901,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
MNK,MNK:US,BBG002BHBHM1,Health Care Sector Update for 10/09/2017: MNK,2017-10-09 13:31:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OJo8fic6W9Y/health-care-sector-update-for-10092017-mnk-cm856887,Top Health care stocks Top Health care stocks JNJ 0 9 JNJ 0 9 PFE 0 3 PFE 0 3 ABT 0 1 ABT 0 1 MRK flatMRK flat AMGN 0 2 AMGN 0 2 Health care shares were mainly higher in pre market trade Monday Health care shares were mainly higher in pre market trade Monday In health
MNK,MNK:US,BBG002BHBHM1,See what the IHS Markit Score report has to say about Mallinckrodt Plc.,2017-10-09 12:03:06 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120306936.html?.tsrc=rss,"Short interest is moderately high for MNK with between 10 and 15% of shares outstanding currently on loan.  Over the last one-month, outflows of investor capital in ETFs holding MNK totaled $3.99 billion."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Will Conduct Phase 4 Trial of H.P. Acthar® Gel (Repository Corticotropin Injection) for Symptomatic Sarcoidosis,2017-10-09 10:20:00 +0000,https://finance.yahoo.com/news/mallinckrodt-conduct-phase-4-trial-102000872.html?.tsrc=rss,"STAINES-UPON-THAMES, United Kingdom, Oct. 9, 2017 /PRNewswire/ -- Mallinckrodt plc (MNK), a leading global specialty pharmaceutical company, today announced it will conduct a new Phase 4, multi-center, randomized, double blind, placebo-controlled study to further assess the efficacy of H.P. Acthar Gel as a therapy option in patients with symptomatic sarcoidosis, one of 19 indications approved by the U.S. Food and Drug Administration (FDA).  ""We are pleased to announce our plans to initiate this study of the efficacy of Acthar therapy as a later line treatment option for sarcoidosis patients with persistent disease,"" said Steven Romano, M.D., Chief Scientific Officer and Executive Vice President at Mallinckrodt."
MNK,MNK:US,BBG002BHBHM1,See what the IHS Markit Score report has to say about Mallinckrodt Plc.,2017-10-04 12:02:34 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120234814.html?.tsrc=rss,"Short interest is moderately high for MNK with between 10 and 15% of shares outstanding currently on loan.  Over the last one-month, outflows of investor capital in ETFs holding MNK totaled $618 million."
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt plc Discusses Pipeline Transformation, Company Outlook at Investor Briefing",2017-10-04 11:00:00 +0000,https://finance.yahoo.com/news/mallinckrodt-plc-discusses-pipeline-transformation-110000711.html?.tsrc=rss,"The event will highlight how Mallinckrodt's ongoing portfolio transformation has enhanced financial strength and broadened future opportunities, providing long-term value for patients and shareholders.  The event general session presentations will be posted throughout the day."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Details Development Pipeline Highlights - Quick Facts,2017-10-04 07:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b-Gx7YxuDa4/mallinckrodt-details-development-pipeline-highlights--quick-facts-20171004-00309,Mallinckrodt Details Development Pipeline Highlights - Quick Facts
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt, NeuroproteXeon Team Up for Inhalation Therapy",2017-10-03 16:39:04 +0000,https://finance.yahoo.com/news/mallinckrodt-neuroprotexeon-team-inhalation-therapy-163904469.html?.tsrc=rss,"Mallinckrodt plc (MNK) entered into a licensing agreement with NeuroproteXeon for the development and commercialization of the latter&apos;s investigational, pharmaceutical-grade xenon gas for inhalation therapy."
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Plc breached its 50 day moving average in a Bullish Manner : MNK-US : October 3, 2017",2017-10-03 12:16:46 +0000,http://finance.yahoo.com/r/9f64d2aa-4717-3bfe-bdfb-b9b9cd304194/mallinckrodt-plc-breached-its-50-day-moving-average-in-a-bullish-manner-mnk-us-october-3-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Mallinckrodt Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more
<b>(Read more...)</b>"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Licenses Inhaled Xenon Gas Therapy Development Product,2017-10-02 10:45:00 +0000,https://finance.yahoo.com/news/mallinckrodt-licenses-inhaled-xenon-gas-104500262.html?.tsrc=rss,"STAINES-UPON-THAMES, United Kingdom, Oct. 2, 2017 /PRNewswire/ -- Mallinckrodt plc (MNK) today announced it has entered into a licensing agreement for development and commercialization of NeuroproteXeon's investigational, pharmaceutical-grade xenon gas for inhalation therapy being evaluated to improve survival and functional outcomes for patients resuscitated after a cardiac arrest.  If approved, xenon gas for inhalation will expand Mallinckrodt's portfolio of hospital drug-device combination products providing therapies for critically ill patients."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt (MNK) Closes InfaCare Pharmaceutical Buyout,2017-09-29 13:01:01 +0000,https://finance.yahoo.com/news/mallinckrodt-mnk-closes-infacare-pharmaceutical-130101013.html?.tsrc=rss,Mallinckrodt (MNK) acquires privately-held InfaCare Pharmaceutical Corporation to diversify portfolio.
MNK,MNK:US,BBG002BHBHM1,See what the IHS Markit Score report has to say about Mallinckrodt Plc.,2017-09-29 12:02:37 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120237178.html?.tsrc=rss,Mallinckrodt Plc NYSE:MNK
MNK,MNK:US,BBG002BHBHM1,Featured Company News - Mallinckrodt Completes Acquisition of InfaCare Pharmaceutical; Acquires Global Rights for Stannsoporfin,2017-09-28 11:50:00 +0000,https://finance.yahoo.com/news/featured-company-news-mallinckrodt-completes-115000668.html?.tsrc=rss,"LONDON, UK / ACCESSWIRE / September 28, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Mallinckrodt PLC (NYSE: MNK ), following which we have published ..."
MNK,MNK:US,BBG002BHBHM1,Fighting the Toxic Nightmare Next Door,2017-09-28 09:00:23 +0000,http://finance.yahoo.com/r/57ef155f-5b1f-3aeb-b605-b53f26ae3622/fighting-the-toxic-nightmare-next-door?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"A radiation-riddled landfill in St. Louis, Trump’s EPA, and two moms who won’t let it go."
MNK,MNK:US,BBG002BHBHM1,See what the IHS Markit Score report has to say about Mallinckrodt Plc.,2017-09-27 12:02:08 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120208705.html?.tsrc=rss,"Short interest is moderately high for MNK with between 10 and 15% of shares outstanding currently on loan.  Over the last one-month, outflows of investor capital in ETFs holding MNK totaled $3.78 billion."
MNK,MNK:US,BBG002BHBHM1,[$$] Mallinckrodt Closes InfaCare Acquisition,2017-09-26 23:54:12 +0000,http://finance.yahoo.com/r/4160b293-4ac4-30cd-9851-f66f242f5a58/mallinckrodt-closes-infacare-acquisition-1506470049?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Mallinckrodt PLC has closed its potential $425 million acquisition of InfaCare Pharmaceutical Corp.
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Completes Acquisition of InfaCare Pharmaceutical Corporation and Stannsoporfin, its Proprietary Therapy in Late-Stage Development for Newborns at Risk for Severe Jaundice",2017-09-25 21:00:00 +0000,https://finance.yahoo.com/news/mallinckrodt-completes-acquisition-infacare-pharmaceutical-210000873.html?.tsrc=rss,"STAINES-UPON-THAMES, United Kingdom, Sept. 25, 2017 /PRNewswire/ -- Mallinckrodt plc (MNK), a leading global specialty pharmaceutical company, today announced it closed the acquisition of InfaCare Pharmaceutical Corporation, a privately held specialty pharmaceutical company focused on development and commercialization of proprietary pharmaceuticals for neonatal and pediatric patient populations.  If approved, InfaCare's developmental product stannsoporfin is expected to become the first and only pharmacologic option indicated for treatment of neonates at risk for developing severe hyperbilirubinemia, or severe jaundice.  ""The addition of stannsoporfin further expands and diversifies Mallinckrodt's pediatric pipeline, and will add strength and breadth to our Specialty Brands business,"" said Mark Trudeau, Chief Executive Officer at Mallinckrodt."
MNK,MNK:US,BBG002BHBHM1,"ETFs with exposure to Mallinckrodt Plc : September 25, 2017",2017-09-25 14:41:27 +0000,http://finance.yahoo.com/r/903dfd50-2913-37ab-bf61-265c41213528/etfs-with-exposure-to-mallinckrodt-plc-september-25-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Mallinckrodt Plc Here are 5 ETFs with the largest exposure to MNK-US. Comparing the performance and risk of Mallinckrodt Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
MNK,MNK:US,BBG002BHBHM1,The Medicines Co. Continues to Focus on Pipeline Development,2017-09-22 16:35:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yJ7vXYibVuM/the-medicines-co-continues-to-focus-on-pipeline-development-cm849632,We issued an updated report on The Medicines Company MDCO on Sep 21 Notably the Medicines Co has undertaken a restructuring program to boost shareholder value In fact the company is exploring options for optimizing capital structure and liquidity position by divesting certain non
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Advocates for Comprehensive, Multi-Prong Action Plan to Fight Opioid Abuse and Misuse in the United States",2017-09-22 10:55:00 +0000,https://finance.yahoo.com/news/mallinckrodt-advocates-comprehensive-multi-prong-105500975.html?.tsrc=rss,"ST. LOUIS, Sept. 22, 2017 /PRNewswire/ -- Mallinckrodt plc (MNK), an industry leader in the effort to address prescription drug diversion and misuse in the United States, today outlined its ""Prescription for America's Opioid Epidemic"" – six integrated policy initiatives that the company believes, if implemented, would significantly advance the fight against prescription drug abuse and misuse, and make measurable positive contributions to fight the country's current opioid epidemic.  ""As an industry pioneer in addressing the problem of prescription drug diversion and misuse and a strong and constant partner to those focused on addressing the problems of drug abuse, Mallinckrodt has developed a unique perspective on potential policy solutions to address the significant problem facing rural areas, towns and cities in virtually every state in the Union."
MNK,MNK:US,BBG002BHBHM1,See what the IHS Markit Score report has to say about Mallinckrodt Plc.,2017-09-21 12:02:13 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120215452.html?.tsrc=rss,Short interest is moderately high for MNK with between 10 and 15% of shares outstanding currently on loan.  This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on August 24.  ETFs that hold MNK had net inflows of $5.58 billion over the last one-month.
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Announces Election Of David Norton To Its Board Of Directors,2017-09-20 10:00:00 +0000,https://finance.yahoo.com/news/mallinckrodt-announces-election-david-norton-100000958.html?.tsrc=rss,"STAINES-UPON-THAMES, United Kingdom, Sept. 20, 2017 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (MNK), a leading global specialty pharmaceutical company, announced today the election of David Norton to the company's Board of Directors, effective immediately.  Mr. Norton, who has more than 30 years of experience in the biopharmaceutical industry, will serve as an independent director on the board's Human Resources and Compensation Committee and Portfolio Committee."
MNK,MNK:US,BBG002BHBHM1,Interesting MNK Put And Call Options For November 17th,2017-09-19 17:39:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-09ERXLS9Qg/interesting-mnk-put-and-call-options-for-november-17th-cm847895,Investors in Mallinckrodt plc Symbol MNK saw new options begin trading this week for the November 17th expiration At Stock Options Channel our YieldBoost formula has looked up and down the MNK options chain for the new November 17th contracts and identified one put and one call contract
MNK,MNK:US,BBG002BHBHM1,"ETFs with exposure to Mallinckrodt Plc : September 14, 2017",2017-09-14 22:37:37 +0000,http://finance.yahoo.com/r/55ea4179-71d2-38f3-8f38-7f7bef9685d1/etfs-with-exposure-to-mallinckrodt-plc-september-14-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Mallinckrodt Plc Here are 5 ETFs with the largest exposure to MNK-US. Comparing the performance and risk of Mallinckrodt Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
MNK,MNK:US,BBG002BHBHM1,"Noteworthy Thursday Option Activity: MNK, FDX, UNFI",2017-09-14 21:37:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TojUjVpXLdw/noteworthy-thursday-option-activity-mnk-fdx-unfi-cm845985,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Mallinckrodt plc Symbol MNK where a total of 11 982 contracts have traded so far representing approximately 1 2 million underlying shares That amounts to about 48 5 of MNK s
MNK,MNK:US,BBG002BHBHM1,See what the IHS Markit Score report has to say about Mallinckrodt Plc.,2017-09-14 12:01:52 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120152576.html?.tsrc=rss,Mallinckrodt Plc NYSE:MNK
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Plc :MNK-US: Earnings Analysis: Q3, 2017 By the Numbers : September 13, 2017",2017-09-13 15:47:58 +0000,http://finance.yahoo.com/r/49640f4b-2172-3024-87e3-f06636f4c7c5/mallinckrodt-plc-mnk-us-earnings-analysis-q3-2017-by-the-numbers-september-13-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Mallinckrodt Plc reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Mallinckrodt Plc – Johnson & Johnson, Mylan N.V., Zogenix, Inc., Depomed, Inc., Teva Pharmaceutical Industries Limited Sponsored ADR and General Electric Company (JNJ-US, MYL-US, ZGNX-US, DEPO-US, TEVA-US and GE-US) ... Read more
<b>(Read more...)</b>"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Firmly In The Red On Downgrade By Mizuho Securities,2017-09-13 14:33:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I9R6QpBdfvc/mallinckrodt-firmly-in-the-red-on-downgrade-by-mizuho-securities-20170913-01015,Mallinckrodt Firmly In The Red On Downgrade By Mizuho Securities
MNK,MNK:US,BBG002BHBHM1,"Early movers: DIS, JWN, AAL, AGN, CNC, TEX, MU, MNK & more",2017-09-13 11:43:57 +0000,http://finance.yahoo.com/r/0f617996-1599-31a4-b7ef-5ccc7b182f83/104707085?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104707085&yptr=yahoo&.tsrc=rss,These are the stocks posting the largest moves before the bell.
MNK,MNK:US,BBG002BHBHM1,The most respected medical journal in the US just eviscerated a drug that's cost taxpayers over $1 billion,2017-09-12 14:29:05 +0000,https://finance.yahoo.com/news/most-respected-medical-journal-us-142905444.html?.tsrc=rss,A new study published by JAMA Internal Medicine poses a really important question to lawmakers...
MNK,MNK:US,BBG002BHBHM1,See what the IHS Markit Score report has to say about Mallinckrodt Plc.,2017-09-11 12:02:36 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120236951.html?.tsrc=rss,Mallinckrodt Plc NYSE:MNK
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Enters Oversold Territory (MNK),2017-09-07 21:51:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y7hFtXSVpq8/mallinckrodt-enters-oversold-territory-mnk-cm842615,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
MNK,MNK:US,BBG002BHBHM1,"A furious employee is suing drugmaker Mallinckrodt over claims about its $38,000-a-dose blockbuster",2017-09-07 16:35:00 +0000,https://finance.yahoo.com/news/furious-employee-suing-drugmaker-mallinckrodt-163500070.html?.tsrc=rss,"The legal challenges at Mallinckrodt, the drugmaker Wall Street loves to hate, are piling up..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt To Present At Wells Fargo Conference; Webcast At 8:50 AM ET,2017-09-07 07:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bpXK1KtMeAg/mallinckrodt-to-present-at-wells-fargo-conference-webcast-at-850-am-et-20170907-00453,Mallinckrodt To Present At Wells Fargo Conference; Webcast At 8:50 AM ET
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Down as District Court Invalidates Inomax Patents,2017-09-07 00:48:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ywfTNC0BLCY/mallinckrodt-down-as-district-court-invalidates-inomax-patents-cm841992,Shares of Mallinckrodt plc MNK were down 12 3 after a U S District Court invalidated 11 patents covering its second largest product Inomax per a Reuters report 160 Moreover Mallinckrodt s stock price has declined 28 7 year to date compared with the industry s fall of 19 5
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Down as District Court Invalidates Inomax Patents,2017-09-06 22:20:10 +0000,https://finance.yahoo.com/news/mallinckrodt-down-district-court-invalidates-222010084.html?.tsrc=rss,Shares of Mallinckrodt plc (MNK) were down 12.3% after a U.S. District Court invalidated 11 patents covering its second-largest product Inomax.
MNK,MNK:US,BBG002BHBHM1,"Why Mallinckrodt, Universal Insurance Holdings, and Cellectis Slumped Today",2017-09-05 22:50:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vDOig7tlFaM/why-mallinckrodt-universal-insurance-holdings-and-cellectis-slumped-today-cm841286,Tuesday was not a good day on Wall Street as the major market indexes closed with losses of in the neighborhood of 1 Uncertainties surrounding North Korea continued to dominate investors attention around the world especially as comments from leaders in Russia and China showed
MNK,MNK:US,BBG002BHBHM1,What's Behind Mallinckrodt's 12.2% Tumble Today,2017-09-05 21:50:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tRlwW45kx0s/whats-behind-mallinckrodts-122-tumble-today-cm841250,What happened Growing concern that generic alternatives to one of its best selling drugs could threaten future sales and that an investigation into the marketing of opioid pain medication could create headwinds sent shares in 160 Mallinckrodt NYSE MNK tumbling 12 3
MNK,MNK:US,BBG002BHBHM1,Why Mallinckrodt Got Crushed,2017-09-05 20:51:00 +0000,http://finance.yahoo.com/r/535698df-4533-3417-a18e-18a77afa2bdf/why-mallinckrodt-got-crushed-1504644691?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"It was a down day for the stock market.  The selloff by the Dow Industrials notwithstanding, Mallinckrodt (MNK) got manhandled after losing its bid to block Praxair (PX)  from marketing a generic version of  the respiratory treatment Inomax.  The court ruled invalidated Mallinckrodt’s patents, and sent the stock plunging more than 12.2% to end the day at $36.12 a share."
MNK,MNK:US,BBG002BHBHM1,"Why Mallinckrodt, Universal Insurance Holdings, and Cellectis Slumped Today",2017-09-05 20:47:00 +0000,http://finance.yahoo.com/r/0f95a246-daf5-36d9-9bfd-fd4f3e3fc0f2/why-mallinckrodt-universal-insurance-holdings-and.aspx?yptr=yahoo&.tsrc=rss,"On a day when markets in general headed lower on macro-level fears, these shares lead the way down due to more company-specific issues."
MNK,MNK:US,BBG002BHBHM1,What&apos;s Behind Mallinckrodt&apos;s 12.2% Tumble Today,2017-09-05 20:45:00 +0000,http://finance.yahoo.com/r/134440df-34ba-38cf-adce-d7a5ad354ed8/whats-behind-mallinckrodts-122-tumble-today.aspx?yptr=yahoo&.tsrc=rss,Courts dealt the company a setback today on one of its best-selling drugs.
MNK,MNK:US,BBG002BHBHM1,"Health Care Sector Update for 09/05/2017: MNK,INSM,CLLS",2017-09-05 20:29:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zy4Zt9J9Fb8/health-care-sector-update-for-09052017-mnkinsmclls-cm841238,Top Health Care StocksTop Health Care Stocks JNJ 0 92 JNJ 0 92 PFE 0 46 PFE 0 46 ABT 0 37 ABT 0 37 MRK 0 37 MRK 0 37 AMGN 1 20 AMGN 1 20 Health care stocks have slowed their prior slide with the NYSE Health Care Index sinking just under 0 3 while shares of health care companies
MNK,MNK:US,BBG002BHBHM1,Wall Street's most hated pharma company just lost a lifeline,2017-09-05 19:45:45 +0000,https://finance.yahoo.com/news/wall-streets-most-hated-pharma-194545461.html?.tsrc=rss,A federal court in Delaware on Tuesday handed Mallinckrodt Pharmaceuticals a stinging...
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt is getting crushed after a judge invalidated many of its patents,2017-09-05 17:10:11 +0000,https://finance.yahoo.com/news/mallinckrodt-getting-crushed-judge-invalidated-171011263.html?.tsrc=rss,Shares of pharmaceutical company Mallinckrodt fell as much as 14.55% on Tuesday after a federal...
MNK,MNK:US,BBG002BHBHM1,The Stock Market Gets Smashed -- Here Are Some Terrible Performers,2017-09-05 17:05:00 +0000,http://finance.yahoo.com/r/14232608-d2bc-31b6-9c49-1233c842c11e/market-s-biggest-losers-tuesday-mnk-kb-tecd-utx.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"The Dow, Nasdaq and S&P were all in the red Tuesday."
MNK,MNK:US,BBG002BHBHM1,U.S. judge invalidates Mallinckrodt patents on respiratory treatment,2017-09-05 15:17:25 +0000,https://finance.yahoo.com/news/u-judge-invalidates-mallinckrodt-patents-151725106.html?.tsrc=rss,A federal court in Delaware on Tuesday invalidated patents held by Mallinckrodt Pharmaceuticals on its Inomax respiratory treatment system. The ruling came in a lawsuit brought by Mallinckrodt against ...
MNK,MNK:US,BBG002BHBHM1,"Stull, Stull & Brody Reminds Investors of Class Action Lawsuit on Behalf of Employee Benefit Plan Purchasers of Mallinckrodt plc Stock",2017-09-01 23:00:00 +0000,https://finance.yahoo.com/news/stull-stull-brody-reminds-investors-230000074.html?.tsrc=rss,"NEW YORK, Sept. 01, 2017-- Stull, Stull & Brody reminds investors that a class action lawsuit was commenced in the United States District Court for the Eastern District of Missouri on behalf of purchasers ..."
MNK,MNK:US,BBG002BHBHM1,See what the IHS Markit Score report has to say about Mallinckrodt Plc.,2017-08-24 12:02:59 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120259266.html?.tsrc=rss,Mallinckrodt Plc NYSE:MNK
MNK,MNK:US,BBG002BHBHM1,See what the IHS Markit Score report has to say about Mallinckrodt Plc.,2017-08-23 12:02:05 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120205033.html?.tsrc=rss,Short interest is moderately high for MNK with between 10 and 15% of shares outstanding currently on loan.  The net inflows of $2.83 billion over the last one-month into ETFs that hold MNK are among the lowest of the last year and appear to be slowing.
MNK,MNK:US,BBG002BHBHM1,Morningstar Runs the Numbers,2017-08-19 10:00:00 +0000,http://finance.yahoo.com/r/02997cc8-8fe7-319a-8ca5-47f09d28973a/article.aspx?id=822476&SR=Yahoo&yptr=yahoo&.tsrc=rss,"We take a numerical look through this week's Morningstar research. Plus, our most popular articles and videos for the week ended Aug. 18."
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Plc – Value Analysis (NYSE:MNK) : August 17, 2017",2017-08-17 01:34:42 +0000,http://finance.yahoo.com/r/d38f9695-b69f-3614-bc90-b8818f90fe57/mallinckrodt-plc-value-analysis-nysemnk-august-17-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Mallinckrodt Plc a score of 50. Our analysis is based on comparing Mallinckrodt Plc with the following peers – Johnson & Johnson, Mylan N.V., Zogenix, Inc., Depomed, Inc., Teva Pharmaceutical Industries Limited Sponsored ADR and General Electric Company (JNJ-US, MYL-US, ZGNX-US, DEPO-US, TEVA-US and GE-US). Investment Outlook ... Read more
<b>(Read more...)</b>"
MNK,MNK:US,BBG002BHBHM1,Analyst: Mallinckrodt Stock Is Undervalued,2017-08-16 19:24:53 +0000,https://finance.yahoo.com/news/analyst-mallinckrodt-stock-undervalued-192453099.html?.tsrc=rss,"Following the investor meeting with the Mallinckrodt PLC (NYSE: MNK ) management, BMO Capital Markets analyst Gary Nachman said the shares of the company are undervalued. BMO Capital Markets reiterated ..."
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt (MNK) Looks Strong on Acthar, Generics Weak",2017-08-15 15:41:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QRYUCHkQiDU/mallinckrodt-mnk-looks-strong-on-acthar-generics-weak-cm832198,We issued an updated report on Mallinckrodt plc MNK on Aug 14 Mallinckrodt develops manufactures markets and distributes branded and generic specialty pharmaceutical and biopharmaceutical products and therapies as well as nuclear medicine products The company has been undertaking
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt (MNK) Looks Strong on Acthar, Generics Weak",2017-08-15 13:52:01 +0000,https://finance.yahoo.com/news/mallinckrodt-mnk-looks-strong-acthar-135201345.html?.tsrc=rss,Mallinckrodt undertaking strategic acquisitions and divestitures to evolve as a high-performing specialty pharmaceutical company.
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt To Present At Morgan Stanley 15th Annual Global Healthcare Conference,2017-08-15 11:45:00 +0000,https://finance.yahoo.com/news/mallinckrodt-present-morgan-stanley-15th-114500226.html?.tsrc=rss,"STAINES-UPON-THAMES, United Kingdom , Aug. 15, 2017 /PRNewswire/ --  Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Tuesday, Sept. 12, 2017 ..."
MNK,MNK:US,BBG002BHBHM1,See what the IHS Markit Score report has to say about Mallinckrodt Plc.,2017-08-14 12:02:22 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120222392.html?.tsrc=rss,Mallinckrodt Plc NYSE:MNK
MNK,MNK:US,BBG002BHBHM1,Edited Transcript of MNK earnings conference call or presentation 8-Aug-17 12:30pm GMT,2017-08-13 12:00:50 +0000,https://finance.yahoo.com/news/edited-transcript-mnk-earnings-conference-181351190.html?.tsrc=rss,Q2 2017 Mallinckrodt Plc Earnings Call
MNK,MNK:US,BBG002BHBHM1,Morningstar Runs the Numbers,2017-08-12 10:00:00 +0000,http://finance.yahoo.com/r/e464044f-3a40-3e77-8292-95f7f90828d1/article.aspx?id=821034&SR=Yahoo&yptr=yahoo&.tsrc=rss,"We take a numerical look through this week's Morningstar research. Plus, our most popular articles and videos for the week ended Aug. 11."
MNK,MNK:US,BBG002BHBHM1,See what the IHS Markit Score report has to say about Mallinckrodt Plc.,2017-08-10 12:04:15 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120415871.html?.tsrc=rss,Short interest is moderate for MNK with between 5 and 10% of shares outstanding currently on loan.  The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  ETFs that hold MNK have been in favor over the last one-month with net inflows of $6.55 billion.
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Was the S&P 500’s Biggest Loser on August 8,2017-08-09 14:39:16 +0000,http://finance.yahoo.com/r/bce092da-a33a-3d93-b4ec-b6d0a657fbf2/mallinckrodt-plc-biggest-loser-sp-500-august-8?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Mallinckrodt was the S&P 500's biggest loser on August 8. Mallinckrodt fell on Tuesday after its mixed quarterly earnings report.
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt beats 2Q profit forecasts,2017-08-09 01:51:16 +0000,https://finance.yahoo.com/news/mallinckrodt-beats-2q-profit-forecasts-102647576.html?.tsrc=rss,"On a per-share basis, the Surrey, Britain-based company said it had net income of 64 cents. Earnings, adjusted for one-time gains and costs, were $1.85 per share. The results exceeded Wall Street expectations. ..."
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt (MNK) Tops Q2 Earnings, Generics Segment Weak",2017-08-08 19:36:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yGT4pTAfOJQ/mallinckrodt-mnk-tops-q2-earnings-generics-segment-weak-cm828979,Mallinckrodt Public Limited Company MNK reported second quarter 2017 results wherein earnings beat expectations but sales missed the same The company reported adjusted earnings of 1 85 per share in the reported quarter beating the Zacks Consensus Estimate of 1 73 Earnings were however
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt (MNK) Tops Q2 Earnings, Generics Segment Weak",2017-08-08 17:50:05 +0000,https://finance.yahoo.com/news/mallinckrodt-mnk-tops-q2-earnings-175005634.html?.tsrc=rss,Mallinckrodt Public Limited Company (MNK) reported second-quarter 2017 results wherein earnings beat expectations but sales missed the same.
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Becomes Oversold (MNK),2017-08-08 17:37:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I44OViUn1g0/mallinckrodt-becomes-oversold-mnk-cm828914,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
MNK,MNK:US,BBG002BHBHM1,It's been a hideous morning for Wall Street's most hated pharma stock,2017-08-08 14:40:51 +0000,https://finance.yahoo.com/news/hideous-morning-wall-streets-most-144051662.html?.tsrc=rss,Mallinckrodt Pharmaceuticals plunged more than 7% on Tuesday after reporting a Q2 earnings miss...
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt (MNK) Tops Q2 Earnings, Misses on Sales",2017-08-08 12:37:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zPKcIUveN_E/mallinckrodt-mnk-tops-q2-earnings-misses-on-sales-cm828516,Ireland based Mallinckrodt Public Limited Company MNK focuses on developing treatments for autoimmune and rare diseases including neurology rheumatology nephrology and pulmonology as well as therapies for pain management The company develops manufactures markets and distributes
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt (MNK) Tops Q2 Earnings, Misses on Sales",2017-08-08 10:38:10 +0000,https://finance.yahoo.com/news/mallinckrodt-mnk-tops-q2-earnings-103810392.html?.tsrc=rss,Mallinckrodt plc (MNK) beat earnings estimates in the second quarter but sales fell short due to weakness in generics segment.
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt plc Reports Earnings Results for Second Quarter of Fiscal 2017,2017-08-08 10:00:00 +0000,https://finance.yahoo.com/news/mallinckrodt-plc-reports-earnings-results-100000830.html?.tsrc=rss,"-- Net sales of $824.5 million -- -- Specialty Brands segment net sales increased 0.9%, 1.2% on a constant-currency basis -- -- Specialty Generics segment net sales decreased 18.0%, 17.8% on a constant-currency ..."
MNK,MNK:US,BBG002BHBHM1,Investor Network: Mallinckrodt Plc to Host Earnings Call,2017-08-08 09:30:00 +0000,https://finance.yahoo.com/news/investor-network-mallinckrodt-plc-host-093000609.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 8, 2017 / Mallinckrodt Plc (NYSE: MNK) will be discussing their earnings results in their Q2 Earnings Call to be held on Tuesday, August 08, 2017 at 8:30 AM Eastern Time. ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Q2 Profit Down; Backs 2017 Adj. EPS View,2017-08-08 06:32:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OlsawyG5l_E/mallinckrodt-q2-profit-down-backs-2017-adj-eps-view-20170808-00324,Mallinckrodt Q2 Profit Down; Backs 2017 Adj. EPS View
MNK,MNK:US,BBG002BHBHM1,"Multnomah County seeks $250M from Purdue, other opioid manufacturers",2017-08-07 21:06:57 +0000,http://finance.yahoo.com/r/3e9ee5a3-16fc-3050-b356-0d989770a88c/multnomah-county-seeks-250m-from-purdue-other.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Multnomah County is the latest local government to sue Purdue Pharma and 22 other opioid manufacturers.  The suit, which seeks $250 million in damages, was filed late last week, days after the Multnomah County Board of Commissioners declared the oversupply of prescription opioids a public nuisance.  “As a matter of common sense and medical evidence, long-term use of opioids — drugs that can kill you or commit you to a lifetime of addictions — does not improve function or quality of life,” the 118-page complaint filed in Multnomah County Circuit Court reads."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt To Present At Wells Fargo Securities 2017 Healthcare Conference,2017-08-07 20:45:00 +0000,https://finance.yahoo.com/news/mallinckrodt-present-wells-fargo-securities-204500992.html?.tsrc=rss,"STAINES-UPON-THAMES, United Kingdom , Aug. 7, 2017 /PRNewswire/ --  Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Thursday, Sept. 7, 2017 ..."
MNK,MNK:US,BBG002BHBHM1,"Drug Stocks Q2 Earnings Roster for Aug 8: ACAD, JAZZ & More",2017-08-07 14:32:02 +0000,https://finance.yahoo.com/news/drug-stocks-q2-earnings-roster-143202883.html?.tsrc=rss,A look at the pharma/biotech companies that are set to report second-quarter results on Aug 8.
MNK,MNK:US,BBG002BHBHM1,Corporate News Blog - Mallinckrodt to Acquire InfaCare Pharmaceutical and its Developmental Product Stannsoporfin,2017-08-07 11:00:00 +0000,https://finance.yahoo.com/news/corporate-news-blog-mallinckrodt-acquire-110000683.html?.tsrc=rss,"Research Desk Line-up: Allergan Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 7, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Mallinckrodt ..."
MNK,MNK:US,BBG002BHBHM1,"AQB Reaps A Bounty, CLSN Ends Dual Listing, MNK Opens Wallet, OMER On Watch",2017-08-07 01:08:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1GgCEbzbk_4/aqb-reaps-a-bounty-clsn-ends-dual-listing-mnk-opens-wallet-omer-on-watch-20170807-00010,"AQB Reaps A Bounty, CLSN Ends Dual Listing, MNK Opens Wallet, OMER On Watch"
MNK,MNK:US,BBG002BHBHM1,Why Mallinckrodt (MNK) Might Surprise This Earnings Season,2017-08-04 14:03:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b9Zi8sM64JQ/why-mallinckrodt-mnk-might-surprise-this-earnings-season-cm827201,Investors are always looking for stocks that are poised to beat at earnings season and Mallinckrodt plc MNK may be one such company The firm has earnings coming up pretty soon and events are shaping up quite nicely for their report That is because Mallinckrodt is seeing favorable
MNK,MNK:US,BBG002BHBHM1,Why Mallinckrodt (MNK) Might Surprise This Earnings Season,2017-08-04 12:37:12 +0000,https://finance.yahoo.com/news/why-mallinckrodt-mnk-might-surprise-123712120.html?.tsrc=rss,Mallinckrodt (MNK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt To Acquire InfaCare Pharmaceutical Corporation And Stannsoporfin, Its Proprietary Therapy In Late-Stage Development For Treatment Of Newborns At Risk For Developing Severe Jaundice",2017-08-04 11:00:00 +0000,https://finance.yahoo.com/news/mallinckrodt-acquire-infacare-pharmaceutical-corporation-110000828.html?.tsrc=rss,"STAINES-UPON-THAMES, United Kingdom, Aug. 4, 2017 /PR Newswire/ -- Mallinckrodt plc (MNK), a leading global specialty pharmaceutical company, and InfaCare Pharmaceutical Corporation today announced that they have entered into an agreement under which Mallinckrodt will acquire InfaCare, a privately held specialty pharmaceutical company focused on development and commercialization of proprietary pharmaceuticals for neonatal and pediatric patient populations.  InfaCare's developmental product stannsoporfin, a heme oxygenase inhibitor, is under investigation for its potential to reduce the production of bilirubin, the elevation of which can contribute to serious consequences in infants."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt To Buy InfaCare - Quick Facts,2017-08-04 07:11:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9tzZtlHpru8/mallinckrodt-to-buy-infacare--quick-facts-20170804-00313,Mallinckrodt To Buy InfaCare - Quick Facts
MNK,MNK:US,BBG002BHBHM1,Teva and 3D Systems slide while Kellogg and Tesla jump,2017-08-03 20:31:51 +0000,https://finance.yahoo.com/news/teva-3d-systems-slide-while-203151062.html?.tsrc=rss,"Stocks that moved substantially or traded heavily on Thursday: Kellogg Co., up $2.92 to $70.36 The maker of Frosted Flakes, Pop Tarts and Eggo waffles said sales fell, but not as much as analysts expected. ..."
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Plc breached its 50 day moving average in a Bearish Manner : MNK-US : August 3, 2017",2017-08-03 13:51:28 +0000,http://finance.yahoo.com/r/4c535ec7-3e36-3a5a-bb46-5670d01702e9/mallinckrodt-plc-breached-its-50-day-moving-average-in-a-bearish-manner-mnk-us-august-3-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Mallinckrodt Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more
<b>(Read more...)</b>"
MNK,MNK:US,BBG002BHBHM1,Can Mallinckrodt (MNK) Deliver a Beat this Earnings Season?,2017-08-01 14:59:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/09JJrkWojsw/can-mallinckrodt-mnk-deliver-a-beat-this-earnings-season-cm825022,Mallinckrodt plc MNK is set to report second quarter 2017 results on Aug 8 Mallinckrodt has delivered an average positive earnings surprise of 5 27 for the four trailing quarters Let s see how things are shaping up for this announcement Mallinckrodt PLC Price and EPS
MNK,MNK:US,BBG002BHBHM1,Can Mallinckrodt (MNK) Deliver a Beat this Earnings Season?,2017-08-01 13:21:01 +0000,https://finance.yahoo.com/news/mallinckrodt-mnk-deliver-beat-earnings-132101779.html?.tsrc=rss,Investor focus is likely to be on Mallinckrodt plc&apos;s (MNK) progress with its strategic acquisitions and pipeline updates.
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Enrolls First Patient In Phase 4 Registry Of INOMAX® (Nitric Oxide) Gas For Inhalation For Pulmonary Hypertension In Neonates,2017-08-01 11:45:00 +0000,https://finance.yahoo.com/news/mallinckrodt-enrolls-first-patient-phase-114500240.html?.tsrc=rss,"-- Observational Registry With Retrospective Data Collection Designed to Evaluate Premature Versus Term and Near-Term Neonates with Pulmonary Hypertension Receiving Inhaled Nitric Oxide -- STAINES-UPON-THAMES, ..."
MNK,MNK:US,BBG002BHBHM1,Is a Surprise in the Cards for Teva (TEVA) in Q2 Earnings?,2017-07-31 16:57:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/skGl8UOq5L0/is-a-surprise-in-the-cards-for-teva-teva-in-q2-earnings-cm824347,Teva Pharmaceutical Industries Ltd TEVA will be reporting second quarter 2017 earnings on Aug 3 before the market opens Last quarter the company delivered in line earnings This generic drug maker s shares have lost 10 8 so far this year while the industry witnessed an increase of 0
MNK,MNK:US,BBG002BHBHM1,Allergan (AGN) to Report Q2 Earnings: What's in the Cards?,2017-07-31 16:56:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GRMxqv27mGg/allergan-agn-to-report-q2-earnings-whats-in-the-cards-cm824328,Allergan plc AGN will be reporting second quarter 2017 earnings on Aug 3 before the market opens Last quarter the company delivered a positive earnings surprise of 0 90 Allergan s share price is up 20 5 this year so far outperforming the 0 4 increase witnessed by the
MNK,MNK:US,BBG002BHBHM1,Allergan (AGN) to Report Q2 Earnings: What&apos;s in the Cards?,2017-07-31 14:48:02 +0000,https://finance.yahoo.com/news/allergan-agn-report-q2-earnings-144802846.html?.tsrc=rss,"While Allergan plc&apos;s (AGN) Q2 sales are likely to be driven by new as well as established products and international growth, earnings will likely be driven by sales growth and cost control."
MNK,MNK:US,BBG002BHBHM1,Summary Review of Clinical and Economic Data on H.P. Acthar® Gel (Repository Corticotropin Injection) Published in Advances in Therapy,2017-07-31 11:45:00 +0000,https://finance.yahoo.com/news/summary-review-clinical-economic-data-114500310.html?.tsrc=rss,"STAINES-UPON-THAMES, England, July 31, 2017 /PRNewswire/ -- Mallinckrodt plc (MNK), a leading global specialty pharmaceutical company, announced the publication of a company-initiated literature review of clinical and economic data on H.P. Acthar® Gel (repository corticotropin injection) across seven autoimmune and inflammatory disorders – all approved indications for the product.  The evidence supported the use of H.P. Acthar Gel across the indications reviewed, pointing to a reduced need for background medications and lower post-therapy healthcare utilization and medical costs."
MNK,MNK:US,BBG002BHBHM1,McCaskill expands opioid probe to include Mallinckrodt,2017-07-28 12:45:10 +0000,http://finance.yahoo.com/r/f6edfda6-60cd-3d90-b087-70ed0648a3b9/mccaskill-expands-opioid-probe-to-include.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Sen. Claire McCaskill has expanded her investigation into the opioid addiction epidemic, requesting information from four additional drug manufacturers including Mallinckrodt LLC.  McCaskill sent a letter to the four companies requesting information about the distribution of opioids and the efforts the companies have made to monitor the diversion of drugs into the black market.  In addition to Mallinckrodt, letters were sent to Endo International, Teva Pharmaceutical Industries Ltd. and Allergan PLC. The senator also requested information from opioid distributors McKesson Corp., Amerisource Bergen Corp. and Cardinal Health Inc."
MNK,MNK:US,BBG002BHBHM1,"Stull, Stull & Brody Announces Class Action Lawsuit on Behalf of Employee Benefit Plan Purchasers of Mallinckrodt plc Stock",2017-07-26 22:30:00 +0000,https://finance.yahoo.com/news/stull-stull-brody-announces-class-223000899.html?.tsrc=rss,"NEW YORK, July 26, 2017-- Stull, Stull & Brody announces that a class action lawsuit was commenced in the United States District Court for the Eastern District of Missouri on behalf of purchasers of stock ..."
MNK,MNK:US,BBG002BHBHM1,"Energy Sector Update for 07/25/2017: MUR,SRCI,QEP",2017-07-25 20:18:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TL3pTRxpWxs/energy-sector-update-for-07252017-mursrciqep-cm821205,Top Energy StocksTop Energy Stocks XOM 0 78 XOM 0 78 CVX 1 57 CVX 1 57 COP 2 86 COP 2 86 SLB 1 23 SLB 1 23 OXY 2 98 OXY 2 98 Energy stocks were ending sharply higher today with the NYSE Energy Sector Index rising over 1 5 while shares of energy companies in the S amp P 500 were
MNK,MNK:US,BBG002BHBHM1,Cramer's lightning round: Get ready for a long stay in th...,2017-07-24 23:08:00 +0000,https://finance.yahoo.com/video/cramers-lightning-round-ready-long-230800892.html?.tsrc=rss,"Jim Cramer rattles off his take on callers' favorite stocks, including one hotel and resort conglomerate."
MNK,MNK:US,BBG002BHBHM1,Cramer's lightning round: Get ready for a long stay in this vacation stock,2017-07-24 22:52:02 +0000,http://finance.yahoo.com/r/8b56a6a4-8416-30ff-be35-44d8069a9f3e/104605072?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104605072&yptr=yahoo&.tsrc=rss,"Jim Cramer rattles off his take on callers' favorite stocks, including one hotel and resort conglomerate."
MNK,MNK:US,BBG002BHBHM1,Cramer&apos;s lightning round: Get ready for a long stay in this vacation stock,2017-07-24 22:52:02 +0000,https://finance.yahoo.com/news/cramer-apos-lightning-round-ready-225202117.html?.tsrc=rss,"Jim Cramer rattles off his take on callers&apos; favorite stocks, including one hotel and resort conglomerate."
MNK,MNK:US,BBG002BHBHM1,"ETFs with exposure to Mallinckrodt Plc : July 24, 2017",2017-07-24 21:19:55 +0000,http://finance.yahoo.com/r/02230604-c73c-38eb-b4a8-53cddd869dfc/etfs-with-exposure-to-mallinckrodt-plc-july-24-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Mallinckrodt Plc Here are 5 ETFs with the largest exposure to MNK-US. Comparing the performance and risk of Mallinckrodt Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt triples its spending on lobbying,2017-07-21 12:15:07 +0000,http://finance.yahoo.com/r/4600d424-c07c-38a6-ad83-8f4f3565e31d/mallinckrodt-triples-its-spending-on-lobbying.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Mallinckrodt PLC spent $610,000 lobbying Congress in the first quarter of 2017, triple the amount the pharmaceutical firm spent on lobbying in 2015's first quarter.  The company's political action committee also has increased its contributions to congressional campaigns, donating $44,000 to lawmakers in the House and Senate in the first quarter, up nearly nine times from 2015, the New York Times reports.  Companies across the pharmaceutical industry have been increasing campaign donations and lobbying spending this year, according to data from Kaiser Health News."
MNK,MNK:US,BBG002BHBHM1,The Highs and Lows for Fallen S&P 500 Stocks,2017-07-20 19:05:45 +0000,http://finance.yahoo.com/r/ec6e72a8-0e35-3b10-9b5f-d4d373079ad8/the-highs-and-lows-for-fallen-s-p-500-stocks-1500577543?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,How the mighty have fallen.
MNK,MNK:US,BBG002BHBHM1,"MGM Resorts, ResMed, Packaging Corporation of America, A.O. Smith and Duke Realty Set to Join S&P 500; Others to Join S&P MidCap 400",2017-07-19 21:49:00 +0000,https://finance.yahoo.com/news/mgm-resorts-resmed-packaging-corporation-214900312.html?.tsrc=rss,"NEW YORK , July 19, 2017 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500 and S&P MidCap 400 indices effective prior to the open of trading on Wednesday, July 26 : MGM ..."
MNK,MNK:US,BBG002BHBHM1,U.S. FDA Designates Mallinckrodt's StrataGraft® as Regenerative Medicine Advanced Therapy,2017-07-18 11:00:00 +0000,https://finance.yahoo.com/news/u-fda-designates-mallinckrodts-stratagraft-110000651.html?.tsrc=rss,"STAINES-UPON-THAMES, United Kingdom, July 18, 2017 /PRNewswire/ -- Mallinckrodt plc (MNK), a leading global specialty pharmaceutical company, today announced that StrataGraft® regenerative skin tissue is among the first products to be designated as a Regenerative Medicine Advanced Therapy (RMAT) by the U.S. Food and Drug Administration (FDA) under the provisions of the 21st Century Cures Act."
MNK,MNK:US,BBG002BHBHM1,"S&P 500 Movers: NRG, FCX",2017-07-17 15:48:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Xd9Bs8NPCZI/sp-500-movers-nrg-fcx-cm816869,In early trading on Monday shares of Freeport McMoran Copper amp Gold topped the list of the day s best performing components of the S amp P 500 index trading up 2 9 Year to date Freeport McMoran Copper amp Gold has lost about 1 7 of its value And the worst performing S amp P
MNK,MNK:US,BBG002BHBHM1,Valeant Unloads Yet Another Unit,2017-07-17 15:30:00 +0000,http://finance.yahoo.com/r/341b0be9-5e6f-31eb-be40-2fa9c3ae61c7/valeant-pharmaceuticals-the-fire-sale-continues-1500305414?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of Valeant Pharmaceuticals International (VRX) are climbing Monday after the drug maker announced the $190 million sale of Obagi Medical Products to Shonghua Finance Acquisition Fund.  The deal is the latest asset sale by the beleaguered drug maker as it labors to meet its goal of $5 billion in debt reduction by February 2018.  The company has shed its iNova division, as well as cancer treatment maker Dendreon, and sold some skin care lines to L’Oreal, and is throwing the proceeds at its debt load."
MNK,MNK:US,BBG002BHBHM1,"ETFs with exposure to Mallinckrodt Plc : July 14, 2017",2017-07-14 19:37:13 +0000,http://finance.yahoo.com/r/2bded048-dd7d-3a89-9c39-7aff7b966cef/etfs-with-exposure-to-mallinckrodt-plc-july-14-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Mallinckrodt Plc Here are 5 ETFs with the largest exposure to MNK-US. Comparing the performance and risk of Mallinckrodt Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
MNK,MNK:US,BBG002BHBHM1,"FDA Panel Backs 2 Biosimilars, ALDR Abuzz, MDXG Q2 Revenue Grows 33%",2017-07-14 02:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7aTL7pt1MeE/fda-panel-backs-2-biosimilars-aldr-abuzz-mdxg-q2-revenue-grows-33-20170714-00061,"FDA Panel Backs 2 Biosimilars, ALDR Abuzz, MDXG Q2 Revenue Grows 33%"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt's MNK-1411 Gets Orphan Drug Status for DMD,2017-07-13 23:46:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ofwTRzDzmxY/mallinckrodts-mnk-1411-gets-orphan-drug-status-for-dmd-cm815916,Mallinckrodt plc MNK announced that the FDA has granted orphan drug designation to its pipeline candidate MNK 1411 which is being evaluated for the treatment of Duchenne muscular dystrophy DMD The candidate has received a Fast Track designation by the FDA for the same indication
MNK,MNK:US,BBG002BHBHM1,InPlay from Briefing.com,2017-07-13 21:51:14 +0000,https://finance.yahoo.com/news/inplay-briefing-com-125529772.html?.tsrc=rss,InPlay from Briefing.com
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt&apos;s MNK-1411 Gets Orphan Drug Status for DMD,2017-07-13 21:47:09 +0000,https://finance.yahoo.com/news/mallinckrodt-apos-mnk-1411-gets-214709827.html?.tsrc=rss,"Mallinckrodt plc (MNK) announced that the FDA has granted orphan drug designation to its pipeline candidate - MNK-1411, which is being evaluated for the treatment of Duchenne muscular dystrophy (DMD)."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Phase 3 Terlipressin Trial Achieves its Enrollment Target Ahead of Schedule,2017-07-13 20:45:00 +0000,https://finance.yahoo.com/news/mallinckrodt-phase-3-terlipressin-trial-204500648.html?.tsrc=rss,"STAINES-UPON-THAMES, United Kingdom, July 13, 2017 /PRNewswire/ -- Mallinckrodt plc (MNK), a leading global specialty pharmaceutical company, today announced it has enrolled the 75th subject in the company's ongoing Phase 3 pivotal trial CONFIRM to evaluate the efficacy and safety of terlipressin (for injection) in subjects with Hepatorenal Syndrome (HRS) type 1.  Phase 3 trial enrollment has been robust and the company has achieved one quarter of its targeted enrollment for this trial aligned with the company's expectations."
MNK,MNK:US,BBG002BHBHM1,"NVS Gets Thumbs Up, Two Biosimilar Candidates To Face FDA Panel, VKTX On Track",2017-07-13 02:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hzBiyLUIVzY/nvs-gets-thumbs-up-two-biosimilar-candidates-to-face-fda-panel-vktx-on-track-20170713-00059,"NVS Gets Thumbs Up, Two Biosimilar Candidates To Face FDA Panel, VKTX On Track"
MNK,MNK:US,BBG002BHBHM1,"After-hours buzz: AMG, MNK & more",2017-07-12 21:40:40 +0000,http://finance.yahoo.com/r/b2a7b104-c800-310d-8ee8-4700d75bbb0f/104582786?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104582786&yptr=yahoo&.tsrc=rss,See which stocks are posting big moves after the bell.
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt gets special FDA status for experimental muscular dystrophy drug,2017-07-12 21:04:42 +0000,http://finance.yahoo.com/r/517e5211-a0af-3a5f-98b2-afdbb6c0e291/Story.aspx?guid=0A8EF15B-08E9-40DF-9979-DB66AD63D80D&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Mallinckrodt PLC shares rose in the extended session Wednesday after the drug maker said the Food and Drug Administration granted a special designation to one of its drugs intended to treat a rare form ...
MNK,MNK:US,BBG002BHBHM1,FDA Grants Orphan Drug Designation to Mallinckrodt Development Product for Potential Treatment of Duchenne Muscular Dystrophy,2017-07-12 20:45:00 +0000,https://finance.yahoo.com/news/fda-grants-orphan-drug-designation-204500198.html?.tsrc=rss,"STAINES-UPON-THAMES, United Kingdom, July 12, 2017 /PRNewswire/ -- Mallinckrodt plc (MNK), a leading specialty pharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to MNK-1411, a long-acting formulation containing cosyntropin acetate under investigation for the treatment of Duchenne muscular dystrophy (DMD).  ""We are pleased the FDA has granted orphan drug status to MNK-1411 for potential treatment of DMD, a serious disease for which there are limited treatment options,"" said Steven Romano, M.D., Executive Vice President and Chief Scientific Officer."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt to Pay $35M for Controlled Substances Probe,2017-07-12 16:48:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jqJiavGeeeE/mallinckrodt-to-pay-35m-for-controlled-substances-probe-cm815133,Mallinckrodt plc MNK recently finalized the agreement which it had reached with the U S Drug Enforcement Administration DEA and the U S Attorneys Offices USAOs for the Eastern District of Michigan and the Northern District of New York The agreement will settle the previously
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt to Pay $35M for Controlled Substances Probe,2017-07-12 14:20:02 +0000,https://finance.yahoo.com/news/mallinckrodt-pay-35m-controlled-substances-142002490.html?.tsrc=rss,Mallinckrodt plc (MNK) recently finalized the agreement which it had reached with the U.S. Drug Enforcement Administration (DEA) and the U.S. Attorneys&apos; Offices (USAOs) for the Eastern District of Michigan and the Northern District of New York.
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt To Pay $35 Mln Fine For Failing To Report Suspicious Order,2017-07-11 21:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/addLJMxYlXU/mallinckrodt-to-pay-35-mln-fine-for-failing-to-report-suspicious-order-20170711-01349,Mallinckrodt To Pay $35 Mln Fine For Failing To Report Suspicious Order
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt settles U.S. opioid drug probe for $35 million,2017-07-11 20:33:47 +0000,https://finance.yahoo.com/news/mallinckrodt-settles-u-opioid-drug-190700166.html?.tsrc=rss,"The deal, in which Mallinckrodt did not admit wrongdoing, marked a record settlement of claims that a drugmaker failed to properly notify the U.S. Drug Enforcement Administration of suspicious orders for drugs such as oxycodone, the Justice Department said.  U.S. Attorney General Jeff Sessions said the settlement will send a message to other drugmakers that the Justice Department will seek to hold them accountable for their actions amid a national opioid addiction epidemic."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Finalizes Previously Announced Agreement with DEA and USAOs,2017-07-11 19:07:00 +0000,https://finance.yahoo.com/news/mallinckrodt-finalizes-previously-announced-agreement-190700586.html?.tsrc=rss,"STAINES-UPON-THAMES, United Kingdom, July 11, 2017 /PRNewswire/ -- Mallinckrodt plc (MNK) confirmed today that it has finalized the agreement reached with the U.S. Drug Enforcement Administration (DEA) and the U.S. Attorneys' Offices (USAOs) for the Eastern District of Michigan and the Northern District of New York, respectively, to settle previously disclosed investigations relating to the company's suspicious order monitoring program, reporting, record keeping and security measures related to manufacturing and distribution of controlled substances.  ""We are proud of the fact that Mallinckrodt has long been an industry leader in actively combatting the serious issue of prescription drug abuse with a demonstrated record of meeting and exceeding the requirements of federal and state laws governing the manufacturing, sale and distribution of controlled substances,"" said Michael-Bryant Hicks, General Counsel, Mallinckrodt."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt settles U.S. opioid drug probe for $35 million,2017-07-11 19:01:43 +0000,https://finance.yahoo.com/news/mallinckrodt-settles-u-opioid-drug-190143866.html?.tsrc=rss,"Mallinckrodt Plc, one of the  largest manufacturers of the generic opioid painkiller  oxycodone, will pay $35 million to resolve allegations that the  company failed to report suspicious drug orders, the U.S.  Justice Department said on Tuesday.  The deal marked a record settlement of claims that a  drugmaker failed to properly notify the U.S. Drug Enforcement  Administration of suspicious orders for drugs such as oxycodone,  the Justice Department said."
MNK,MNK:US,BBG002BHBHM1,"S&P 500 Movers: KORS, WDC",2017-07-11 15:46:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lK7xyh-Noaw/sp-500-movers-kors-wdc-cm814412,In early trading on Tuesday shares of Western Digital WDC topped the list of the day s best performing components of the S amp P 500 index trading up 2 5 Year to date Western Digital registers a 34 6 gain And the worst performing S amp P 500 component thus far on the day
MNK,MNK:US,BBG002BHBHM1,L Brands Was the S&P 500’s Top Loser on July 6,2017-07-07 15:36:32 +0000,http://finance.yahoo.com/r/423cfc90-ba83-3560-8bae-7ed8621b5c33/l-brands-sp-500s-top-loser-june-6?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,L Brands was the top loser in the S&P 500 on Thursday. L Brands fell on July 6 due to weaker-than-expected sales numbers for June.
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Plc breached its 50 day moving average in a Bearish Manner : MNK-US : July 7, 2017",2017-07-07 13:42:16 +0000,http://finance.yahoo.com/r/389cb6e8-863d-331b-aeb5-be0af50fd95c/mallinckrodt-plc-breached-its-50-day-moving-average-in-a-bearish-manner-mnk-us-july-7-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Mallinckrodt Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more
<b>(Read more...)</b>"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Announces Specialty Brands Investor Briefing,2017-07-05 20:30:00 +0000,https://finance.yahoo.com/news/mallinckrodt-announces-specialty-brands-investor-203000850.html?.tsrc=rss,"-- R&D-Focused Event to Highlight Commercial Portfolio and Growing Pipeline -- STAINES-UPON-THAMES, United Kingdom , July 5, 2017 /PRNewswire/ --  Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical ..."
MNK,MNK:US,BBG002BHBHM1,Analyst: Mallinckrodt Investors Seem To Be Pricing In Extreme Issues For Acthar,2017-06-29 15:42:02 +0000,https://finance.yahoo.com/news/analyst-mallinckrodt-investors-seem-pricing-154202126.html?.tsrc=rss,"After completing a sum-of-the-parts analysis, UBS analyst Marc Goodman still sees Mallinckrodt PLC (NYSE: MNK ) as a strong risk/reward play. Goodman maintained his Buy rating and 12-month $70 price target. ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt plc To Report Earnings Results for Second Quarter of Fiscal 2017,2017-06-29 11:30:00 +0000,https://finance.yahoo.com/news/mallinckrodt-plc-report-earnings-results-113000330.html?.tsrc=rss,"STAINES-UPON-THAMES, United Kingdom , June 29, 2017 /PRNewswire/ --  Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, announced today it will report fiscal 2017 second quarter ..."
MNK,MNK:US,BBG002BHBHM1,Health Economic Data on Burden of Hepatorenal Syndrome Published in Current Medical Research and Opinion,2017-06-23 11:30:00 +0000,https://finance.yahoo.com/news/health-economic-data-burden-hepatorenal-113000953.html?.tsrc=rss,"-- Long Hospital Stays, Frequent Medical Visits and Hospital Readmissions Drive Costs, Payer Burden -- STAINES-UPON-THAMES, United Kingdom , June 23, 2017 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), ..."
MNK,MNK:US,BBG002BHBHM1,There's frightening new data on the effects of a blockbuster drug Wall Street loves to hate,2017-06-23 03:22:00 +0000,https://finance.yahoo.com/news/theres-frightening-data-effects-blockbuster-143714761.html?.tsrc=rss,Adverse events for those taking Mallinckrodt Pharmaceuticals' drug Acthar spiked last year...
MNK,MNK:US,BBG002BHBHM1,Andrew Left Predicts Eventual DOJ Prosecution Of Mallinckrodt For Selling HP Acthar Without Proven Efficacy,2017-06-22 16:26:18 +0000,https://finance.yahoo.com/news/andrew-left-predicts-eventual-doj-162618004.html?.tsrc=rss,"In response to Mallinckrodt PLC (NYSE: MNK )’s Thursday report downplaying recent safety and cost concerns for its controversial HP Acthar Gel, Citron Research noted that the company is in “full damage ..."
MNK,MNK:US,BBG002BHBHM1,"S&P 500 Movers: ACN, ORCL",2017-06-22 15:23:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JHSvcQrbUZY/sp-500-movers-acn-orcl-cm806823,In early trading on Thursday shares of Oracle ORCL topped the list of the day s best performing components of the S amp P 500 index trading up 9 2 Year to date Oracle registers a 31 5 gain And the worst performing S amp P 500 component thus far on the day is Accenture
MNK,MNK:US,BBG002BHBHM1,Here's where big oil companies feel the pain of lower crude prices: NYSE trader,2017-06-21 17:52:07 +0000,https://finance.yahoo.com/video/heres-where-big-oil-companies-175207741.html?.tsrc=rss,"Crude oil is now in its 6th bear market in 4 years. If the price falls further, what are the effects on the big global energy companies and the US shale oil companies? Yahoo Finance's Alexis Christoforous is joined by Keith Bliss of Cuttone and Company from the floor of the New York Stock Exchange to discuss."
MNK,MNK:US,BBG002BHBHM1,Drug stocks rally after Trump decides no price controls—yet: NYSE trader,2017-06-21 17:52:07 +0000,https://finance.yahoo.com/video/drug-stocks-rally-trump-decides-175207894.html?.tsrc=rss,"The health care sector is a standout today, despite most other sectors being in the red. Part of it has to do with the Senate health care bill expected to be released Thursday. Part of it is President's executive order on Tuesday on the pharmaceutical sector. Yahoo Finance's Alexis Christoforous is joined by Keith Bliss of Cuttone and Company from the floor of the New York Stock Exchange to discuss."
MNK,MNK:US,BBG002BHBHM1,Check out how the shorts have been piling into Wall Street's most controversial pharma stock,2017-06-20 17:52:59 +0000,https://finance.yahoo.com/news/check-shorts-piling-wall-streets-175259039.html?.tsrc=rss,"Over the last couple of months, Wall Street short sellers have been piling into a drug company..."
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Plc breached its 50 day moving average in a Bullish Manner : MNK-US : June 20, 2017",2017-06-20 12:26:22 +0000,http://finance.yahoo.com/r/aba71122-ccdf-3474-813b-9fb1a5f62276/mallinckrodt-plc-breached-its-50-day-moving-average-in-a-bullish-manner-mnk-us-june-20-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Mallinckrodt Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish 50 ... Read more
<b>(Read more...)</b>"
MNK,MNK:US,BBG002BHBHM1,"ETFs with exposure to Mallinckrodt Plc : June 19, 2017",2017-06-19 19:43:52 +0000,http://finance.yahoo.com/r/f0b9b857-d6d8-36d3-8706-1a1f0004ce2f/etfs-with-exposure-to-mallinckrodt-plc-june-19-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Mallinckrodt Plc Here are 5 ETFs with the largest exposure to MNK-US. Comparing the performance and risk of Mallinckrodt Plc with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
<b>(Read more...)</b>"
MNK,MNK:US,BBG002BHBHM1,Is Mallinckrodt (MNK) a Great Stock for Value Investors?,2017-06-19 15:24:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Yi99o4ky_yY/is-mallinckrodt-mnk-a-great-stock-for-value-investors-cm805036,Value investing is easily one of the most popular ways to find great stocks in any market environment After all who wouldn t want to find stocks that are either flying under the radar and are compelling buys or offer up tantalizing discounts when compared to fair value One way to find
MNK,MNK:US,BBG002BHBHM1,Is Mallinckrodt (MNK) a Great Stock for Value Investors?,2017-06-19 13:30:01 +0000,https://finance.yahoo.com/news/mallinckrodt-mnk-great-stock-value-133001490.html?.tsrc=rss,Value investing is easily one of the most popular ways to find great stocks in any market environment.
MNK,MNK:US,BBG002BHBHM1,A Wall Street investor call revealed part of the secret of why drugs are so expensive,2017-06-19 12:04:36 +0000,https://finance.yahoo.com/news/wall-street-investor-call-revealed-120436311.html?.tsrc=rss,Mallinckrodt Pharmaceuticals is facing scrutiny over the price of its blockbuster drug Acthar...
MNK,MNK:US,BBG002BHBHM1,3 Biotech Stocks That Could Become M&A Targets,2017-06-17 12:20:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fp5gOJQfjGM/3-biotech-stocks-that-could-become-ma-targets-cm804682,Biotech firms Mallinckrodt PLC NYSE MNK Tesaro Inc NASDAQ TSRO and Incyte Corp NASDAQ INCY could all be M amp A targets and if buyers appear for them owning their shares could pay off However these are risky stocks and there s no guarantee that deals
MNK,MNK:US,BBG002BHBHM1,3 Biotech Stocks That Could Become M&A Targets,2017-06-17 10:42:00 +0000,http://finance.yahoo.com/r/42ea15c0-553d-30ff-b63b-10096d826a49/3-biotech-stocks-that-could-become-ma-targets.aspx?yptr=yahoo&.tsrc=rss,"There are reasons to think other drugmakers might see Mallinckrodt, Tesaro, and Incyte as tempting acquisitions, which makes them potential opportunities for risk-tolerant investors."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Initiates Amyotrophic Lateral Sclerosis Study,2017-06-16 22:19:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FE3kzqnkRJU/mallinckrodt-initiates-amyotrophic-lateral-sclerosis-study-cm804612,Mallinckrodt plc MNK announced that it has enrolled the first patient in its phase IIB study PENNANT The study is designed to assess the efficacy and safety of H P Acthar Gel for the treatment of amyotrophic lateral sclerosis ALS The study will enroll patients between ages 18 to 75
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Initiates Amyotrophic Lateral Sclerosis Study,2017-06-16 20:22:08 +0000,https://finance.yahoo.com/news/mallinckrodt-initiates-amyotrophic-lateral-sclerosis-202208122.html?.tsrc=rss,"Mallinckrodt plc (MNK) announced that it has enrolled the first patient in its phase IIB study, PENNANT."
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Plc :MNK-US: Earnings Analysis: Q2, 2017 By the Numbers : June 16, 2017",2017-06-16 16:10:40 +0000,http://finance.yahoo.com/r/49d48db1-98e3-397e-9952-33298d3e9c28/mallinckrodt-plc-mnk-us-earnings-analysis-q2-2017-by-the-numbers-june-16-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Mallinckrodt Plc reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Mallinckrodt Plc – Johnson & Johnson, Mylan N.V., Zogenix, Inc., Depomed, Inc., General Electric Company and Teva Pharmaceutical Industries Limited Sponsored ADR (JNJ-US, MYL-US, ZGNX-US, DEPO-US, GE-US and TEVA-US) ... Read more
<b>(Read more...)</b>"
MNK,MNK:US,BBG002BHBHM1,Valeant: Stop Looking in the Rearview Mirror!,2017-06-16 14:54:00 +0000,http://finance.yahoo.com/r/69438647-ba8c-3191-ae88-69965c377bac/valeant-stop-looking-in-the-rearview-mirror-1497624875?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Shares of specialty pharmaceutical companies, including Valeant Pharmaceuticals International (VRX), Horizon Pharma (HZNP), Perrigo (PRGO), and Mallinckrodt (MNK), have been under pressure for a while now, as investors have remained focused on their business models of raising prices.  In offering her upbeat view on specialty-pharmaceutical companies, Chen recommends investors to not ""look back, because objects in the rearview mirror can appear closer than they are."" In fact, she claims that management has already started to pivot from the old model of constantly rising prices, and the ones that can ""innovate and/or save the healthcare system money can thrive under the new order."" Chen initiated coverage on Aclaris Therapeutics (ACRS), Horizon Pharma, Impax Laboratories (IPXL), Mallinckrodt, Perrigo, Theravance Biopharma (TBPH), Valeant, Zoetis (ZTS), and Shire (SHPG), which she calls her ""highest conviction recommendation."
MNK,MNK:US,BBG002BHBHM1,Opioid Marketing Under Bipartisan Investigation,2017-06-15 15:19:00 +0000,http://finance.yahoo.com/r/d00836e7-6c58-395d-8aab-e341e56c9c99/opioid-marketing-under-bipartisan-investigation.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Individual state investigations of opioid marketing practices has lead to a multistate investigation of the prescription painkiller industry.
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt sued by Tennessee prosecutors,2017-06-15 12:35:10 +0000,http://finance.yahoo.com/r/f82d417c-04b3-3032-97b6-10b9b803777a/mallinckrodt-sued-by-tennessee-prosecutors.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Mallinckrodt is among drug makers being sued by three Tennessee attorneys general for their alleged role in the opioid abuse epidemic in the state.  The prosecutors for three Tennessee judicial districts that together represent nine counties filed the lawsuit Tuesday in Sullivan County Circuit Court against opioid makers Mallinckrodt, Purdue Pharma and Endo Pharmaceuticals, the Knoxville News Sentinel reports."
MNK,MNK:US,BBG002BHBHM1,"ALDX Down But Not Out, BTX On Track, MNK Exploring New Use For Acthar",2017-06-15 02:26:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aXMjId0nzxE/aldx-down-but-not-out-btx-on-track-mnk-exploring-new-use-for-acthar-20170615-00053,"ALDX Down But Not Out, BTX On Track, MNK Exploring New Use For Acthar"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Enrolls First Patient in Phase 2B Trial of H.P. Acthar® Gel (Repository Corticotropin Injection) for Amyotrophic Lateral Sclerosis (ALS),2017-06-14 20:30:00 +0000,https://finance.yahoo.com/news/mallinckrodt-enrolls-first-patient-phase-203000514.html?.tsrc=rss,"STAINES-UPON-THAMES, United Kingdom, June 14, 2017 /PRNewswire/ -- Mallinckrodt plc (MNK), a leading global specialty pharmaceutical company, today confirmed enrollment of the first patient in the company's Phase 2B study designed to assess the efficacy and safety of H.P. Acthar® Gel (repository corticotropin injection) as a treatment for amyotrophic lateral sclerosis (ALS).  The U.S. Food and Drug Administration (FDA) previously granted the company's request for a Fast Track designation and orphan status for its H.P. Acthar Gel Investigational New Drug application in patients with ALS."
MNK,MNK:US,BBG002BHBHM1,Is Mallinckrodt in Talks to Be Sold?,2017-06-13 21:28:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6Rsd55c8lzA/is-mallinckrodt-in-talks-to-be-sold-cm802956,At the start of June fellow Fool Eric Volkman noted 160 that Mallinckrodt PLC NYSE MNK 160 was considering the sale of its generic drug business for as much as 2 billion Today Wall Street research firm Wells Fargo is out with a note saying that the company is
MNK,MNK:US,BBG002BHBHM1,Is Mallinckrodt in Talks to Be Sold?,2017-06-13 20:01:00 +0000,http://finance.yahoo.com/r/5b990f34-b952-36e0-b628-cd4ee29f6a54/is-mallincrodt-in-talks-to-be-sold.aspx?yptr=yahoo&.tsrc=rss,The generic and specialty drug maker could become an M&A target.
MNK,MNK:US,BBG002BHBHM1,"S&P 500 Movers: MYL, MNK",2017-06-13 15:28:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ch6TrbJ-Oe8/sp-500-movers-myl-mnk-cm802654,In early trading on Tuesday shares of Mallinckrodt MNK topped the list of the day s best performing components of the S amp P 500 index trading up 3 8 Year to date Mallinckrodt has lost about 13 6 of its value And the worst performing S amp P 500 component thus far on the day
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt (MNK) Down 10% Since Earnings Report: Can It Rebound?,2017-06-12 09:26:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zncdsbSO8WY/mallinckrodt-mnk-down-10-since-earnings-report-can-it-rebound-cm801739,It has been about a month since the last earnings report for Mallinckrodt PLC MNK Shares have lost about 10 in that time frame underperforming the market Will the recent negative trend continue leading up to the stock s next earnings release or is it due for a breakout Before we dive
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt (MNK) Down 10% Since Earnings Report: Can It Rebound?,2017-06-12 07:45:07 +0000,https://finance.yahoo.com/news/mallinckrodt-mnk-down-10-since-074507561.html?.tsrc=rss,MNK reported earnings 30 days ago. What&apos;s next for the company? We take a look at earnings estimates for some clues.
MNK,MNK:US,BBG002BHBHM1,Stocks That Fell to 3-Year Lows in the Week of June 9,2017-06-11 17:05:16 +0000,https://finance.yahoo.com/news/stocks-fell-3-lows-week-170516977.html?.tsrc=rss,"BT Group PLC (BT), Mallinckrodt PLC (MNK), Rite Aid Corp (RAD), and Frontier Communications Corp (FTR) have declined to their respective three-year lows."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt (MNK) Commences Phase III Study of StrataGraft,2017-06-08 17:26:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xJDBRdQ_VyY/mallinckrodt-mnk-commences-phase-iii-study-of-stratagraft-cm800701,Mallinckrodt plc MNK has enrolled the first patient in phase III study assessing StrataGraft regenerative skin tissue for promoting autologous skin regeneration in patients with thermal burns The company s share price decreased 19 7 year to date compared with the Zacks classified
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt (MNK) Commences Phase III Study of StrataGraft,2017-06-08 15:09:03 +0000,https://finance.yahoo.com/news/mallinckrodt-mnk-commences-phase-iii-150903543.html?.tsrc=rss,"Mallinckrodt plc (MNK) has enrolled the first patient in phase III study, assessing StrataGraft regenerative skin tissue for promoting autologous skin regeneration in patients with thermal burns."
MNK,MNK:US,BBG002BHBHM1,Intellipharmaceutics Announces Launch of Generic Seroquel XR,2017-06-07 17:28:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_VbWI4C1sKw/intellipharmaceutics-announces-launch-of-generic-seroquel-xr-cm800155,Intellipharmaceutics International Inc IPCI announced the launch of a generic version of schizophrenia 160 drug Seroquel XR by its marketing and distribution partner in the U S Mallinckrodt Public Limited Company MNK The launch was preceded by FDA approval of the company s abbreviated
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Enrolls First Patient in Phase 3 Trial of StrataGraft® Regenerative Skin Tissue,2017-06-07 11:30:00 +0000,https://finance.yahoo.com/news/mallinckrodt-enrolls-first-patient-phase-113000594.html?.tsrc=rss,"STAINES-UPON-THAMES, United Kingdom, June 7, 2017 /PRNewswire/ -- Mallinckrodt plc (MNK), a leading global specialty pharmaceutical company, today confirmed enrollment of the first patient in the company's Phase 3 study assessing the efficacy and safety of StrataGraft regenerative skin tissue in the promotion of autologous skin regeneration of complex skin defects due to thermal burns that contain intact dermal elements.  ""There have been few advancements in burn surgery in the last two to three decades,"" said lead investigator James H. Holmes, IV, M.D., Director of the Burn Center at Wake Forest Baptist Medical Center and Associate Professor of Surgery, Winston-Salem, NC.  The Phase 3 clinical study is entitled ""A Phase 3 Open-label, Controlled, Randomized, Multicenter Study Evaluating the Efficacy and Safety of StrataGraft Skin Tissue in Promoting Autologous Skin Tissue Regeneration of Complex Skin Defects Due to Thermal Burns That Contain Intact Dermal Elements and for Which Excision and Autografts Are Clinically Indicated."" The study will include patients with 3-49% total body surface area complex skin defects due to thermal burns with intact dermal elements for which excision and autografting are clinically indicated."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Enrolls Patient In Trial Of StrataGraft Regenerative Skin Tissue,2017-06-07 07:47:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FnlbZjfwhPY/mallinckrodt-enrolls-patient-in-trial-of-stratagraft-regenerative-skin-tissue-20170607-00330,Mallinckrodt Enrolls Patient In Trial Of StrataGraft Regenerative Skin Tissue
MNK,MNK:US,BBG002BHBHM1,Jim Chanos' pharma short got crushed after an ally bashed it to all Wall Street,2017-06-06 04:14:00 +0000,https://finance.yahoo.com/news/jim-chanos-pharma-short-got-041400282.html?.tsrc=rss,Mallinckrodt Pharmaceuticals dropped Monday after executives at one of its key distributors...
MNK,MNK:US,BBG002BHBHM1,Jim Chanos' pharma short got crushed after an ally bashed it to all Wall Street,2017-06-06 04:14:00 +0000,https://finance.yahoo.com/news/jim-chanos-pharma-short-got-041400363.html?.tsrc=rss,Mallinckrodt Pharmaceuticals dropped Monday after executives at one of its key distributors...
MNK,MNK:US,BBG002BHBHM1,Top Market News: What Happened In Investing Today,2017-06-05 23:02:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O_PSjX5FQM8/top-market-news-what-happened-in-investing-today-cm799025,By SA Editor Mike Taylor CFA BySA Editor Mike Taylor CFA Citron Finds A Typo Citron Finds A TypoCitron Finds A Typo Citron Research has been negative of HP Acthar gel since before Mallinckrodt MNK owned it I can find a Citron report dating back to July 2012 framing a
MNK,MNK:US,BBG002BHBHM1,Here's Why Mallinckrodt (MNK) Shares are Lower Today,2017-06-05 23:01:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YZHEGIm8Y9w/heres-why-mallinckrodt-mnk-shares-are-lower-today-cm799036,On Monday shares of pharmaceutical company Mallinckrodt Plc MNK are slipping down about 5 to 40 50 per share in afternoon trading MNK dropped about 8 in heavy morning trading after a new report from short seller Citron Research targeted the company Citron s report focused
MNK,MNK:US,BBG002BHBHM1,What Happened in the Stock Market Today,2017-06-05 23:00:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XD3n6i0qaQc/what-happened-in-the-stock-market-today-cm799032,Stocks remained largely unchanged on Monday with the Dow Jones Industrial Average DJINDICES DJI and the S amp P 500 SNPINDEX GSPC 160 losing less than 0 15 each Today s stock market Index Percentage Change Point
MNK,MNK:US,BBG002BHBHM1,What Happened in the Stock Market Today,2017-06-05 20:57:00 +0000,http://finance.yahoo.com/r/e2cbf81b-896d-31e2-8b73-e0d9ef80c74a/what-happened-in-the-stock-market-today.aspx?yptr=yahoo&.tsrc=rss,"On a flat day for Wall Street, shares of Buffalo Wild Wings and Mallinckrodt sank."
MNK,MNK:US,BBG002BHBHM1,Jim Chanos' pharma short got crushed after an ally bashed it to all Wall Street,2017-06-05 20:46:00 +0000,https://finance.yahoo.com/news/one-wall-streets-most-hated-161811050.html?.tsrc=rss,Mallinckrodt Pharmaceuticals dropped Monday after executives at one of its key distributors...
MNK,MNK:US,BBG002BHBHM1,Here&apos;s Why Mallinckrodt (MNK) Shares are Lower Today,2017-06-05 20:26:08 +0000,https://finance.yahoo.com/news/apos-why-mallinckrodt-mnk-shares-202608099.html?.tsrc=rss,"On Monday, shares of pharmaceutical company Mallinckrodt Plc. (MNK) are slipping, down about 5% to $40.50 per share in afternoon trading--MNK dropped about 8% in heavy morning trading--after a new report from short-seller Citron Research targeted the company."
MNK,MNK:US,BBG002BHBHM1,"Noteworthy Monday Option Activity: AMGN, WYN, MNK",2017-06-05 18:59:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YEOx0UyqO7g/noteworthy-monday-option-activity-amgn-wyn-mnk-cm798902,Among the underlying components of the S amp P 500 index we saw noteworthy options trading volume today in Amgen Inc Symbol AMGN where a total of 25 035 contracts have traded so far representing approximately 2 5 million underlying shares That amounts to about 78 1 of AMGN s average
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt stock tumbles after new Citron Research report targets $40,000-a-vial drug",2017-06-05 18:36:43 +0000,http://finance.yahoo.com/r/35fd0ef1-039b-337b-947f-98d0e2160d2a/Story.aspx?guid=EF8FE49E-4A01-11E7-A1D7-BEF8BED2BE0B&siteid=yhoof2&yptr=yahoo&.tsrc=rss,The short-seller claimed a recent development could send Mallinckrodt shares to zero and make the company bankrupt.
MNK,MNK:US,BBG002BHBHM1,"S&P 500 Movers: PRGO, CSRA",2017-06-05 16:02:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zR4ILRNqb7w/sp-500-movers-prgo-csra-cm798692,In early trading on Monday shares of CSRA CSRA topped the list of the day s best performing components of the S amp P 500 index trading up 2 2 Year to date CSRA has lost about 2 3 of its value And the worst performing S amp P 500 component thus far on the day is Perrigo
MNK,MNK:US,BBG002BHBHM1,"Citron Takes Aim at Mallinckrodt, Blasts Acthar Gel Medication",2017-06-05 15:58:00 +0000,http://finance.yahoo.com/r/29400b3c-a47c-36a6-b459-d19e06af1f3a/citron-takes-aim-at-mallinckrodt-blasts-acthar-gel-medication.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Citron attacked Mallinckrodt's partnership with Express Scripts ESRX, liking it to the role specialty prescription company Philidor played for embattled pharma company Valeant."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt stock drops 8% on new Citron Research report,2017-06-05 15:15:16 +0000,http://finance.yahoo.com/r/73812f0f-8917-3b79-8eea-cf8610d795fe/Story.aspx?guid=8CFC1FE9-CD6F-4CA0-BFC6-7A8320051779&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Mallinckrodt PLC shares dropped 8% in heavy morning trade Monday after short-seller Citron Research released a new report criticizing the pharmaceutical company. Citron Research has previously targeted ...
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt considering sale of generic drugs unit: Report,2017-06-01 12:50:13 +0000,http://finance.yahoo.com/r/9b4c087a-c0ac-3040-ab24-1fae0e97b099/mallinckrodt-considering-sale-of-generic-drugs.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Mallinckrodt Plc reportedly is considering a sale of its generic drug unit, a division that accounted for about 30 percent of the company's first quarter sales.  A sale of the division could bring in as much as $2 billion and allow Mallinckrodt to focus on more profitable branded drugs,  sources told Reuters.  The sources said Mallinckrodt has hired investment bank Credit Suisse Group to oversee the sale process for the division, Reuters reports."
MNK,MNK:US,BBG002BHBHM1,Instant Analysis: Mallinckrodt Considering Sale of Generics Unit,2017-06-01 12:33:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oNXOPamDv10/instant-analysis-mallinckrodt-considering-sale-of-generics-unit-cm797232,What happened Mallinckrodt s NYSE MNK legacy business might soon be changing hands Reuters citing people familiar with the matter reported that the pharmaceutical company is exploring a divestment of its generic drug operations Such a deal could total up to 2
MNK,MNK:US,BBG002BHBHM1,Instant Analysis: Mallinckrodt Considering Sale of Generics Unit,2017-06-01 11:04:00 +0000,http://finance.yahoo.com/r/d5fd43e0-3c1e-32e4-abf3-0cac69a7d422/instant-analysis-mallinckrodt-considering-sale-of.aspx?yptr=yahoo&.tsrc=rss,"Mallinckrodt&apos;s onetime core business is up for grabs, according to a Reuters report."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Inquires Into Sale of Generic Drug Unit,2017-05-31 17:22:00 +0000,http://finance.yahoo.com/r/c30c333d-1ed1-335a-a54d-742082b4e17e/mallinckrodt-inquires-into-sale-of-generic-drug-unit.html?puc=yahoov&cm_ven=YAHOOV&yptr=yahoo&.tsrc=rss,Shares of drug maker Mallinckrodt were falling Wednesday afternoon
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Explores Sale of Generic Drug Unit,2017-05-31 16:57:00 +0000,http://finance.yahoo.com/r/5588f07e-ebf1-33ab-b42b-bf13a5f87c56/mallinckrodt-explores-sale-of-generic-drug-unit.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The unit accounted for about 30% of the company's revenue in the first quarter.
MNK,MNK:US,BBG002BHBHM1,"Morning Movers: Kors Crumbles on Guidance, Exact Sciences Climbs",2017-05-31 12:52:00 +0000,http://finance.yahoo.com/r/038801c0-4a61-32c0-b89e-797826bd4af3/morning-movers-kors-crumbles-on-emorning-movers-kors-crumbles-on-guidance-exact-sciences-climbsarnings-exact-sciences-climbs-1496235151?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"The S&P 500 looks set for a higher open today after its seven-day winning streak ended yesterday. S&P 500 futures have risen 0.2%, while Dow Jones Industrial Average futures have advanced 0.2%. Nasdaq ..."
MNK,MNK:US,BBG002BHBHM1,"After-hours buzz: MNK, ARI, and more",2017-05-30 22:03:24 +0000,https://finance.yahoo.com/news/hours-buzz-mnk-ari-more-220324450.html?.tsrc=rss,See which stocks are posting big moves after the bell.
MNK,MNK:US,BBG002BHBHM1,"After-hours buzz: MNK, ARI, and more",2017-05-30 22:03:24 +0000,http://finance.yahoo.com/r/9c9454f6-ae32-3d73-84dc-dec666583c71/104500063?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104500063&yptr=yahoo&.tsrc=rss,See which stocks are posting big moves after the bell.
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Was the S&P 500’s Top Gainer on May 26,2017-05-29 14:38:12 +0000,http://finance.yahoo.com/r/38161a7e-d513-3cd6-b9f9-2adcaaff554f/mallinckrodt-pharmaceuticals-sp-500s-top-gainer-may-26?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Mallinckrodt Pharmaceuticals, which produces specialty pharmaceutical products such as generic drugs and imaging agents, surged to a ten-day high on May 26."
MNK,MNK:US,BBG002BHBHM1,The Hot Stock: Mallinckrodt Jumps 5.6%,2017-05-26 21:01:00 +0000,http://finance.yahoo.com/r/4ad0614d-a7a1-3fb4-83c5-1fe052a10040/the-hot-stock-mallinckrodt-jumps-5-6-1495832489?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Mallinckrodt (MNK) soared to the top of the S&P 500 today after offering preliminary observations on patients who had been enrolled in a study on the use of Acthar in the treatment of multiple sclerosis relapses.  Mallinckrodt gained 5.6% to $43.28 today, while the S&P 500 finished little changed at 2,415.82.  Mallinckrodt's market capitalization rose to $4.3 billion today from $4.1 billion yesterday."
MNK,MNK:US,BBG002BHBHM1,One of the most hated drug companies on Wall Street is facing another nasty probe,2017-05-26 18:51:25 +0000,https://finance.yahoo.com/news/one-most-hated-drug-companies-185125861.html?.tsrc=rss,"Senator Claire McCaskill (D-MO) has sent a letter to Mallinckrodt Pharmaceuticals, asking the..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Highlights First Patients in Company-Sponsored Prospective Observational Registry on the Use of H.P. Acthar® Gel (Repository Corticotropin Injection) Following Acute Multiple Sclerosis Relapse,2017-05-25 21:00:00 +0000,https://finance.yahoo.com/news/mallinckrodt-highlights-first-patients-company-210000378.html?.tsrc=rss,"STAINES-UPON-THAMES, United Kingdom, May 25, 2017 /PRNewswire/ --  Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, highlights the first patients enrolled in an ongoing ..."
MNK,MNK:US,BBG002BHBHM1,First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse,2017-05-23 21:00:00 +0000,https://finance.yahoo.com/news/first-patient-enrolled-mallinckrodt-phase-210000200.html?.tsrc=rss,"STAINES-UPON-THAMES, United Kingdom, May 23, 2017 /PRNewswire/ -- Mallinckrodt plc (MNK), a leading global specialty pharmaceutical company, today confirmed enrollment of the first patient in the company's Phase 4 pilot study assessing the efficacy of H.P. Acthar® Gel (repository corticotropin injection) for the management of exacerbations of relapsing and remitting multiple sclerosis (RRMS) in patients whose relapse symptoms have not responded to a course of high-dose corticosteroids.  ""Some MS patients may have relapse symptoms that don't resolve with steroid therapy, and in my experience, H.P. Acthar Gel may provide benefit in these cases,"" said Aaron Miller, M.D., a program advisor and participating site investigator from the Icahn School of Medicine at Mount Sinai in New York."
MNK,MNK:US,BBG002BHBHM1,Oversold Conditions For Mallinckrodt (MNK),2017-05-23 17:14:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J3K0I29qfSM/oversold-conditions-for-mallinckrodt-mnk-cm793381,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt & Express Scripts: What Chanos Got Wrong,2017-05-22 13:32:00 +0000,http://finance.yahoo.com/r/4f312796-a786-3cfc-9c05-0d427b40987c/mallinckrodt-express-scripts-what-chanos-got-wrong-1495459963?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Last week, short-sell Jim Chanos  made his bear case for  Mallinckrodt (MNK) and Express Scripts (ESRX) at the SALT Conference.  Mallinckrodt released a statement on Friday taking issue with numerous components of Chanos' argument, including the percentage of its profit that comes from Acthar: Mallinckrodt does not publicly disclose profitability of the individual products in its diversified portfolio.  Inflated assertions regarding H.P. Acthar® Gel’s contribution to the company’s overall profitability are incorrect."
MNK,MNK:US,BBG002BHBHM1,Top hedge fund managers shared these 5 trade ideas at the SALT Conference,2017-05-20 17:32:13 +0000,https://finance.yahoo.com/news/hedge-fund-managers-share-best-trade-ideas-173213844.html?.tsrc=rss,Some big name money managers shared their best long and short ideas at the SALT Conference.
MNK,MNK:US,BBG002BHBHM1,"Short-seller criticizes 'murky alliance' between Mallinckrodt, Express Scripts",2017-05-19 22:50:12 +0000,http://finance.yahoo.com/r/d19ab0d0-4354-3441-81f6-102a4480481b/short-seller-criticizes-murky-alliance-between.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Short-seller Jim Chanos slammed the alliance between Mallinckrodt Plc and Express Scripts, which is the exclusive distributor for Mallinckrodt's Acthar drug.  During a hedge fund conference in Las Vegas Thursday, Chanos called the partnership a ""murky alliance"" that increases drug prices, Reuters reports.  Chanos also said Mallinckrodt is a ""one-product company"" that will face increased scrutiny as concern grows about high drug prices, the Wall Street Journal reports."
MNK,MNK:US,BBG002BHBHM1,Jim Chanos has a way to profit on the drug overpricing backlash and still hates Tesla,2017-05-19 12:36:53 +0000,https://finance.yahoo.com/news/jim-chanos-way-profit-drug-123653467.html?.tsrc=rss,"The S&P is trying to prune its losses for the week, but some analysts warn that going long too soon could prove costly. For those not going long, Jim Chanos is offering up short ideas — among pharma stocks, ..."
MNK,MNK:US,BBG002BHBHM1,Jim Chanos has a way to profit on the drug overpricing backlash and still hates Tesla,2017-05-19 12:36:53 +0000,http://finance.yahoo.com/r/49654e26-04fb-3e45-a5e6-1f52b69b2ab7/Story.aspx?guid=5E0CE098-3C6A-11E7-A351-2794AC72FE71&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"The S&P is trying to prune its losses for the week, but some analysts warn that going long too soon could prove costly. For those not going long, Jim Chanos is offering up short ideas — among pharma stocks, ..."
MNK,MNK:US,BBG002BHBHM1,[$$] Jim Chanos Predicts Stock Drop for Mallinckrodt,2017-05-18 23:38:55 +0000,http://finance.yahoo.com/r/f1a477f2-cac2-3b19-8b49-9ceb94e9b1e2/jim-chanos-predicts-stock-drop-for-mallinckrodt-1495150731?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,Noted short-seller Jim Chanos predicted a fall for shares of pharmaceutical maker Mallinckrodt PLC at the annual SALT hedge fund conference in Las Vegas on Thursday.
MNK,MNK:US,BBG002BHBHM1,Jim Chanos is shorting 2 drug stocks with a &apos;murky alliance&apos;,2017-05-18 21:19:16 +0000,https://finance.yahoo.com/news/jim-chanos-shorting-2-drug-stocks-murky-alliance-211916139.html?.tsrc=rss,"Short-seller Jim Chanos contended that the companies have a “murky alliance” that may lead to “performance-enhancing drug prices,” but investors may “feel the blues.”"
MNK,MNK:US,BBG002BHBHM1,"Chanos on Mallinckrodt, Express Scripts, Tesla and China",2017-05-18 20:24:26 +0000,http://finance.yahoo.com/r/5a2dab21-5809-30f2-9e51-3e9a24d55c57/chanos-on-mallinckrodt-express-scripts-and-tesla-video?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Jim Chanos, Kynikos Associates president and founder, explains why he's shorting Mallinckrodt Plc and Express Scripts Holding Co., his views on Tesla Inc. and his approach to investing in China. He speaks ..."
MNK,MNK:US,BBG002BHBHM1,Two More Stock Picks From Hedge Fund Leaders at SALT,2017-05-18 20:21:00 +0000,http://finance.yahoo.com/r/968bda03-470a-3d60-8eb1-94aa2781c3db/two-more-stock-picks-from-hedge-fund-leaders-at-salt.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Kynikos Associates' James Chanos, famous for his shorting campaign at Enron, on Thursday presented a short campaign."
MNK,MNK:US,BBG002BHBHM1,Why Chanos Is Shorting Mallinckrodt and Express Scripts,2017-05-18 20:06:26 +0000,http://finance.yahoo.com/r/050149f0-3131-3a16-8dc9-738f0dbee127/chanos-is-shorting-mallinckrodt-and-express-scripts-video?utm_source=yahoo&utm_medium=bd&utm_campaign=headline&cmpId=yhoo.headline&yptr=yahoo&.tsrc=rss,"Jim Chanos, Kynikos Associates president and founder, explains why he's shorting Mallinckrodt Plc and Express Scripts Holding Co. He speaks with Bloomberg's Erik Schatzker at the annual SkyBridge Alternatives ..."
MNK,MNK:US,BBG002BHBHM1,Edited Transcript of MNK earnings conference call or presentation 8-May-17 12:30pm GMT,2017-05-12 21:01:00 +0000,https://finance.yahoo.com/news/edited-transcript-mnk-earnings-conference-180613973.html?.tsrc=rss,Q1 2017 Mallinckrodt Plc Earnings Call
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt To Present At Goldman Sachs 38th Annual Global Healthcare Conference,2017-05-12 11:30:00 +0000,http://finance.yahoo.com/news/mallinckrodt-present-goldman-sachs-38th-113000848.html?.tsrc=rss,"STAINES-UPON-THAMES, England, May 12, 2017 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Tuesday, June 13, 2017, at the Goldman ..."
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Plc – Value Analysis (NYSE:MNK) : May 9, 2017",2017-05-09 21:35:50 +0000,http://finance.yahoo.com/r/91f5403d-a4ec-3b85-93df-5eaa56310f80/mallinckrodt-plc-value-analysis-nysemnk-may-9-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Mallinckrodt Plc a score of 41. Our analysis is based on comparing Mallinckrodt Plc with the following peers – Johnson & Johnson, Mylan N.V., Zogenix, Inc., Depomed, Inc., General Electric Company and Teva Pharmaceutical Industries Limited Sponsored ADR (JNJ-US, MYL-US, ZGNX-US, DEPO-US, GE-US and TEVA-US). Investment Outlook ... Read more
<b>(Read more...)</b>"
MNK,MNK:US,BBG002BHBHM1,Edited Transcript of MNK earnings conference call or presentation 8-May-17 12:30pm GMT,2017-05-09 12:40:57 +0000,http://finance.yahoo.com/news/edited-transcript-mnk-earnings-conference-180613973.html?.tsrc=rss,Q1 2017 Mallinckrodt Plc Earnings Call
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt (MNK) Tops Q1 Earnings, Sales",2017-05-08 20:03:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NCRhPTodSbg/mallinckrodt-mnk-tops-q1-earnings-sales-cm786091,Ireland based Mallinckrodt Public Limited Company MNK focuses on developing treatments for autoimmune and rare diseases including neurology rheumatology nephrology and pulmonology as well as therapies for pain management The company develops manufactures markets and distributes
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Earnings, Revenues Beat Estimates in Q1",2017-05-08 20:02:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pm1rg4F5og0/mallinckrodt-earnings-revenues-beat-estimates-in-q1-cm786073,Mallinckrodt Public Limited Company MNK reported first quarter 2017 results wherein both 160 sales and earnings beat expectations The company reported adjusted earnings of 1 68 per share in the reported quarter beating the Zacks Consensus Estimate of 1 63 Earnings were however down
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Earnings, Revenues Beat Estimates in Q1",2017-05-08 18:19:06 +0000,http://finance.yahoo.com/news/mallinckrodt-earnings-revenues-beat-estimates-181906469.html?.tsrc=rss,Mallinckrodt Public Limited Company (MNK) reported first-quarter 2017 results wherein both sales and earnings beat expectations.
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt (MNK) Tops Q1 Earnings, Sales",2017-05-08 17:31:05 +0000,http://finance.yahoo.com/news/mallinckrodt-mnk-tops-q1-earnings-173105635.html?.tsrc=rss,Mallinckrodt beats on earnings and sales in the first quarter.
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt's stock jumps after profit and sales beat,2017-05-08 13:01:29 +0000,http://finance.yahoo.com/r/bba0852a-6990-3cf9-8163-96498eb0e7c6/Story.aspx?guid=77F656BB-2092-4F0C-935B-1D168ED09BE7&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"Shares of Mallinckrodt PLC rallied 5.1% in premarket trade Monday, after the drug maker reported first-quarter results that beat expectations. Net income rose to $399.2 million, or $3.85 a share, from ..."
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Plc breached its 50 day moving average in a Bullish Manner : MNK-US : May 8, 2017",2017-05-08 12:26:38 +0000,http://finance.yahoo.com/r/ca4aa884-0dc8-355f-8fd3-bbc1ff4b5331/mallinckrodt-plc-breached-its-50-day-moving-average-in-a-bullish-manner-mnk-us-may-8-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Mallinckrodt Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more
<b>(Read more...)</b>"
MNK,MNK:US,BBG002BHBHM1,"Earnings Reaction History: Mallinckrodt plc, 45.5% Follow-Through Indicator, 5.7% Sensitive",2017-05-08 11:01:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R7HqhlMWS60/earnings-reaction-history-mallinckrodt-plc-455-follow-through-indicator-57-sensitive-cm785562,Expected Earnings Release 05 08 2017 PremarketExpected Earnings Release 05 08 2017 Premarket Avg Extended Hours Dollar Volume 2 575 086Avg Extended Hours Dollar Volume 2 575 086 Mallinckrodt plc MNK is due to issue its quarterly earnings report in the upcoming extended hours
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt tops Street 1Q forecasts,2017-05-08 10:12:29 +0000,http://finance.yahoo.com/news/mallinckrodt-tops-street-1q-forecasts-101229689.html?.tsrc=rss,"The Derbyshire, Britain-based company said it had profit of $3.85 per share. Earnings, adjusted for one-time gains and costs, were $1.68 per share. The results beat Wall Street expectations. The average ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt plc Reports Earnings Results for First Quarter of Fiscal 2017,2017-05-08 10:00:00 +0000,http://finance.yahoo.com/news/mallinckrodt-plc-reports-earnings-results-100000828.html?.tsrc=rss,"STAINES-UPON-THAMES, United Kingdom, May 8, 2017 /PRNewswire/ --  Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today reported results for the first quarter fiscal 2017. ..."
MNK,MNK:US,BBG002BHBHM1,"Pre-Market Earnings Report for May 8, 2017 :  JD, SYY, NWL, TSN, XEC, AES, ON, FDC, VVC, MNK, KITE, PAH",2017-05-05 20:14:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SRSwGml3gGk/pre-market-earnings-report-for-may-8-2017-jd-syy-nwl-tsn-xec-aes-on-fdc-vvc-mnk-kite-pah-cm785251,The following companies are expected to report earnings prior to market open on 05 08 2017 Visit our Earnings Calendar for a full list of expected earnings releases JD com Inc JD is reporting for the quarter ending March 31 2017 The internet company
MNK,MNK:US,BBG002BHBHM1,First Patient Enrolled in Mallinckrodt Phase 2 Trial of StrataGraft® Regenerative Skin Tissue,2017-05-04 20:30:00 +0000,http://finance.yahoo.com/news/first-patient-enrolled-mallinckrodt-phase-203000946.html?.tsrc=rss,"""We are dedicated to providing regenerative medicine advanced therapies to patients with serious complex skin wounds, such as burns and other trauma,"" said Lynn Allen-Hoffmann, Senior Vice President, Regenerative Medicine at Mallinckrodt."
MNK,MNK:US,BBG002BHBHM1,What's in Store for Mallinckrodt (MNK) This Earnings Season?,2017-05-03 23:10:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/P2vG1nwYXO0/whats-in-store-for-mallinckrodt-mnk-this-earnings-season-cm783827,Mallinckrodt plc MNK is set to report first quarter fiscal 2017 results on May 8 The company s track record has been impressive so far Mallinckrodt delivered a positive average earnings surprise of 8 7 in the last four trailing quarters Let s see how things are shaping up for
MNK,MNK:US,BBG002BHBHM1,What&apos;s in Store for Mallinckrodt (MNK) This Earnings Season?,2017-05-03 20:50:08 +0000,http://finance.yahoo.com/news/apos-store-mallinckrodt-mnk-earnings-205008880.html?.tsrc=rss,Mallinckrodt plc (MNK) is set to report first-quarter fiscal 2017 results on May 8.
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Celebrates 30th Anniversary of THERAKOS® Photopheresis Therapy,2017-05-03 12:05:00 +0000,http://finance.yahoo.com/news/mallinckrodt-celebrates-30th-anniversary-therakos-120500285.html?.tsrc=rss,"STAINES-UPON-THAMES, England, May 3, 2017 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, marked the 30 th anniversary of THERAKOS ® Photopheresis at the ..."
MNK,MNK:US,BBG002BHBHM1,Implied PPH Analyst Target Price: $64,2017-05-01 14:28:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ua6zPY-t2qg/implied-pph-analyst-target-price-64-cm781880,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Data from New Company-Sponsored Studies Presented at American Academy of Neurology 69th Annual Meeting,2017-04-28 12:25:00 +0000,http://finance.yahoo.com/news/mallinckrodt-data-company-sponsored-studies-122500262.html?.tsrc=rss,"STAINES-UPON-THAMES, United Kingdom, April 28, 2017 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, announced new results from two company-sponsored studies: ..."
MNK,MNK:US,BBG002BHBHM1,"Agree To Buy Mallinckrodt At $30, Earn 8.3% Using Options",2017-04-27 17:30:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ix6MZEpmD0w/agree-to-buy-mallinckrodt-at-30-earn-83-using-options-cm780498,Investors eyeing a purchase of Mallinckrodt plc Symbol MNK stock but tentative about paying the going market price of 46 32 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the January 2019
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt To Present At UBS Global Healthcare Conference,2017-04-24 20:30:00 +0000,http://finance.yahoo.com/news/mallinckrodt-present-ubs-global-healthcare-203000818.html?.tsrc=rss,"STAINES-UPON-THAMES, England, April 24, 2017 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Tuesday, May 23, 2017, at the UBS ..."
MNK,MNK:US,BBG002BHBHM1,"A city in Illinois realized it was spending a lot of money on one drug, so it sued the maker",2017-04-22 14:14:32 +0000,http://finance.yahoo.com/news/city-illinois-realized-spending-lot-141432716.html?.tsrc=rss,"ROCKFORD, Illinois — This city 90 miles from Chicago runs its own health plan for its hundreds..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt faces lawsuit from Illinois city,2017-04-10 12:25:08 +0000,http://finance.yahoo.com/r/4814ff17-c850-3b8f-b322-35fbeeca54d8/mallinckrodt-faces-lawsuit-from-illinois-city.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"The city of Rockford, Illinois, is suing Mallinckrodt over the price of the company's top-selling drug.  Rockford claims that Mallinckrodt is charging an exorbitant price for Acthar, which is list at about $35,000 a vial, Business Insider reports.  The city alleges in its suit, filed in the U.S. District Court for the Northern District of Illinois, that in 2015 it paid almost $500,000 for nine Achtar prescriptions to treat two children."
MNK,MNK:US,BBG002BHBHM1,An Illinois city just stepped into the war against big pharma over drug pricing,2017-04-07 17:14:39 +0000,http://finance.yahoo.com/news/illinois-town-just-stepped-war-171439325.html?.tsrc=rss,"Rockford, Illinois, is suing Mallinckrodt Pharmaceuticals over the price of one of the company's..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt resigns from pharmaceutical trade group,2017-04-06 12:05:10 +0000,http://finance.yahoo.com/r/b25bb134-b2f1-3696-8c67-46af9f2c47de/mallinckrodt-resigns-from-pharmaceutical-trade.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Mallinckrodt PLC reportedly has resigned from the Pharmaceutical Research and Manufacturers Association as the trade group considers changes to its bylaws that could require members to invest significant money into the development of new drugs.  PhRMA will vote on the changes to its membership requirements at its board meeting in May, sources told the Wall Street Journal.  Mallinckrodt decided to resign from the group, which represents many of the world's larges pharmaceutical firms, before the changes are made that could exclude the company, the source told the newspaper."
MNK,MNK:US,BBG002BHBHM1,[$$] Mallinckrodt Leaves Pharmaceutical Trade Group Ahead of Potential Changes to Bylaws,2017-04-06 04:28:34 +0000,http://finance.yahoo.com/r/29b4e11a-883b-3b2c-b7dc-005a51b20630/mallinckrodt-leaves-pharmaceutical-trade-group-ahead-of-potential-changes-to-bylaws-1491406538?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,Mallinckrodt PLC resigned from the Pharmaceutical Research and Manufacturers Association on Monday ahead of potential changes to the trade group’s by-laws that could exclude companies that don’t spend ...
MNK,MNK:US,BBG002BHBHM1,One of the most controversial drug companies in America is out of the industry's lobby,2017-04-05 16:50:16 +0000,http://finance.yahoo.com/news/one-most-controversial-drug-companies-165016249.html?.tsrc=rss,"Mallinckrodt Pharmaceuticals is no longer a member of the powerful pharmaceutical lobby, the..."
MNK,MNK:US,BBG002BHBHM1,A senator found Medicare blowing hundreds of millions on a drug private insurers wouldn't touch — and nothing happened,2017-04-05 12:12:00 +0000,http://finance.yahoo.com/news/senator-found-medicare-spending-hundreds-121200946.html?.tsrc=rss,You would think that if a US senator had it on good authority that Medicare was spending hundreds...
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt To Present At Deutsche Bank 42nd Annual Healthcare Conference,2017-04-05 11:00:00 +0000,http://finance.yahoo.com/news/mallinckrodt-present-deutsche-bank-42nd-110000796.html?.tsrc=rss,"STAINES-UPON-THAMES, England, April 5, 2017 /PRNewswire/ --  Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Wednesday, May 3, 2017, at the ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt to pay $35M in deal to end feds' opioid probe,2017-04-03 22:47:19 +0000,http://finance.yahoo.com/r/9241c344-82ba-33db-be3d-ffe377786e57/mallinckrodt-pay-35m-deal-end-feds-opioid-probe-215958162--finance.html?.tsrc=rss,"TRENTON, N.J. (AP) — A top maker of brand-name and generic narcotic painkillers has agreed to pay the U.S. government $35 million to resolve a probe of its distribution of those drugs."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt to pay $35M in deal to end feds' opioid probe,2017-04-03 22:47:13 +0000,http://sg.finance.yahoo.com/news/mallinckrodt-pay-35m-deal-end-215952635.html,Mallinckrodt to pay $35M in deal to end feds' opioid probe
MNK,MNK:US,BBG002BHBHM1,Opioid maker Mallinckrodt agrees to $35 mln U.S. drugs probes settlement,2017-04-03 15:31:09 +0000,http://finance.yahoo.com/news/opioid-maker-mallinckrodt-agrees-35-153109281.html?.tsrc=rss,"Mallinckrodt Plc, a manufacturer  of the generic opioid painkiller oxycodone, said on Monday it  had agreed to pay $35 million to resolve U.S. probes into its  monitoring and reporting of suspicious orders of controlled  substances.  Mallinckrodt confirmed the proposed settlement after The  Washington Post published a report on the probe, the first time  the U.S. Drug Enforcement Administration had targeted an opioid  manufacturer over violations of laws intended to prevent the  diversion of drugs to the black market."
MNK,MNK:US,BBG002BHBHM1,Opioid maker Mallinckrodt agrees to $35 mln U.S. drugs probes settlement,2017-04-03 15:31:09 +0000,http://finance.yahoo.com/news/opioid-maker-mallinckrodt-agrees-35-153109281.html,"[Reuters] - Mallinckrodt Plc, a manufacturer of the generic opioid painkiller oxycodone, said on Monday it had agreed to pay $35 million to resolve U.S. probes into its monitoring and reporting of suspicious orders of controlled substances. Mallinckrodt confirmed the proposed settlement after The Washington Post published a report on the probe, the first time the U.S. Drug Enforcement Administration had targeted an opioid manufacturer over violations of laws intended to prevent the diversion of drugs to the black market."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt reaches $35 million settlement in U.S. drug probe,2017-04-03 14:07:13 +0000,http://finance.yahoo.com/news/mallinckrodt-reaches-35-million-settlement-140713909.html,Mallinckrodt reaches $35 million settlement in U.S. drug probe
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt reaches $35 million settlement in U.S. drug probe,2017-04-03 14:07:13 +0000,http://finance.yahoo.com/news/mallinckrodt-reaches-35-million-settlement-140713909.html?.tsrc=rss,"Mallinckrodt Plc, a manufacturer  of the generic painkiller oxycodone, said on Monday it had  reached a $35 million settlement to resolve U.S. probes into its  monitoring and reporting of suspicious orders of controlled  substances.  The drug company said that the agreement in principle is  subject to additional review and approval by the U.S. Justice  Department and U.S. Drug Enforcement Administration and will not  have a material effect on Mallinckrodt's financial condition."
MNK,MNK:US,BBG002BHBHM1,"MALLINCKRODT 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Mallinckrodt Public Limited Company - (MNK)",2017-03-25 02:50:00 +0000,http://finance.yahoo.com/news/mallinckrodt-72-hour-deadline-alert-025000504.html,"[Business Wire] - Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until March 27, 2017 to file lead plaintiff applications in a securities class action lawsuit against Mallinckrodt Public Limited Company ."
MNK,MNK:US,BBG002BHBHM1,"MALLINCKRODT 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Mallinckrodt Public Limited Company - (MNK)",2017-03-25 02:50:00 +0000,http://finance.yahoo.com/news/mallinckrodt-72-hour-deadline-alert-025000504.html?.tsrc=rss,"Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until March 27, 2017 to file lead plaintiff applications in a securities class action lawsuit against Mallinckrodt Public Limited Company ."
MNK,MNK:US,BBG002BHBHM1,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK,2017-03-25 00:07:00 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-000700416.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / March 24, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against Mallinckrodt plc (""Mallinckrodt"" or the ""Company"") (NYSE: MNK) ..."
MNK,MNK:US,BBG002BHBHM1,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK,2017-03-25 00:07:00 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-000700416.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 24, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against Mallinckrodt plc (""Mallinckrodt"" or the ""Company"") (NYSE: MNK) ..."
MNK,MNK:US,BBG002BHBHM1,EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Mallinckrodt Public Limited Company - MNK,2017-03-24 20:45:00 +0000,http://finance.yahoo.com/news/equity-alert-rosen-law-firm-204500089.html,"[PR Newswire] - NEW YORK, March 24, 2017 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Mallinckrodt Public Limited Company ..."
MNK,MNK:US,BBG002BHBHM1,EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Mallinckrodt Public Limited Company - MNK,2017-03-24 20:45:00 +0000,http://finance.yahoo.com/news/equity-alert-rosen-law-firm-204500089.html?.tsrc=rss,"NEW YORK, March 24, 2017 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Mallinckrodt Public Limited Company ..."
MNK,MNK:US,BBG002BHBHM1,3 Top Generic Drug Companies to Buy in 2017,2017-03-24 19:59:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/abOopc99nI4/3-top-generic-drug-companies-to-buy-in-2017-cm765405,Generic drug companies are anything but generic Some definitely stand out from the rest If you re looking to invest in generic drug stocks in 2017 you ll want to find the companies best positioned to succeed in a crowded market Here s why Lannett NYSE LCI
MNK,MNK:US,BBG002BHBHM1,3 Top Generic Drug Companies to Buy in 2017,2017-03-24 18:43:00 +0000,http://finance.yahoo.com/r/18b8108c-20e1-38f4-b879-158bc8de42b9/3-top-generic-drug-companies-to-buy-in-2017.aspx?yptr=yahoo&.tsrc=rss,"Thinking about buying generic drug stocks? Lannett, Mallinckrodt, and Mylan look like bargains."
MNK,MNK:US,BBG002BHBHM1,3 Top Generic Drug Companies to Buy in 2017,2017-03-24 18:43:00 +0000,https://www.fool.com/investing/2017/03/24/3-top-generic-drug-companies-to-buy-in-2017.aspx,3 Top Generic Drug Companies to Buy in 2017
MNK,MNK:US,BBG002BHBHM1,"MNK DEADLINE: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Mallinckrodt plc and a Lead Plaintiff Deadline of March 27, 2017",2017-03-24 16:10:00 +0000,http://finance.yahoo.com/news/mnk-deadline-law-offices-vincent-161000857.html,"[GlobeNewswire] - NEW YORK, March 24, 2017-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Columbia on behalf of investors who purchased Mallinckrodt ..."
MNK,MNK:US,BBG002BHBHM1,"MNK DEADLINE: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Mallinckrodt plc and a Lead Plaintiff Deadline of March 27, 2017",2017-03-24 16:10:00 +0000,http://finance.yahoo.com/news/mnk-deadline-law-offices-vincent-161000857.html?.tsrc=rss,"NEW YORK, March 24, 2017-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Columbia on behalf of investors who purchased Mallinckrodt ..."
MNK,MNK:US,BBG002BHBHM1,March 27 Deadline Alert: Law Offices of Howard G. Smith Reminds Mallinckrodt Public Limited Company Investors of Upcoming Lead Plaintiff Deadline,2017-03-24 15:26:00 +0000,http://finance.yahoo.com/news/march-27-deadline-alert-law-152600617.html?.tsrc=rss,"Law Offices of Howard G. Smith reminds investors of the upcoming March 27, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Mallinckrodt Public Limited Company securities between November 25, 2014 and January 18, 2017, inclusive ."
MNK,MNK:US,BBG002BHBHM1,March 27 Deadline Alert: Law Offices of Howard G. Smith Reminds Mallinckrodt Public Limited Company Investors of Upcoming Lead Plaintiff Deadline,2017-03-24 15:26:00 +0000,http://finance.yahoo.com/news/march-27-deadline-alert-law-152600617.html,"[Business Wire] - Law Offices of Howard G. Smith reminds investors of the upcoming March 27, 2017 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Mallinckrodt Public Limited Company securities between November 25, 2014 and January 18, 2017, inclusive ."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt plc To Report Earnings Results For First Quarter Of Fiscal 2017,2017-03-24 11:00:00 +0000,http://finance.yahoo.com/news/mallinckrodt-plc-report-earnings-results-110000856.html?.tsrc=rss,"STAINES-UPON-THAMES, United Kingdom, March 24, 2017 /PRNewswire/ --  Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, announced today it will report fiscal 2017 ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt plc To Report Earnings Results For First Quarter Of Fiscal 2017,2017-03-24 11:00:00 +0000,http://finance.yahoo.com/news/mallinckrodt-plc-report-earnings-results-110000856.html,"[PR Newswire] - STAINES-UPON-THAMES, United Kingdom, March 24, 2017 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, announced today it will report fiscal 2017 ..."
MNK,MNK:US,BBG002BHBHM1,"DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Mallinckrodt Public Limited Company (MNK) & Lead Plaintiff Deadline: March 27, 2017",2017-03-23 14:10:00 +0000,http://finance.yahoo.com/news/deadline-alert-bronstein-gewirtz-grossman-141000232.html,"[GlobeNewswire] - NEW YORK, March 23, 2017-- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Mallinckrodt Public Limited Company and certain ..."
MNK,MNK:US,BBG002BHBHM1,"Sears, Nike and US Bancorp stumble while FedEx, Duluth rise",2017-03-22 20:29:16 +0000,http://sg.finance.yahoo.com/news/sears-nike-us-bancorp-stumble-202916635.html,"Sears, Nike and US Bancorp stumble while FedEx, Duluth rise"
MNK,MNK:US,BBG002BHBHM1,Oversold Conditions For Mallinckrodt (MNK),2017-03-21 18:08:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S-_Cuws17k4/oversold-conditions-for-mallinckrodt-mnk-cm763672,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
MNK,MNK:US,BBG002BHBHM1,Something weird's going on with the doctors prescribing one of pharma's most controversial blockbuster drugs,2017-03-21 16:41:58 +0000,http://finance.yahoo.com/news/something-weirds-going-doctors-prescribing-164158656.html?.tsrc=rss,The effectiveness of Mallinckrodt Pharmaceuticals' blockbuster drug H.P. Acthar over cheaper...
MNK,MNK:US,BBG002BHBHM1,Something weird's going on with the doctors prescribing one of pharma's most controversial blockbuster drugs,2017-03-21 16:41:58 +0000,http://finance.yahoo.com/news/something-weirds-going-doctors-prescribing-164158656.html,Something weird's going on with the doctors prescribing one of pharma's most controversial blockbuster drugs
MNK,MNK:US,BBG002BHBHM1,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline – MNK,2017-03-20 14:00:00 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-140000355.html,"[GlobeNewswire] - NEW YORK, March 20, 2017-- Pomerantz LLP announces that a class action lawsuit has been filed against Mallinckrodt plc and certain of its officers. The class action, filed in United States District Court, ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Completes Sale Of Its Intrathecal Therapy Business To Piramal Enterprises Limited For Approximately $203 Million,2017-03-20 11:00:00 +0000,http://finance.yahoo.com/news/mallinckrodt-completes-sale-intrathecal-therapy-110000625.html,"[PR Newswire] - STAINES-UPON-THAMES, United Kingdom, March 20, 2017 /PRNewswire/ -- Mallinckrodt plc (MNK), a leading specialty pharmaceutical company, announced today it has closed the sale of its Intrathecal Therapy business to Piramal Enterprises Limited's subsidiary in the U.K., Piramal Critical Care, for approximately $203 million, including fixed and contingent consideration. Mallinckrodt's divesture of this business is aligned with the company's ongoing focus on driving return on invested capital, and contributes to the strategic transformation of the company."
MNK,MNK:US,BBG002BHBHM1,"EXPANDED CLASS PERIOD: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in Mallinckrodt plc -- Lead Plaintiff Deadline of March 27, 2017",2017-03-17 13:35:00 +0000,http://finance.yahoo.com/news/expanded-class-period-levi-korsinsky-133500430.html,"[Business Wire] - The following statement is being issued by Levi & Korsinsky, LLP:"
MNK,MNK:US,BBG002BHBHM1,"UPDATE: Hagens Berman Alerts Mallinckrodt Investors to the Expanded Class Period and Reminds them of the March 27, 2017 Lead Plaintiff Deadline",2017-03-15 20:00:00 +0000,http://finance.yahoo.com/news/hagens-berman-alerts-mallinckrodt-investors-200000206.html,"[GlobeNewswire] - SAN FRANCISCO, March 15, 2017-- Hagens Berman Sobol Shapiro LLP alerts investors in Mallinckrodt PLC to the expanded class period and reminds them of the March 27, 2017 Lead Plaintiff deadline.. If you ..."
MNK,MNK:US,BBG002BHBHM1,"MALLINCKRODT SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC Announces Filing of Class Action Lawsuit Against Mallinckrodt Public Limited Company With Expanded Class Period - (MNK)",2017-03-14 00:31:40 +0000,http://finance.yahoo.com/news/mallinckrodt-shareholder-alert-former-louisiana-003140076.html,"[Marketwired] - Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., alert investors that shareholder class actions have been filed against Mallinckrodt Public Limited ..."
MNK,MNK:US,BBG002BHBHM1,Short-seller Left on Intel-Mobileye: Didn't expect whatso...,2017-03-13 21:33:00 +0000,http://finance.yahoo.com/video/short-seller-left-intel-mobileye-213300313.html,Short-seller Left on Intel-Mobileye: Didn't expect whatso...
MNK,MNK:US,BBG002BHBHM1,"MNK SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Mallinckrodt plc and a Lead Plaintiff Deadline of March 27, 2017",2017-03-13 15:13:00 +0000,http://finance.yahoo.com/news/mnk-shareholder-alert-law-offices-151300765.html,"[Business Wire] - The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Columbia on behalf of investors who purchased Mallinckrodt plc securities between November 25, 2014, and January 18, 2017."
MNK,MNK:US,BBG002BHBHM1,"DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Mallinckrodt Public Limited Company (MNK) and Lead Plaintiff Deadline: March 27, 2017",2017-03-13 14:24:00 +0000,http://finance.yahoo.com/news/deadline-alert-bronstein-gewirtz-grossman-142400862.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 13, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Mallinckrodt Public Limited Company (""Mallinckrodt"" ..."
MNK,MNK:US,BBG002BHBHM1,"SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors who Suffered Losses in Excess of $100,000 Investing in Mallinckrodt plc to Contact the Firm before Imminent Lead Plaintiff Deadline",2017-03-12 19:22:00 +0000,http://finance.yahoo.com/news/shareholder-alert-faruqi-faruqi-llp-192200269.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 12, 2017 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Mallinckrodt plc (""Mallinckrodt"" or the ""Company"") (NYSE: ..."
MNK,MNK:US,BBG002BHBHM1,"MALLINCKRODT SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Mallinckrodt Public Limited Company -",2017-03-11 03:50:00 +0000,http://finance.yahoo.com/news/mallinckrodt-shareholder-alert-former-louisiana-035000425.html,"[GlobeNewswire] - NEW ORLEANS, La., March 10, 2017-- Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., reminds investors that they have until March 27, 2017 to file ..."
MNK,MNK:US,BBG002BHBHM1,Pawar Law Group Announces Filing of Securities Class Action Lawsuit Against Mallinckrodt Public Limited Company - MNK,2017-03-11 02:41:00 +0000,http://finance.yahoo.com/news/pawar-law-group-announces-filing-024100658.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 10, 2017 / The Pawar Law Group announces a class action lawsuit on behalf of Mallinckrodt Public Limited Company ( NYSE: MNK ) investors who purchased Mallinckrodt stock ..."
MNK,MNK:US,BBG002BHBHM1,SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK,2017-03-11 01:20:00 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-012000304.html,"[PR Newswire] - NEW YORK, March 10, 2017 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Mallinckrodt plc (""Mallinckrodt"" or the ""Company"") (MNK) and certain of its officers. The class action, filed in United States District Court, District of Columbia, is on behalf of a class consisting of investors who purchased or otherwise acquired Mallinckrodt securities, seeking to recover compensable damages caused by defendants' violations of the Securities Exchange Act of 1934. If you are a shareholder who purchased Mallinckrodt securities between November 25, 2014 and January 18, 2017, both dates inclusive, you have until March 27, 2017 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll free, ext."
MNK,MNK:US,BBG002BHBHM1,"MNK Investors Deadline Reminder: Hagens Berman Reminds Mallinckrodt Investors of March 27, 2017 Lead Plaintiff Deadline and Alerts Them to the SEC Inquiry",2017-03-10 21:00:00 +0000,http://finance.yahoo.com/news/mnk-investors-deadline-reminder-hagens-210000684.html,"[GlobeNewswire] - SAN FRANCISCO, March 10, 2017-- Hagens Berman Sobol Shapiro LLP reminds investors in Mallinckrodt PLC of the March 27, 2017 Lead Plaintiff deadline and alerts them to the Company’ s receipt of a subpoena ..."
MNK,MNK:US,BBG002BHBHM1,MNK ALERT: Rosen Law Firm Reminds Mallinckrodt Public Limited Company Investors of Important Deadline in Class Action – MNK,2017-03-10 20:52:22 +0000,http://finance.yahoo.com/news/mnk-alert-rosen-law-firm-205222938.html,"[GlobeNewswire] - NEW YORK, March 10, 2017-- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Mallinckrodt Public Limited Company securities from November 25, 2014 through January 18, 2017, inclusive ..."
MNK,MNK:US,BBG002BHBHM1,"SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Mallinckrodt Public Limited Company (MNK) and Lead Plaintiff Deadline: March 27, 2017",2017-03-08 15:24:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-152400976.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 8, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Mallinckrodt Public Limited Company (""Mallinckrodt"" ..."
MNK,MNK:US,BBG002BHBHM1,"S&P 500 Movers: ENDP, SRCL",2017-03-07 18:14:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2z2nYw2U1ZU/sp-500-movers-endp-srcl-cm757329,In early trading on Tuesday shares of Stericycle topped the list of the day s best performing components of the S amp P 500 index trading up 1 7 Year to date Stericycle registers a 5 4 gain And the worst performing S amp P 500 component thus far on the day is Endo
MNK,MNK:US,BBG002BHBHM1,"Pharma, Biotech Stocks Fall on Trump Tweets, GOP Health Care Plan",2017-03-07 17:38:00 +0000,http://finance.yahoo.com/news/pharma-biotech-stocks-fall-trump-173800221.html,"Pharma, Biotech Stocks Fall on Trump Tweets, GOP Health Care Plan"
MNK,MNK:US,BBG002BHBHM1,UPDATE - SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Mallinckrodt plc and Certain Officers – MNK,2017-03-07 17:33:33 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-173333409.html,"[GlobeNewswire] - NEW YORK, March 07, 2017-- Pomerantz LLP announces that a class action lawsuit has been filed against Mallinckrodt plc and certain of its officers. The class action, filed in United States District Court, ..."
MNK,MNK:US,BBG002BHBHM1,These stocks are getting whacked after the GOP unveils its Obamacare replacement,2017-03-07 16:17:12 +0000,http://finance.yahoo.com/news/these-stocks-are-getting-whacked-after-the-gop-unveils-its-obamacare-replacement-161712523.html,These stocks are getting whacked after the GOP unveils its Obamacare replacement
MNK,MNK:US,BBG002BHBHM1,SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Mallinckrodt plc and Certain Officers – MNK,2017-03-06 22:26:22 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-222622535.html,"[GlobeNewswire] - NEW YORK, March 06, 2017-- Pomerantz LLP announces that a class action lawsuit has been filed against Mallinckrodt plc and certain of its officers. The class action, filed in United States District Court, ..."
MNK,MNK:US,BBG002BHBHM1,"When Journalists And Companies Don't See Eye-To-Eye On Coverage, Things Can Get Messy",2017-03-05 01:02:34 +0000,http://finance.yahoo.com/news/journalists-companies-dont-see-eye-010234006.html,"When Journalists And Companies Don't See Eye-To-Eye On Coverage, Things Can Get Messy"
MNK,MNK:US,BBG002BHBHM1,"INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in Mallinckrodt plc -- Lead Plaintiff Deadline of March 27, 2017",2017-03-03 15:11:00 +0000,http://finance.yahoo.com/news/investor-alert-levi-korsinsky-llp-151100709.html,"[Business Wire] - The following statement is being issued by Levi & Korsinsky, LLP:"
MNK,MNK:US,BBG002BHBHM1,Enterprise’s Benoist sells over $1 million worth of stock: Insider trading for Feb. 21-28,2017-03-02 16:35:09 +0000,http://www.bizjournals.com/stlouis/news/2017/03/02/enterprise-s-benoist-sells-over-1-million-worth-of.html?ana=yahoo,Enterprise’s Benoist sells over $1 million worth of stock: Insider trading for Feb. 21-28
MNK,MNK:US,BBG002BHBHM1,"MALLINCKRODT PLC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of M",2017-03-01 21:57:16 +0000,http://biz.yahoo.com/e/170301/mnk8-k.html,"MALLINCKRODT PLC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of M"
MNK,MNK:US,BBG002BHBHM1,8:03 am Mallinckrodt plc's Board of Directors authorizes an incremental $1.0 billion repurchase of ordinary shares,2017-03-01 13:03:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#mnk,8:03 am Mallinckrodt plc's Board of Directors authorizes an incremental $1.0 billion repurchase of ordinary shares
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt plc Board Expands Company's Share Repurchase Plan by $1.0 Billion; Company Announces Results of 2017 Annual General Meeting,2017-03-01 13:00:00 +0000,http://finance.yahoo.com/news/mallinckrodt-plc-board-expands-companys-130000974.html,"[PR Newswire] - STAINES-UPON-THAMES, United Kingdom, March 1, 2017 /PRNewswire/ -- Mallinckrodt plc (MNK), a leading global specialty pharmaceutical company, today announced the results from its 2017 Annual General Meeting. Additionally, the company's Board of Directors authorized an incremental repurchase of ordinary shares."
MNK,MNK:US,BBG002BHBHM1,"SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Mallinckrodt plc To Contact The Firm Before Lead Plaintiff Deadline",2017-02-28 21:21:00 +0000,http://finance.yahoo.com/news/shareholder-alert-faruqi-faruqi-llp-212100609.html,"[PR Newswire] - NEW YORK, Feb. 28, 2017 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Mallinckrodt plc (""Mallinckrodt"" or the ""Company"") (MNK) of the March 27, 2017 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers. The lawsuit has been filed in the U.S. District Court for the District of Columbia on behalf of all those who purchased Mallinckrodt stock or options between November 25, 2014 and January 18, 2017 (the ""Class Period""). The case, SHENK v. MALLINCKRODT PLC et al., No. 17-cv-00145 was filed on January 23, 2017."
MNK,MNK:US,BBG002BHBHM1,MNK INVESTORS ALERT: Lieff Cabraser Reminds Investors of Deadline in Class Action Against Mallinckrodt plc,2017-02-28 19:54:00 +0000,http://finance.yahoo.com/news/mnk-investors-alert-lieff-cabraser-195400693.html,"[Business Wire] - The law firm of Lieff Cabraser Heimann & Bernstein, LLP reminds investors of the upcoming deadline to move for appointment as lead plaintiff in securities class litigation brought on behalf of investors who purchased or otherwise acquired the securities of Mallinckrodt plc between November 25, 2014 and January 18, 2017, inclusive ."
MNK,MNK:US,BBG002BHBHM1,"MNK SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Mallinckrodt plc and a Lead Plaintiff Deadline of March 27, 2017",2017-02-27 15:37:00 +0000,http://finance.yahoo.com/news/mnk-shareholder-alert-law-offices-153700578.html,"[Business Wire] - The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Columbia on behalf of investors who purchased Mallinckrodt plc securities between November 25, 2014, and January 18, 2017."
MNK,MNK:US,BBG002BHBHM1,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Mallinckrodt Public Limited Company (MNK) and Lead Plaintiff Deadline: March 27, 2017",2017-02-27 15:14:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-151400367.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / February 27, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Mallinckrodt Public Limited Company (""Mallinckrodt"" ..."
MNK,MNK:US,BBG002BHBHM1,"DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Mallinckrodt Public Limited Company To Contact The Firm",2017-02-26 11:00:00 +0000,http://finance.yahoo.com/news/deadline-alert-brower-piven-alerts-110000976.html,"[Business Wire] - The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Columbia on behalf of purchasers of Mallinckrodt Public Limited Company securities during the period between November 25, 2014 and January 18, 2017, inclusive ."
MNK,MNK:US,BBG002BHBHM1,"MALLINCKRODT SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Mallinckrodt Public Limited Company –",2017-02-25 03:50:00 +0000,http://finance.yahoo.com/news/mallinckrodt-shareholder-alert-former-louisiana-035000579.html,"[Business Wire] - Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., reminds investors that they have until March 27, 2017 to file lead plaintiff applications in a securities class action lawsuit against Mallinckrodt Public Limited Company , if they purchased the Company’s securities between November 25, 2014 and January 18, 2017, inclusive ."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt To Present At Barclays Global Healthcare Conference,2017-02-24 21:30:00 +0000,http://finance.yahoo.com/news/mallinckrodt-present-barclays-global-healthcare-213000183.html,"[PR Newswire] - STAINES-UPON-THAMES, United Kingdom, Feb. 24, 2017 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Wednesday, March 15, 2017, ..."
MNK,MNK:US,BBG002BHBHM1,"MALLINCKRODT PLC Files SEC form 8-K, Change in Directors or Principal Officers",2017-02-23 21:03:27 +0000,http://biz.yahoo.com/e/170223/mnk8-k.html,"MALLINCKRODT PLC Files SEC form 8-K, Change in Directors or Principal Officers"
MNK,MNK:US,BBG002BHBHM1,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Mallinckrodt Public Limited Company (MNK) and Lead Plaintiff Deadline - March 27, 2017",2017-02-23 15:09:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-150900674.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / February 23, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Mallinckrodt Public Limited Company (""Mallinckrodt"" ..."
MNK,MNK:US,BBG002BHBHM1,"MNK INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Mallinckrodt plc and a Lead Plaintiff Deadline of March 27, 2017",2017-02-22 16:47:55 +0000,http://finance.yahoo.com/news/mnk-investor-alert-law-offices-164755278.html,"[GlobeNewswire] - NEW YORK, Feb. 22, 2017-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Columbia on behalf of investors who purchased Mallinckrodt ..."
MNK,MNK:US,BBG002BHBHM1,Coverage initiated on Mallinckrodt plc by Canaccord Genuity,2017-02-22 15:21:13 +0000,http://finance.yahoo.com/q/ud?s=MNK,Coverage initiated on Mallinckrodt plc by Canaccord Genuity
MNK,MNK:US,BBG002BHBHM1,EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Mallinckrodt Public Limited Company – MNK,2017-02-20 21:00:30 +0000,http://finance.yahoo.com/news/equity-alert-rosen-law-firm-210030877.html,"[GlobeNewswire] - NEW YORK, Feb. 20, 2017-- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Mallinckrodt Public Limited Company securities from ..."
MNK,MNK:US,BBG002BHBHM1,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed a Complaint to Recover Losses Suffered by Investors in Mallinckrodt plc",2017-02-17 15:50:38 +0000,http://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-155038102.html,"[GlobeNewswire] - NEW YORK, Feb. 17, 2017-- The following statement is being issued by Levi & Korsinsky, LLP:. To: All persons or entities who purchased or otherwise acquired common stock shares of Mallinckrodt plc between ..."
MNK,MNK:US,BBG002BHBHM1,Dow Didn't Need a Break,2017-02-17 14:54:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-XRc5lmQCFU/dow-didnt-need-a-break-cm749354,For the most part stocks took a break from their torrid pace on Thursday However if the session had been just a few minutes longer the major indices may have been able to finish in positive territory again thanks to a late day rally In the end though only the Dow managed to come all the
MNK,MNK:US,BBG002BHBHM1,"Blog Coverage The Biologics License Application for Mylan-Biocon's Proposed Biosimilar - Pegfilgrastim, Gets Accepted by US FDA for Review",2017-02-17 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-biologics-license-application-131500763.html,"[Accesswire] - Upcoming AWS Coverage on Mallinckrodt Post-Earnings Results LONDON, UK / ACCESSWIRE / February 17, 2017 / Active Wall St. blog coverage looks at the headline from Mylan N.V (NASDAQ: MYL ) as the Company ..."
MNK,MNK:US,BBG002BHBHM1,"We dug into the drug company Martin Shkreli sold out to the feds, and man is it ugly",2017-02-16 18:43:00 +0000,http://finance.yahoo.com/news/dug-drug-martin-shkreli-sold-183712948.html,"We dug into the drug company Martin Shkreli sold out to the feds, and man is it ugly"
MNK,MNK:US,BBG002BHBHM1,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Mallinckrodt Public Limited Company (MNK) & Lead Plaintiff Deadline -- March 27, 2017",2017-02-16 15:10:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-151000676.html,"[GlobeNewswire] - NEW YORK, Feb. 16, 2017-- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Mallinckrodt Public Limited Company and certain ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt plc -- Moody's assigns Ba1 to Mallinckrodt's new senior secured term loan,2017-02-15 22:47:08 +0000,http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_362175&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20170215_PR_362175,Mallinckrodt plc -- Moody's assigns Ba1 to Mallinckrodt's new senior secured term loan
MNK,MNK:US,BBG002BHBHM1,"SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Mallinckrodt Public Limited Company (MNK) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit",2017-02-15 20:49:46 +0000,http://finance.yahoo.com/news/shareholder-alert-brower-piven-encourages-204946755.html,"[GlobeNewswire] - STEVENSON, Md., Feb. 15, 2017-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court ..."
MNK,MNK:US,BBG002BHBHM1,Eli Lilly Is Great Stock to Buy Now,2017-02-15 15:42:00 +0000,https://www.thestreet.com/story/14002149/1/eli-lilly-is-great-stock-to-buy-now.html?puc=yahoo&cm_ven=YAHOO,Eli Lilly Is Great Stock to Buy Now
MNK,MNK:US,BBG002BHBHM1,MNK INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against Mallinckrodt plc,2017-02-14 14:00:00 +0000,http://finance.yahoo.com/news/mnk-investors-alert-lieff-cabraser-140000099.html,"[Business Wire] - The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action litigation has been filed on behalf of investors who purchased or otherwise acquired the securities of Mallinckrodt plc between November 25, 2014 and January 18, 2017, inclusive ."
MNK,MNK:US,BBG002BHBHM1,"INVESTOR ALERT: Levi & Korsinsky, LLP Files Complaint to Recover Losses Suffered by Investors in Mallinckrodt plc Lead Plaintiff Deadline of March 27, 2017",2017-02-13 18:59:00 +0000,http://finance.yahoo.com/news/investor-alert-levi-korsinsky-llp-185900722.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / February 13, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired common stock shares of ..."
MNK,MNK:US,BBG002BHBHM1,Medicare spent $650M on 1 drug of questionable use: OHSU study,2017-02-13 18:13:12 +0000,http://www.bizjournals.com/portland/news/2017/02/13/medicare-spent-650m-on-1-drug-of-questionable-use.html?ana=yahoo,Medicare spent $650M on 1 drug of questionable use: OHSU study
MNK,MNK:US,BBG002BHBHM1,MALLINCKRODT PLC Financials,2017-02-11 18:04:07 +0000,http://finance.yahoo.com/q/is?s=mnk,MALLINCKRODT PLC Financials
MNK,MNK:US,BBG002BHBHM1,"MALLINCKRODT SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Mallinckrodt Public Limited Company -",2017-02-11 03:50:00 +0000,http://finance.yahoo.com/news/mallinckrodt-shareholder-alert-former-louisiana-035000076.html,"[PR Newswire] - NEW ORLEANS, Feb. 10, 2017 /PRNewswire/ -- Kahn Swick & Foti, LLC (""KSF"") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., reminds investors that they have until ..."
MNK,MNK:US,BBG002BHBHM1,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Mallinckrodt Public Limited Company (MNK) and Lead Plaintiff Deadline - March 27, 2017",2017-02-10 15:20:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-152000926.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / February 10, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Mallinckrodt Public Limited Company (""Mallinckrodt"" ..."
MNK,MNK:US,BBG002BHBHM1,"LESS THAN TWO MONTHS REMAIN FOR MALLINCKRODT INVESTORS: Hagens Berman Reminds Mallinckrodt Investors of March 27, 2017 Lead Plaintiff Deadline",2017-02-10 14:30:00 +0000,http://finance.yahoo.com/news/less-two-months-remain-mallinckrodt-143000363.html,"[GlobeNewswire] - SAN FRANCISCO, Feb. 10, 2017-- Hagens Berman Sobol Shapiro LLP reminds investors in Mallinckrodt PLC of the March 27, 2017 Lead Plaintiff deadline.. If you purchased or otherwise acquired securities of ..."
MNK,MNK:US,BBG002BHBHM1,MNK LOSS NOTICE: Rosen Law Firm Reminds Mallinckrodt Public Limited Company Investors of Important Deadline in Class Action,2017-02-08 22:47:00 +0000,http://finance.yahoo.com/news/mnk-loss-notice-rosen-law-224700054.html,"[Business Wire] - Rosen Law Firm, a global investor rights law firm, reminds purchasers of Mallinckrodt Public Limited Company securities from November 25, 2014 through January 18, 2017, inclusive of the important March 27, 2017 lead plaintiff deadline in the class action."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt receives subpoenas,2017-02-08 21:05:06 +0000,http://www.bizjournals.com/stlouis/news/2017/02/08/mallinckrodt-receives-subpoenas.html?ana=yahoo,Mallinckrodt receives subpoenas
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Plc :MNK-US: Earnings Analysis: Q1, 2017 By the Numbers : February 8, 2017",2017-02-08 15:55:01 +0000,http://www.capitalcube.com/blog/index.php/mallinckrodt-plc-mnk-us-earnings-analysis-q1-2017-by-the-numbers-february-8-2017/,"Mallinckrodt Plc :MNK-US: Earnings Analysis: Q1, 2017 By the Numbers : February 8, 2017"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Stock Dives On Guidance For Toppling Generics In 2017,2017-02-07 21:44:51 +0000,http://www.investors.com/news/technology/mallinckrodt-stock-dives-on-guidance-for-toppling-generics-in-2017/,Mallinckrodt Stock Dives On Guidance For Toppling Generics In 2017
MNK,MNK:US,BBG002BHBHM1,Edited Transcript of MNK earnings conference call or presentation 7-Feb-17 1:30pm GMT,2017-02-07 21:07:50 +0000,http://finance.yahoo.com/news/edited-transcript-mnk-earnings-conference-210750761.html,Edited Transcript of MNK earnings conference call or presentation 7-Feb-17 1:30pm GMT
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt (MNK) Tops on Earnings in Transition Quarter,2017-02-07 18:18:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fz9EcY_pMUc/mallinckrodt-mnk-tops-on-earnings-in-transition-quarter-cm744349,Mallinckrodt Public Limited Company MNK reported positive results for the transition quarter Oct 1 to Dec 30 2016 beating both sales and earnings expectations The last quarter of 2016 was the planned transition period as the company aligns to a calendar based financial year The
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt (MNK) Tops on Earnings in Transition Quarter,2017-02-07 15:56:03 +0000,http://finance.yahoo.com/news/mallinckrodt-mnk-tops-earnings-transition-155603778.html,Mallinckrodt (MNK) Tops on Earnings in Transition Quarter
MNK,MNK:US,BBG002BHBHM1,"Stocks to Watch: General Motors, Mallinckrodt, Centene",2017-02-07 14:25:49 +0000,http://blogs.wsj.com/moneybeat/2017/02/07/stocks-to-watch-general-motors-mallinckrodt-centene/?mod=yahoo_hs,"Stocks to Watch: General Motors, Mallinckrodt, Centene"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt (MNK) Tops  Earnings & Sales Estimates,2017-02-07 14:20:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TUQvTOSWE2I/mallinckrodt-mnk-tops-earnings-sales-estimates-cm744122,Ireland based Mallinckrodt Public Limited Company MNK focuses on developing treatments for autoimmune and rare diseases including neurology rheumatology nephrology and pulmonology as well as therapies for pain management The company develops manufactures markets and distributes
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Plc 2016 Transition Period Earnings Call scheduled for 8:30 am ET today,2017-02-07 13:30:00 +0000,http://biz.yahoo.com/cc/5/154865.html,Mallinckrodt Plc 2016 Transition Period Earnings Call scheduled for 8:30 am ET today
MNK,MNK:US,BBG002BHBHM1,"Early movers: GM, KORS, FOXA, GPS, CNC, MNK & more",2017-02-07 13:17:11 +0000,http://www.cnbc.com/id/104266281?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104266281,"Early movers: GM, KORS, FOXA, GPS, CNC, MNK & more"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt (MNK) Tops Earnings & Sales Estimates,2017-02-07 13:06:01 +0000,http://finance.yahoo.com/news/mallinckrodt-mnk-tops-earnings-sales-130601816.html,Mallinckrodt (MNK) Tops Earnings & Sales Estimates
MNK,MNK:US,BBG002BHBHM1,Q1 2017 Mallinckrodt Plc Earnings Release - Before Market Open,2017-02-07 12:07:06 +0000,http://biz.yahoo.com/research/earncal/20170207.html?t=mnk,Q1 2017 Mallinckrodt Plc Earnings Release - Before Market Open
MNK,MNK:US,BBG002BHBHM1,"Earnings Reaction History: Mallinckrodt plc, 45.5% Follow-Through Indicator, 5.7% Sensitive",2017-02-07 11:37:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/niWxwo9eXRg/earnings-reaction-history-mallinckrodt-plc-455-follow-through-indicator-57-sensitive-cm743957,Expected Earnings Release 02 07 2017 PremarketExpected Earnings Release 02 07 2017 Premarket Avg Extended Hours Dollar Volume 2 591 854Avg Extended Hours Dollar Volume 2 591 854 Mallinckrodt plc MNK is due to issue its quarterly earnings report in the upcoming extended hours
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt reports 4Q loss,2017-02-07 11:16:31 +0000,http://sg.finance.yahoo.com/news/mallinckrodt-reports-4q-loss-111631896.html,Mallinckrodt reports 4Q loss
MNK,MNK:US,BBG002BHBHM1,"MALLINCKRODT PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits",2017-02-07 11:09:02 +0000,http://biz.yahoo.com/e/170207/mnk8-k.html,"MALLINCKRODT PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt plc Reports Transition Period Results and Announces 2017 Guidance,2017-02-07 11:00:00 +0000,http://finance.yahoo.com/news/mallinckrodt-plc-reports-transition-period-110000969.html,"[PR Newswire] - STAINES-UPON-THAMES, United Kingdom, Feb. 7, 2017 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today reported results for the transition period from ..."
MNK,MNK:US,BBG002BHBHM1,Levi & Korsinsky Notifies Shareholders of a Complaint Filed in U.S. District Court to Recover Losses Suffered by Investors in Mallinckrodt (MNK),2017-02-06 19:33:23 +0000,http://ir.baystreet.ca/article.aspx?id=458&1486409603,Levi & Korsinsky Notifies Shareholders of a Complaint Filed in U.S. District Court to Recover Losses Suffered by Investors in Mallinckrodt (MNK)
MNK,MNK:US,BBG002BHBHM1,Could President Trump's Policies Be Terrible for These Healthcare Stocks?,2017-02-06 14:31:50 +0000,http://www.fool.com/investing/2017/02/05/could-president-trumps-policies-be-terrible-for-th.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Could President Trump's Policies Be Terrible for These Healthcare Stocks?
MNK,MNK:US,BBG002BHBHM1,"Drug Stocks Reporting Earnings on Feb 7: GILD, MNK & More",2017-02-06 13:45:01 +0000,http://finance.yahoo.com/news/drug-stocks-reporting-earnings-feb-134501581.html,"Drug Stocks Reporting Earnings on Feb 7: GILD, MNK & More"
MNK,MNK:US,BBG002BHBHM1,Could President Trump's Policies Be Terrible for These Healthcare Stocks?,2017-02-05 18:17:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fxPC7KV1LFA/could-president-trumps-policies-be-terrible-for-these-healthcare-stocks-cm743374,Help or hurt That s the question investors are trying to answer about how President Trump s policies might impact healthcare stocks So far specific policy proposals put forward by the president appear likely to cause significant problems for certain healthcare stocks Here s why
MNK,MNK:US,BBG002BHBHM1,"INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Mallinckrodt Public Limited Company To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit",2017-02-03 19:16:00 +0000,http://finance.yahoo.com/news/investor-alert-brower-piven-encourages-191600397.html,"[Business Wire] - The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Columbia on behalf of purchasers of Mallinckrodt Public Limited Company securities during the period between November 25, 2014 and January 18, 2017, inclusive ."
MNK,MNK:US,BBG002BHBHM1,Bartosiak: Trading Mallinckrodt's (MNK) Earnings with Options,2017-02-03 01:31:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g-xlhz6OQx4/bartosiak-trading-mallinckrodts-mnk-earnings-with-options-cm742616,On Tuesday February 7 th Mallinckrodt MNK will release its fourth quarter earnings results before the bell The company is a Zacks Rank 5 Strong Sell and have a Value Growth and Momentum score of A Dave will look at Mallinckrodt s past earnings take a look at what is currently
MNK,MNK:US,BBG002BHBHM1,Bartosiak: Trading Mallinckrodt's (MNK) Earnings with Options,2017-02-02 23:12:11 +0000,http://finance.yahoo.com/news/bartosiak-trading-mallinckrodts-mnk-earnings-231211949.html,Bartosiak: Trading Mallinckrodt's (MNK) Earnings with Options
MNK,MNK:US,BBG002BHBHM1,"Deals, Bargain Price Make Mallinckrodt a Good Pharma Buy",2017-02-02 20:54:00 +0000,https://www.thestreet.com/story/13976857/1/deals-bargain-price-make-mallinckrodt-a-good-pharma-buy.html?puc=yahoo&cm_ven=YAHOO,"Deals, Bargain Price Make Mallinckrodt a Good Pharma Buy"
MNK,MNK:US,BBG002BHBHM1,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Mallinckrodt Public Limited Company (MNK) and Lead Plaintiff Deadline - March 27, 2017",2017-02-02 15:34:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-153400452.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / February 2, 2017 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Mallinckrodt Public Limited Company (""Mallinckrodt"" ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt (MNK) Earnings This Quarter: Stock to Disappoint?,2017-02-01 21:30:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BlJhQrVQ56E/mallinckrodt-mnk-earnings-this-quarter-stock-to-disappoint-cm741800,Mallinckrodt plc MNK is set to report results for the quarter ended Dec 30 2016 on Feb 7 We note that this quarter is a transition quarter for the company In May 2016 Mallinckrodt announced that its board of directors has approved a change in the company s fiscal year end to the last
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt (MNK) Earnings This Quarter: Stock to Disappoint?,2017-02-01 19:51:07 +0000,http://finance.yahoo.com/news/mallinckrodt-mnk-earnings-quarter-stock-195107729.html,Mallinckrodt (MNK) Earnings This Quarter: Stock to Disappoint?
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Sells Spinal Unit for $171M Upfront,2017-02-01 17:31:00 +0000,http://www.investopedia.com/news/mallinckrodt-sells-spinal-drug-unit-mnk/?partner=YahooSA,Mallinckrodt Sells Spinal Unit for $171M Upfront
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt to Sell Intrathecal Therapy Business for $203M,2017-02-01 01:30:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yN4SP4QBw4A/mallinckrodt-to-sell-intrathecal-therapy-business-for-203m-cm741232,Mallinckrodt plc MNK entered into an agreement with the Piramal Enterprises Limited s subsidiary Piramal Critical Care in the U K to sell its Intrathecal Therapy business for approximately 203 million Mallinckrodt s share price declined 24 0 in the past one year compared with
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt to Sell Intrathecal Therapy Business for $203M,2017-01-31 23:32:11 +0000,http://finance.yahoo.com/news/mallinckrodt-sell-intrathecal-therapy-business-233211587.html,Mallinckrodt to Sell Intrathecal Therapy Business for $203M
MNK,MNK:US,BBG002BHBHM1,"MNK SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Mallinckrodt plc and a Lead Plaintiff Deadline of March 27, 2017",2017-01-31 17:47:32 +0000,http://finance.yahoo.com/news/mnk-shareholder-alert-law-offices-174732585.html,"[GlobeNewswire] - NEW YORK, Jan. 31, 2017-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Columbia on behalf of investors who purchased Mallinckrodt ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Divests Drug Delivery Unit as Shedding Continues,2017-01-30 20:18:00 +0000,https://www.thestreet.com/story/13971407/1/mallinckrodt-divests-drug-delivery-unit-as-shedding-continues.html?puc=yahoo&cm_ven=YAHOO,Mallinckrodt Divests Drug Delivery Unit as Shedding Continues
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt sells Intrathecal Therapy business in $203 million deal,2017-01-30 14:00:09 +0000,http://www.bizjournals.com/stlouis/news/2017/01/30/mallinckrodt-sells-intrathecal-therapybusiness-in.html?ana=yahoo,Mallinckrodt sells Intrathecal Therapy business in $203 million deal
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt To Sell Intrathecal Therapy Business To Piramal Enterprises Limited For Approximately $203 Million,2017-01-30 11:00:00 +0000,http://finance.yahoo.com/news/mallinckrodt-sell-intrathecal-therapy-business-110000430.html,"[PR Newswire] - STAINES-UPON-THAMES, United Kingdom, Jan. 30, 2017 /PRNewswire/ -- Mallinckrodt plc (MNK), a leading specialty pharmaceutical company, announced today it has entered into an agreement under which it will sell its Intrathecal Therapy business to Piramal Enterprises Limited's subsidiary in the U.K., Piramal Critical Care, for approximately $203 million, including fixed and contingent consideration. Piramal Critical Care is an integral business unit of Piramal Enterprises Limited and a global leader in the field of anesthesia."
MNK,MNK:US,BBG002BHBHM1,"MALLINCKRODT SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Mallinckrodt Public Limited Company -",2017-01-28 03:50:00 +0000,http://finance.yahoo.com/news/mallinckrodt-shareholder-alert-former-louisiana-035000273.html,"[Marketwired] - Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., reminds investors that they have until March 27, 2017 to file lead plaintiff applications in a securities ..."
MNK,MNK:US,BBG002BHBHM1,"MALLINCKRODT PLC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Fi",2017-01-27 20:38:28 +0000,http://biz.yahoo.com/e/170127/mnk8-k.html,"MALLINCKRODT PLC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Fi"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Completes Sale Of Its Nuclear Imaging Business To IBA Molecular For Approximately $690 Million,2017-01-27 20:30:00 +0000,http://finance.yahoo.com/news/mallinckrodt-completes-sale-nuclear-imaging-203000139.html,"[PR Newswire] - STAINES-UPON-THAMES, England, Jan. 27, 2017 /PRNewswire/ -- Mallinckrodt plc (MNK), a leading specialty pharmaceutical company, announced today that it has closed the sale of its global Nuclear Imaging business to IBA Molecular (IBAM) for approximately $690 million before tax, including up-front and contingent considerations and the assumption of long-term obligations. Mallinckrodt's Nuclear Imaging operations encompass two manufacturing facilities and a total of more than 800 employees in locations across the globe, including nearly 350 in the St. Louis, Mo. area. The entire workforce and the manufacturing facilities have been transferred to IBAM."
MNK,MNK:US,BBG002BHBHM1,"SHAREHOLDER COMPLAINT FILED: Levi & Korsinsky, LLP Files Complaint to Recover Losses Suffered by Investors in Mallinckrodt plc",2017-01-27 19:45:00 +0000,http://finance.yahoo.com/news/shareholder-complaint-filed-levi-korsinsky-194500825.html,"[PR Newswire] - NEW YORK, Jan. 27, 2017 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired common stock shares of Mallinckrodt ..."
MNK,MNK:US,BBG002BHBHM1,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mallinckrodt plc - MNK,2017-01-27 18:42:00 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-184200478.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / January 27, 2017 / Pomerantz LLP is investigating claims on behalf of investors of Mallinckrodt plc (""Mallinckrodt"" or the ""Company"") (NYSE: MNK). Such investors ..."
MNK,MNK:US,BBG002BHBHM1,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Mallinckrodt Public Limited Company (MNK) and Lead Plaintiff Deadline - March 27, 2017",2017-01-27 15:10:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-151000050.html,"[GlobeNewswire] - NEW YORK, Jan. 27, 2017-- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Mallinckrodt Public Limited Company and certain ..."
MNK,MNK:US,BBG002BHBHM1,TWO MONTHS REMAIN FOR MALLINCKRODT PLC INVESTORS: Hagens Berman Alerts Mallinckrodt Investors to Securities Class Action and Lead Plaintiff Deadline,2017-01-27 14:30:00 +0000,http://finance.yahoo.com/news/two-months-remain-mallinckrodt-plc-143000850.html,"[GlobeNewswire] - SAN FRANCISCO, Jan. 27, 2017-- Hagens Berman Sobol Shapiro LLP alerts investors in Mallinckrodt PLC to the securities class action lawsuit filed in the U.S. District Court for the District of Columbia ..."
MNK,MNK:US,BBG002BHBHM1,"SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Mallinckrodt Public Limited Company (MNK) To Contact Brower Piven Before The Lead Plain",2017-01-27 03:30:00 +0000,http://finance.yahoo.com/news/shareholder-alert-brower-piven-notifies-033000783.html,"[GlobeNewswire] - STEVENSON, Md., Jan. 26, 2017-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court ..."
MNK,MNK:US,BBG002BHBHM1,Robbins Arroyo LLP: Mallinckrodt plc (MNK) Misled Shareholders According to a Recently Filed Class Action,2017-01-26 23:08:00 +0000,http://finance.yahoo.com/news/robbins-arroyo-llp-mallinckrodt-plc-230800753.html,[Business Wire] - Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against Mallinckrodt plc in the U.S. District Court for the District of Columbia.
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt To Present At Leerink Partners 6th Annual Global Healthcare Conference,2017-01-26 22:00:00 +0000,http://finance.yahoo.com/news/mallinckrodt-present-leerink-partners-6th-220000168.html,"[PR Newswire] - STAINES-UPON-THAMES, United Kingdom, Jan. 26, 2017 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Wednesday, Feb. 15, 2017, ..."
MNK,MNK:US,BBG002BHBHM1,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mallinckrodt plc - MNK,2017-01-26 21:36:00 +0000,http://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-213600733.html,"[PR Newswire] - NEW YORK, Jan. 26, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Mallinckrodt plc (""Mallinckrodt"" or the ""Company"") (NYSE: MNK). Such investors ..."
MNK,MNK:US,BBG002BHBHM1,INVESTOR ALERT: Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Mallinckrodt Public Limited Company Investors and Encourages Investors to Contact the Firm,2017-01-26 15:30:00 +0000,http://finance.yahoo.com/news/investor-alert-glancy-prongay-murray-153000846.html,"[Business Wire] - Glancy Prongay & Murray LLP announces that a class action lawsuit has been filed on behalf of investors who purchased Mallinckrodt Public Limited Company securities between November 25, 2014 and January 18, 2017, inclusive ."
MNK,MNK:US,BBG002BHBHM1,"IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Mallinckrodt PLC., and Encourages Investors with Losses to Contact the Firm",2017-01-25 20:26:00 +0000,http://finance.yahoo.com/news/important-shareholder-alert-khang-khang-202600590.html,"[Accesswire] - IRVINE, CA / ACCESSWIRE / January 25, 2017 / Khang & Khang LLP (the ""Firm"") announces the filing of a class action lawsuit against Mallinckrodt PLC (""Mallinckrodt"" or the ""Company"") ..."
MNK,MNK:US,BBG002BHBHM1,The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Mallinckrodt Public Limited Company Investors and Encourages Investors to Contact the Firm,2017-01-25 19:24:00 +0000,http://finance.yahoo.com/news/law-offices-howard-g-smith-192400697.html,"[Business Wire] - Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Mallinckrodt Public Limited Company securities between November 25, 2014 and January 18, 2017, inclusive ."
MNK,MNK:US,BBG002BHBHM1,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Mallinckrodt Public Limited Company (MNK) and Lead Plaintiff Deadline - March 27, 2017",2017-01-25 18:02:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-180200703.html,"[PR Newswire] - NEW YORK, Jan. 25, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Mallinckrodt Public Limited Company ..."
MNK,MNK:US,BBG002BHBHM1,First Week of MNK March 17th Options Trading,2017-01-25 17:34:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sMuGeRvNTss/first-week-of-mnk-march-17th-options-trading-cm738121,Investors in Mallinckrodt plc Symbol MNK saw new options become available this week for the March 17th expiration At Stock Options Channel our YieldBoost formula has looked up and down the MNK options chain for the new March 17th contracts and identified one put and one call contract
MNK,MNK:US,BBG002BHBHM1,INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Mallinckrodt PLC and Encourages Investors with Losses to Contact the Firm,2017-01-25 16:03:00 +0000,http://finance.yahoo.com/news/investor-alert-lundin-law-pc-160300754.html,"[Business Wire] - Lundin Law PC, a shareholder rights firm announces a class action lawsuit against Mallinckrodt PLC . Investors who purchased or otherwise acquired Mallinckrodt PLC shares between November 25, 2014 and January 18, 2017 inclusive , are encouraged to contact the firm in advance of the March 27, 2017 lead plaintiff deadline."
MNK,MNK:US,BBG002BHBHM1,"SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Mallinckrodt plc To Contact The Firm Before Lead Plaintiff Deadline",2017-01-25 14:35:00 +0000,http://finance.yahoo.com/news/shareholder-alert-faruqi-faruqi-llp-143500908.html,"[GlobeNewswire] - NEW YORK, Jan. 25, 2017-- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Mallinckrodt plc of the March 27, 2017 deadline to seek the role of lead plaintiff in a federal ..."
MNK,MNK:US,BBG002BHBHM1,IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Mallinckrodt PLC and Encourages Investors with Losses to Contact the Firm,2017-01-25 02:01:00 +0000,http://finance.yahoo.com/news/important-investor-alert-khang-khang-020100605.html,"[Business Wire] - Khang & Khang LLP announces the filing of a class action lawsuit against Mallinckrodt PLC . Investors who purchased or otherwise acquired Mallinckrodt shares between November 25, 2014 and January 18, 2017 inclusive , are encouraged to contact the firm in advance of the March 27, 2017 lead plaintiff deadline."
MNK,MNK:US,BBG002BHBHM1,"MALLINCKRODT SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Mallinckrodt Public Limited Company –",2017-01-25 01:37:50 +0000,http://finance.yahoo.com/news/mallinckrodt-shareholder-alert-former-louisiana-013750584.html,"[GlobeNewswire] - NEW ORLEANS, Jan. 24, 2017-- Kahn Swick & Foti, LLC and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., reminds investors that they have until March 27, 2017 to file lead plaintiff ..."
MNK,MNK:US,BBG002BHBHM1,Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Mallinckrodt plc (MNK),2017-01-25 01:00:00 +0000,http://finance.yahoo.com/news/gainey-mckenna-egleston-announces-class-010000953.html,"[GlobeNewswire] - NEW YORK, Jan. 24, 2017-- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against Mallinckrodt plc in the United States District Court for the District of Columbia on behalf ..."
MNK,MNK:US,BBG002BHBHM1,SHAREHOLDER ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit against Mallinckrodt PLC and Encourages Investors with Losses to Contact the Firm,2017-01-25 00:17:00 +0000,http://finance.yahoo.com/news/shareholder-alert-goldberg-law-pc-001700368.html,"[Business Wire] - Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Mallinckrodt PLC ."
MNK,MNK:US,BBG002BHBHM1,Levi & Korsinsky Notifies Shareholders of a Complaint Filed in U.S. District Court to Recover Losses Suffered by Investors in Mallinckrodt plc (MNK),2017-01-24 21:55:45 +0000,http://finance.yahoo.com/news/levi-korsinsky-notifies-shareholders-complaint-215545875.html,"[GlobeNewswire] - NEW YORK, Jan. 24, 2017-- Levi & Korsinsky, LLP announced that a class action has commenced in the USDC for the District of Columbia on behalf of purchasers of Mallinckrodt plc who purchased shares between ..."
MNK,MNK:US,BBG002BHBHM1,EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Mallinckrodt plc,2017-01-24 20:31:00 +0000,http://finance.yahoo.com/news/equity-alert-rosen-law-firm-203100917.html,"[Business Wire] - Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Mallinckrodt plc securities from November 25, 2014 through January 18, 2017, inclusive ."
MNK,MNK:US,BBG002BHBHM1,Shareholder Class Action Filed Against Mallinckrodt plc - MNK,2017-01-24 16:15:00 +0000,http://finance.yahoo.com/news/shareholder-class-action-filed-against-161500317.html,"[PR Newswire] - RADNOR, Pa., Jan. 24, 2017 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that it has filed a shareholder class action lawsuit against Mallinckrodt plc (MNK) (""Mallinckrodt"" or the ""Company"") on behalf of purchasers of the Company's securities between November 25, 2014 and January 18, 2017, inclusive (the ""Class Period""). The action was filed in the U.S. District Court for the District of Columbia and is captioned Shenk v. Mallinckrodt plc, et al., No. 1:17-cv-00145. Mallinckrodt investors who wish to discuss this action and their legal options are encouraged to contact Kessler Topaz Meltzer & Check (Darren J. Check, Esq., D. Seamus Kaskela, Esq."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Fined $100M For Antitrust Violations,2017-01-23 13:43:00 +0000,http://www.investopedia.com/news/mallinckrodt-fined-100m-price-fixing-mnk/?partner=YahooSA,Mallinckrodt Fined $100M For Antitrust Violations
MNK,MNK:US,BBG002BHBHM1,Is Mallinckrodt (MNK) a Top Choice for Value Investors?,2017-01-20 16:38:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9eAo2jiLFV4/is-mallinckrodt-mnk-a-top-choice-for-value-investors-cm735977,Value investing is easily one of the most popular ways to find great stocks in any market environment After all who wouldn t want to find stocks that are either flying under the radar and are compelling buys or offer up tantalizing discounts when compared to fair value One way to find
MNK,MNK:US,BBG002BHBHM1,Is Mallinckrodt (MNK) a Top Choice for Value Investors?,2017-01-20 14:50:02 +0000,http://finance.yahoo.com/news/mallinckrodt-mnk-top-choice-value-145002039.html,Is Mallinckrodt (MNK) a Top Choice for Value Investors?
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt to Pay $100M Fine to FTC for Questcor Matter,2017-01-20 01:36:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4nJLzU22rLU/mallinckrodt-to-pay-100m-fine-to-ftc-for-questcor-matter-cm735760,Mallinckrodt plc MNK will have to pay a fine of 100 million to the U S Federal Trade Commission FTC to resolve the latter s investigation into the acquisition of Synacthen Depot by its Questcor division Synacthen Depot is a synthetic adrenocorticotropic hormone ACTH
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt to Pay $100M Fine to FTC for Questcor Matter,2017-01-19 23:01:11 +0000,http://finance.yahoo.com/news/mallinckrodt-pay-100m-fine-ftc-230111790.html,Mallinckrodt to Pay $100M Fine to FTC for Questcor Matter
MNK,MNK:US,BBG002BHBHM1,"Notable Thursday Option Activity: PANW, UVV, MNK",2017-01-19 22:38:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jrAQBKP40Ms/notable-thursday-option-activity-panw-uvv-mnk-cm735703,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Palo Alto Networks Inc Symbol PANW where a total volume of 11 319 contracts has been traded thus far today a contract volume which is representative of approximately 1
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Rebounds After FTC Probe; Doubts Rival Will Get FDA Nod,2017-01-19 21:05:24 +0000,http://www.investors.com/news/technology/mallinckrodt-rebounds-after-ftc-probe-doubts-rival-will-get-fda-nod/,Mallinckrodt Rebounds After FTC Probe; Doubts Rival Will Get FDA Nod
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt's Worries Aren't Over,2017-01-19 20:08:12 +0000,http://www.bloomberg.com/gadfly/articles/2017-01-19/mallinckrodt-s-acthar-worries-aren-t-over?cmpid=yhoo.headline,Mallinckrodt's Worries Aren't Over
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt plc -- Moody's: Mallinckrodt's settlement with the FTC is credit negative,2017-01-19 19:31:02 +0000,http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_360946&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20170119_PR_360946,Mallinckrodt plc -- Moody's: Mallinckrodt's settlement with the FTC is credit negative
MNK,MNK:US,BBG002BHBHM1,"ETFs with exposure to Mallinckrodt Plc : January 19, 2017",2017-01-19 18:25:31 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-mallinckrodt-plc-january-19-2017/,"ETFs with exposure to Mallinckrodt Plc : January 19, 2017"
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt shares reverse some losses after FTC settlement on $34,000 drug",2017-01-19 15:59:45 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=352E4546-DE5E-11E6-94B7-26B6B423C0E1&siteid=yhoof2,"Mallinckrodt shares reverse some losses after FTC settlement on $34,000 drug"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt: Time to Buy?,2017-01-19 15:35:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/01/19/mallinckrodt-time-to-buy-2/?mod=yahoobarrons&ru=yahoo,Mallinckrodt: Time to Buy?
MNK,MNK:US,BBG002BHBHM1,"GNC Plummets, Mallinckrodt Regains Ground Ahead of Market's Open",2017-01-19 14:07:00 +0000,https://www.thestreet.com/story/13959037/1/gnc-plummets-mallinckrodt-regains-ground-ahead-of-market-s-open.html?puc=yahoo&cm_ven=YAHOO,"GNC Plummets, Mallinckrodt Regains Ground Ahead of Market's Open"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt to pay $100 million in settlement with FTC,2017-01-19 13:55:06 +0000,http://www.bizjournals.com/stlouis/news/2017/01/19/mallinckrodt-to-pay-100-million-in-settlement-with.html?ana=yahoo,Mallinckrodt to pay $100 million in settlement with FTC
MNK,MNK:US,BBG002BHBHM1,"Stock Futures Decline as Housing Starts Climb, Jobless Claims Fall",2017-01-19 13:44:00 +0000,https://www.thestreet.com/story/13957767/1/stock-futures-decline-as-netflix-leaps-kinder-morgan-slumps.html?puc=yahoo&cm_ven=YAHOO,"Stock Futures Decline as Housing Starts Climb, Jobless Claims Fall"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Plc Conference Call to Discuss Agreement with U.S.Federal Trade Commission scheduled for 7:30 am ET today,2017-01-19 12:30:00 +0000,http://biz.yahoo.com/cc/6/155176.html,Mallinckrodt Plc Conference Call to Discuss Agreement with U.S.Federal Trade Commission scheduled for 7:30 am ET today
MNK,MNK:US,BBG002BHBHM1,"Why Pearson, Cameco, and Mallinckrodt Slumped Today",2017-01-19 02:37:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qsfOHpCAlrk/why-pearson-cameco-and-mallinckrodt-slumped-today-cm735166,Wednesday was a lackluster day for the stock market with major market benchmarks finishing the trading session mixed The S amp P 500 and Nasdaq Composite rose slightly but the Dow Jones Industrials lost ground as the positive influence of gains in the financial sector was offset
MNK,MNK:US,BBG002BHBHM1,[$$] Mallinckrodt Settles Antitrust Allegations on Unlawful Drug Monopoly,2017-01-19 01:01:09 +0000,http://www.wsj.com/articles/mallinckrodt-to-pay-100-million-to-settle-antitrust-allegations-on-unlawful-drug-monopoly-1484774686?mod=yahoo_hs,[$$] Mallinckrodt Settles Antitrust Allegations on Unlawful Drug Monopoly
MNK,MNK:US,BBG002BHBHM1,Drug firm to pay $100M to settle charges linked to Martin Shkreli-backed lawsuit,2017-01-19 00:40:12 +0000,http://www.bizjournals.com/newyork/news/2017/01/18/drug-firm-to-pay-100m-to-settle-charges-linked-to.html?ana=yahoo,Drug firm to pay $100M to settle charges linked to Martin Shkreli-backed lawsuit
MNK,MNK:US,BBG002BHBHM1,"Why Pearson, Cameco, and Mallinckrodt Slumped Today",2017-01-19 00:32:00 +0000,http://www.fool.com/investing/2017/01/18/why-pearson-cameco-and-mallinckrodt-slumped-today.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,"Why Pearson, Cameco, and Mallinckrodt Slumped Today"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt to pay $100 million to settle U.S. probe on drug pricing,2017-01-18 23:58:44 +0000,http://in.finance.yahoo.com/news/mallinckrodt-pay-100-million-settle-235844965.html,Mallinckrodt to pay $100 million to settle U.S. probe on drug pricing
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt to pay $100 mln to settle U.S. probe on drug pricing,2017-01-18 23:56:45 +0000,http://finance.yahoo.com/news/mallinckrodt-pay-100-mln-settle-215431595.html,"[Reuters] - Mallinckrodt Plc has agreed to pay $100 million to settle allegations that a subsidiary broke U.S. antitrust law by sharply increasing the price of a multiple sclerosis drug while ensuring that no rival medicine appeared on the market, the Federal Trade Commission said on Wednesday. Mallinckrodt's share price dropped sharply to just under $43 from above $49 on a report Wednesday, which proved incorrect, that the FTC would sue Mallinckrodt. In 2001, Questcor bought the rights to Acthar, a type of hormone-based drug used to treat infantile spasms as well as multiple sclerosis."
MNK,MNK:US,BBG002BHBHM1,The Biggest Loser: Mallinckrodt Slumps 5.8%,2017-01-18 23:08:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/01/18/the-biggest-loser-mallinckrodt-slumps-5-8/?mod=yahoobarrons&ru=yahoo,The Biggest Loser: Mallinckrodt Slumps 5.8%
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Hit With $100M Fine for Squelching Rival to Infant Seizure Drug,2017-01-18 23:01:00 +0000,https://www.thestreet.com/story/13958340/1/mallinckrodt-hit-with-100m-fine-for-squelching-rival-to-infant-seizure-drug.html?puc=yahoo&cm_ven=YAHOO,Mallinckrodt Hit With $100M Fine for Squelching Rival to Infant Seizure Drug
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt And Federal Trade Commission Resolve Questcor Matter,2017-01-18 22:54:00 +0000,http://finance.yahoo.com/news/mallinckrodt-federal-trade-commission-resolve-225400884.html,"[PR Newswire] - STAINES-UPON-THAMES, United Kingdom, Jan. 18, 2017 /PRNewswire/ -- Mallinckrodt plc (MNK), a leading global specialty pharmaceutical company, today announced that it has reached agreement with the U.S. Federal Trade Commission (FTC) to resolve, without admission of wrongdoing, the previously disclosed FTC investigation into the acquisition by Questcor Pharmaceuticals, Inc., of Synacthen® Depot, a synthetic ACTH product, in 2013. The product became part of Mallinckrodt's portfolio with its August 2014 acquisition of Questcor. Under the agreement, Mallinckrodt will license the drug to a licensee, identified by the FTC as Marathon Pharmaceuticals, LLC, to develop and pursue possible U.S. Food and Drug Administration (FDA) approval of Synacthen Depot in two indications – Infantile Spasms (IS) and Nephrotic Syndrome (NS)."
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Dives, Rebounds, Retreats On FTC Drug Price Settlement",2017-01-18 21:18:35 +0000,http://www.investors.com/news/technology/mallinckrodt-dives-says-its-reached-ftc-drug-price-settlement/,"Mallinckrodt Dives, Rebounds, Retreats On FTC Drug Price Settlement"
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt to pay $100 million to settle FTC, state charges on antitrust violations",2017-01-18 21:05:05 +0000,http://www.cnbc.com/id/104226268?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104226268,"Mallinckrodt to pay $100 million to settle FTC, state charges on antitrust violations"
MNK,MNK:US,BBG002BHBHM1,"Macy’s, DryShips Slide into Wednesday’s 52-Week Low Club",2017-01-18 21:04:04 +0000,http://finance.yahoo.com/news/macy-dryships-slide-wednesday-52-210404223.html,"Macy’s, DryShips Slide into Wednesday’s 52-Week Low Club"
MNK,MNK:US,BBG002BHBHM1,Why Mallinckrodt is Crumbling,2017-01-18 21:03:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/01/18/why-mallinckrodt-is-crumbling/?mod=yahoobarrons&ru=yahoo,Why Mallinckrodt is Crumbling
MNK,MNK:US,BBG002BHBHM1,Mallinkrodt Shares Tank Despite $100 Million FTC Deal,2017-01-18 21:01:00 +0000,https://www.thestreet.com/story/13958250/1/mallinkrodt-reaches-100-million-settlement-with-ftc.html?puc=yahoo&cm_ven=YAHOO,Mallinkrodt Shares Tank Despite $100 Million FTC Deal
MNK,MNK:US,BBG002BHBHM1,"FTC, states settle with Mallinckrodt over Acthar",2017-01-18 20:54:39 +0000,http://finance.yahoo.com/news/ftc-states-settle-mallinckrodt-over-205439246.html,"[Reuters] - Mallinckrodt Plc, which bought Questcor Pharmaceuticals in 2014, has agreed to pay $100 million to settle allegations that Questcor broke antitrust law in pricing its multiple sclerosis drug H.P. Acthar ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt says it has settled with the FTC over allegedly using its monopoly to hike drug prices,2017-01-18 20:51:25 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=F92EE8FC-8F0F-4C1D-8B8F-EA32B7199745&siteid=yhoof2,Mallinckrodt says it has settled with the FTC over allegedly using its monopoly to hike drug prices
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt erases losses, says they settled with FTC",2017-01-18 20:28:00 +0000,http://finance.yahoo.com/video/mallinckrodt-erases-losses-says-settled-202800736.html,"Mallinckrodt erases losses, says they settled with FTC"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Responds to Media Reports Regarding Previously Disclosed FTC Investigation,2017-01-18 20:10:00 +0000,http://finance.yahoo.com/news/mallinckrodt-responds-media-reports-regarding-201000247.html,"[PR Newswire] - STAINES-UPON-THAMES, United Kingdom, Jan. 18, 2017 /PRNewswire/ -- In response to media reports that appeared in today's press regarding the previously disclosed U.S. Federal Trade Commission (FTC) investigation, ..."
MNK,MNK:US,BBG002BHBHM1,FTC set to file suit against Mallinckrodt for using monopoly to jack up drug prices,2017-01-18 19:57:42 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=7CE76CEA-DDB5-11E6-94B7-26B6B423C0E1&siteid=yhoof2,FTC set to file suit against Mallinckrodt for using monopoly to jack up drug prices
MNK,MNK:US,BBG002BHBHM1,These 3 Healthcare Stocks Are Ridiculously Cheap,2017-01-18 17:28:32 +0000,http://www.fool.com/investing/2017/01/18/these-3-healthcare-stocks-are-ridiculously-cheap.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,These 3 Healthcare Stocks Are Ridiculously Cheap
MNK,MNK:US,BBG002BHBHM1,These 3 Healthcare Stocks Are Ridiculously Cheap,2017-01-18 14:39:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B3Q16PZ8H18/these-3-healthcare-stocks-are-ridiculously-cheap-cm734629,Although 2016 wasn t exactly the greatest year for healthcare stocks in general there really aren t very many true bargains to be found in the industry However three healthcare stocks do appear to be priced well below what they re worth Here s why Gilead Sciences NASDAQ
MNK,MNK:US,BBG002BHBHM1,Blog Coverage Mesoblast Receives Payment from Mallinckrodt,2017-01-13 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-mesoblast-receives-payment-131500541.html,"[Accesswire] - LONDON, UK / ACCESSWIRE / January 13, 2017 / Active Wall St. blog coverage looks at the headline from Mesoblast Ltd. (NASDAQ: MESO ) and Mallinckrodt PLC (NYSE: MNK ). Mesoblast announced that it has received ..."
MNK,MNK:US,BBG002BHBHM1,What's behind Mallinckrodt put trade,2017-01-13 12:14:42 +0000,http://finance.yahoo.com/news/whats-behind-mallinckrodt-put-trade-121442228.html,What's behind Mallinckrodt put trade
MNK,MNK:US,BBG002BHBHM1,"Notable Thursday Option Activity: MNK, CELG, DE",2017-01-12 20:57:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LJOOUILlJ8o/notable-thursday-option-activity-mnk-celg-de-cm732960,Looking at options trading activity among components of the S amp P 500 index there is noteworthy activity today in Mallinckrodt plc Symbol MNK where a total volume of 10 012 contracts has been traded thus far today a contract volume which is representative of approximately 1 0
MNK,MNK:US,BBG002BHBHM1,"KemPharm CEO On Recent Results, Catalysts And Prospects: 'ADHD Is By Far The Larger Market Opportunity'",2017-01-12 19:34:23 +0000,http://finance.yahoo.com/news/kempharm-ceo-recent-results-catalysts-193423591.html,"KemPharm CEO On Recent Results, Catalysts And Prospects: 'ADHD Is By Far The Larger Market Opportunity'"
MNK,MNK:US,BBG002BHBHM1,Trump takes aim at pharma,2017-01-12 11:58:28 +0000,http://finance.yahoo.com/video/trump-takes-aim-pharma-115828948.html,Trump takes aim at pharma
MNK,MNK:US,BBG002BHBHM1,The 10 Worst Stocks in the S&P 500 in 2016,2017-01-09 03:48:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OlrGtWoEujY/the-10-worst-stocks-in-the-sp-500-in-2016-cm730855,2016 was a good year for the S amp P 500 SNPINDEX GSPC giving investors double digit percentage gains with a total return of about 12 After a flat 2015 that was welcome news for those who invest in the S amp P 500 through index funds Yet even though the S amp P did well
MNK,MNK:US,BBG002BHBHM1,Stock Exchange: 3 Provocative Ideas From The Panel,2017-01-06 12:37:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RH_9iy_CnpM/stock-exchange-3-provocative-ideas-from-the-panel-cm730200,By Jeff Miller ByJeff Miller Last week s Stock Exchange was a discussion of how to find new trading ideas There are always plenty of names floated but that is more about media than method If you missed last week because of the holidays you might find it useful to catch up
MNK,MNK:US,BBG002BHBHM1,"Notable Thursday Option Activity: MNK, HUM, DVN",2017-01-05 20:37:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F-birnf2l90/notable-thursday-option-activity-mnk-hum-dvn-cm730041,Among the underlying components of the S amp P 500 index we saw noteworthy options trading volume today in Mallinckrodt plc Symbol MNK where a total of 9 906 contracts have traded so far representing approximately 990 600 underlying shares That amounts to about 54 8 of MNK s average
MNK,MNK:US,BBG002BHBHM1,Karen Sheehy to Succeed Raymond Furey as Chief Compliance Officer of Mallinckrodt,2017-01-05 01:44:07 +0000,http://www.publicnow.com/view/672B250F3602B80C3862EFECF35960F0C6E3F309,"[at noodls] - STAINES-UPON-THAMES, UNITED KINGDOM - Jan. 4, 2017 - Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, announced today that Karen Sheehy, J.D., has been appointed to serve as the ..."
MNK,MNK:US,BBG002BHBHM1,"ETFs with exposure to Mallinckrodt Plc : January 3, 2017",2017-01-03 19:29:56 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-mallinckrodt-plc-january-3-2017/,"ETFs with exposure to Mallinckrodt Plc : January 3, 2017"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt: Turning Into Sourdough?,2016-12-29 14:34:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/29/mallinckrodt-turning-into-sourdough/?mod=yahoobarrons&ru=yahoo,Mallinckrodt: Turning Into Sourdough?
MNK,MNK:US,BBG002BHBHM1,Citron Research Tweet Pulled NVIDIA Prices Lower on December 28,2016-12-29 13:32:36 +0000,http://marketrealist.com/2016/12/citron-research-tweet-pulled-nvidia-prices-lower-december-28/?utm_source=yahoo&utm_medium=feed,Citron Research Tweet Pulled NVIDIA Prices Lower on December 28
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt plc To Report Earnings Results For Transition Period Of Oct. 1, 2016, To Dec. 30, 2016, On Feb. 7, 2017",2016-12-29 12:52:05 +0000,http://www.publicnow.com/view/092D89F113490D7651CD7937CC3A966CF67FC254,"[at noodls] - Mallinckrodt plc To Report Earnings Results For Transition Period Of Oct. 1, 2016, To Dec. 30, 2016, On Feb. 7, 2017 The text version of this document is not available at the moment. The original content ..."
MNK,MNK:US,BBG002BHBHM1,The Biggest Loser: Mallinckrodt Drops 2.7%,2016-12-27 21:07:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/27/the-biggest-loser-mallinckrodt-drops-2-7/?mod=yahoobarrons&ru=yahoo,The Biggest Loser: Mallinckrodt Drops 2.7%
MNK,MNK:US,BBG002BHBHM1,Tuesday's ETF with Unusual Volume: URTH,2016-12-27 20:57:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2sRqMYaDrYQ/tuesdays-etf-with-unusual-volume-urth-cm726620,The iShares MSCI World ETF URTH is seeing unusually high volume in afternoon trading Tuesday with over 96 000 shares traded versus three month average volume of about 27 000 Shares of URTH were up about 0 1 on the day Components of that ETF with the highest volume on Tuesday
MNK,MNK:US,BBG002BHBHM1,Medicare spending on Mallinckrodt drug tops $500 million,2016-12-27 14:00:08 +0000,http://www.bizjournals.com/stlouis/news/2016/12/27/medicare-spending-on-mallinckrodt-drug-tops-500.html?ana=yahoo,Medicare spending on Mallinckrodt drug tops $500 million
MNK,MNK:US,BBG002BHBHM1,Blog Coverage Mallinckrodt and Mesoblast Enter Into Equity Purchase Agreement,2016-12-27 13:15:00 +0000,http://finance.yahoo.com/news/blog-coverage-mallinckrodt-mesoblast-enter-131500313.html,"[Accesswire] - LONDON, UK / ACCESSWIRE / December 27, 2016 / Active Wall St. blog coverage looks at the headline from Mallinckrodt PLC (NYSE: MNK) and Mesoblast Ltd (NASDAQ: MESO) as the Companies announced on December ..."
MNK,MNK:US,BBG002BHBHM1,"ETFs with exposure to Mallinckrodt Plc : December 23, 2016",2016-12-23 17:56:48 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-mallinckrodt-plc-december-23-2016/,"ETFs with exposure to Mallinckrodt Plc : December 23, 2016"
MNK,MNK:US,BBG002BHBHM1,Valeant Pharmaceuticals: A Trump Winner or Loser?,2016-12-23 16:17:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/12/23/valeant-pharmaceuticals-a-trump-winner-or-loser/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: A Trump Winner or Loser?
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt enters $21 million equity purchase agreement with Mesoblast,2016-12-23 13:37:51 +0000,http://www.bizjournals.com/stlouis/news/2016/12/23/mallinckrodt-enters-21-million-equity-purchase.html?ana=yahoo,"[at American City Business Journals] - Mallinckrodt Pharmaceuticals is investing more than $21 million in an equity purchase agreement with Australia-based Mesoblast Ltd. regarding two of the company's drugs. Under terms of the deal, Mallinckrodt will have up to nine months to conclude commercial and development agreements for Mesoblasts's therapy products used to treat chronic low back pain and acute graft versus host disease. Mallinckrodt is purchasing about 20.04 million (or 4.99 percent) of Mesoblast's shares at a price of $1.4761 in Austrialian dollars (or about $1.06 in U.S. dollars) per share."
MNK,MNK:US,BBG002BHBHM1,"Agree To Buy Mallinckrodt At $35, Earn 14.6% Using Options",2016-12-20 17:59:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9JTAClrSwHE/agree-to-buy-mallinckrodt-at-35-earn-146-using-options-cm724084,Investors considering a purchase of Mallinckrodt plc Symbol MNK stock but tentative about paying the going market price of 53 33 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the
MNK,MNK:US,BBG002BHBHM1,"Year In Review 2016: Leadership changes at Express Scripts, Centene expansion headline health care",2016-12-19 20:30:09 +0000,http://www.bizjournals.com/stlouis/news/2016/12/19/year-in-review-2016-leadership-changes-at-express.html?ana=yahoo,"Year In Review 2016: Leadership changes at Express Scripts, Centene expansion headline health care"
MNK,MNK:US,BBG002BHBHM1,The Most Expensive Drugs of 2016,2016-12-19 12:35:49 +0000,http://www.fool.com/investing/2016/12/18/the-most-expensive-drugs-of-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The Most Expensive Drugs of 2016
MNK,MNK:US,BBG002BHBHM1,The Most Expensive Drugs of 2016,2016-12-18 17:57:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_-tI5zo30LU/the-most-expensive-drugs-of-2016-cm722995,Prescription drug prices have gotten out of control for many Americans and many insurers Some drugs cost as much as premium sports cars Here are the five most expensive prescription drugs in 2016 as compiled by prescription drug comparison website GoodRx and which companies
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt To Present At J.P. Morgan 35th Annual Healthcare Conference,2016-12-15 12:30:00 +0000,http://finance.yahoo.com/news/mallinckrodt-present-j-p-morgan-123000460.html,"[PR Newswire] - STAINES-UPON-THAMES, England, Dec. 15, 2016 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Monday, Jan. 9, 2017, at the J.P. ..."
MNK,MNK:US,BBG002BHBHM1,How you can bottom-feed for stocks left behind in the Trump rally,2016-12-15 10:21:17 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=88D5449A-C22C-11E6-9465-DAC2D347F235&siteid=yhoof2,How you can bottom-feed for stocks left behind in the Trump rally
MNK,MNK:US,BBG002BHBHM1,"S&P 500 Movers: UHS, AKAM",2016-12-14 16:57:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bjtrVi3cv7k/sp-500-movers-uhs-akam-cm721368,In early trading on Wednesday shares of Akamai Technologies AKAM topped the list of the day s best performing components of the S amp P 500 index trading up 4 0 Year to date Akamai Technologies registers a 28 8 gain And the worst performing S amp P 500 component thus far on
MNK,MNK:US,BBG002BHBHM1,"ETFs with exposure to Mallinckrodt Plc : December 13, 2016",2016-12-13 16:35:53 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-mallinckrodt-plc-december-13-2016/,"ETFs with exposure to Mallinckrodt Plc : December 13, 2016"
MNK,MNK:US,BBG002BHBHM1,Why Depomed Inc. Got Wacked Today,2016-12-12 20:56:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TQxUsPFOb18/why-depomed-inc-got-wacked-today-cm720330,Image source Getty Images What happened Depomed NASDAQ DEPO is down more than 10 at 2 46 p m EST after Mark Timney the CEO of privately held Purdue Pharma said his company wasn t looking to buy the fellow drugmaker So what There was no hemming or hawing in Timney
MNK,MNK:US,BBG002BHBHM1,Why Depomed Inc. Got Wacked Today,2016-12-12 19:52:47 +0000,http://www.fool.com/investing/2016/12/12/why-depomed-inc-got-wacked-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Depomed Inc. Got Wacked Today
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Plc :MNK-US: Earnings Analysis: 2016 By the Numbers : December 12, 2016",2016-12-12 13:04:14 +0000,http://www.capitalcube.com/blog/index.php/mallinckrodt-plc-mnk-us-earnings-analysis-2016-by-the-numbers-december-12-2016/,"Mallinckrodt Plc :MNK-US: Earnings Analysis: 2016 By the Numbers : December 12, 2016"
MNK,MNK:US,BBG002BHBHM1,Biotechs Bolstered on 21st Century Cures Passage,2016-12-08 14:27:00 +0000,https://www.thestreet.com/story/13919134/1/biotechs-bolstered-on-21st-century-cures-passage.html?puc=yahoo&cm_ven=YAHOO,Biotechs Bolstered on 21st Century Cures Passage
MNK,MNK:US,BBG002BHBHM1,Health Economic Data on OFIRMEV® (Acetaminophen) Injection Presented at 28th Annual National Forum of the Institute for Healthcare Improvement,2016-12-07 12:30:00 +0000,http://finance.yahoo.com/news/health-economic-data-ofirmev-acetaminophen-123000467.html,"[PR Newswire] - CHESTERFIELD, United Kingdom, Dec. 7, 2016 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, announced results from a retrospective, claims-based ..."
MNK,MNK:US,BBG002BHBHM1,Analysts see these large-cap U.S. stocks rising at least 30% in 2017,2016-12-07 10:13:32 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=D5E8AC58-BBC5-11E6-A1DD-DE321B99EF6C&siteid=yhoof2,Analysts see these large-cap U.S. stocks rising at least 30% in 2017
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Pharmaceuticals Earns Top Marks In 2017 Corporate Equality Index,2016-12-05 22:00:00 +0000,http://finance.yahoo.com/news/mallinckrodt-pharmaceuticals-earns-top-marks-220000970.html,"[PR Newswire] - CHESTERFIELD, United Kingdom, Dec. 5, 2016 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (MNK), a leading global specialty pharmaceutical company, today announced that it received a perfect score of 100 percent on the 2017 Corporate Equality Index (CEI), a national benchmarking survey and report on corporate policies and practices related to lesbian, gay, bisexual and transgender (LGBT) workplace equality, administered by the Human Rights Campaign (HRC) Foundation. Mallinckrodt joins the ranks of 517 major U.S. businesses which also earned top marks this year. ""We are committed to and believe strongly in the power of equality, both in its importance within our company and its positive difference within our communities,"" said Mallinckrodt President and Chief Executive Officer Mark Trudeau."
MNK,MNK:US,BBG002BHBHM1,How Beaten-Down Mallinckrodt Can Turn Things Around,2016-12-02 20:46:43 +0000,http://www.fool.com/investing/2016/12/02/how-beaten-down-mallinckrodt-can-turn-things-aroun.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,How Beaten-Down Mallinckrodt Can Turn Things Around
MNK,MNK:US,BBG002BHBHM1,Analysts Are Bullish on Valeant,2016-12-02 16:04:40 +0000,http://marketrealist.com/2016/11/analysts-are-bullish-on-valeant/?utm_source=yahoo&utm_medium=feed,Analysts Are Bullish on Valeant
MNK,MNK:US,BBG002BHBHM1,"Lifshitz & Miller Law Firm Announces Investigation of Georgetown Bancorp, Inc., Lattice Semiconductor Corporation, Mallinckrodt Public Limited Company, Mentor Graphics Corporation, PAREXEL International Corporation, Resource Capital Corp., ",2016-12-01 16:45:00 +0000,http://finance.yahoo.com/news/lifshitz-miller-law-firm-announces-164500194.html,"[PR Newswire] - NEW YORK, Dec.1, 2016 /PRNewswire/ -- Georgetown Bancorp, Inc. (GTWN) Lifshitz & Miller announces an investigation into possible breaches of fiduciary duties by the GTWN board in connection with the sale ..."
MNK,MNK:US,BBG002BHBHM1,"ETFs with exposure to Mallinckrodt Plc : December 1, 2016",2016-12-01 16:42:10 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-mallinckrodt-plc-december-1-2016/,"ETFs with exposure to Mallinckrodt Plc : December 1, 2016"
MNK,MNK:US,BBG002BHBHM1,4 Stocks with Low Price-to-Cash-Flow Ratio to Buy Now,2016-12-01 16:21:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R3nEBhf2-ac/4-stocks-with-low-price-to-cash-flow-ratio-to-buy-now-cm716343,It is far better to buy a wonderful company at a fair price than a fair company at a wonderful price Warren Buffett The strategy is quite simple find stocks that are trading below their inherent worth Investment in stocks made on diligent value analysis is usually considered one of
MNK,MNK:US,BBG002BHBHM1,Inside the Double-Digit Fall for Mallinckrodt’s Specialty Generics Business in 2016,2016-11-30 21:04:13 +0000,http://marketrealist.com/2016/11/inside-the-double-digit-fall-for-mallinckrodts-specialty-generics-business-in-2016/?utm_source=yahoo&utm_medium=feed,Inside the Double-Digit Fall for Mallinckrodt’s Specialty Generics Business in 2016
MNK,MNK:US,BBG002BHBHM1,How Did Mallinckrodt’s Specialty Brands Perform in 2016?,2016-11-30 20:04:13 +0000,http://marketrealist.com/2016/11/how-did-mallinckrodts-specialty-brands-perform-in-2016/?utm_source=yahoo&utm_medium=feed,How Did Mallinckrodt’s Specialty Brands Perform in 2016?
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Tops 4Q Earnings, Shares Tumble (MNK)",2016-11-30 19:19:00 +0000,http://www.investopedia.com/news/mallinckrodt-tops-4q-earnings-shares-tumble-mnk/?partner=YahooSA,"Mallinckrodt Tops 4Q Earnings, Shares Tumble (MNK)"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt’s Revenue Growth in Fiscal 4Q16,2016-11-30 17:34:56 +0000,http://marketrealist.com/2016/11/mallinckrodts-revenue-growth-in-fiscal-4q16/?utm_source=yahoo&utm_medium=feed,Mallinckrodt’s Revenue Growth in Fiscal 4Q16
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Plc :MNK-US: Earnings Analysis: Q4, 2016 By the Numbers : November 30, 2016",2016-11-30 14:35:12 +0000,http://www.capitalcube.com/blog/index.php/mallinckrodt-plc-mnk-us-earnings-analysis-q4-2016-by-the-numbers-november-30-2016/,"Mallinckrodt Plc :MNK-US: Earnings Analysis: Q4, 2016 By the Numbers : November 30, 2016"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt To Present At BMO Capital Markets 2016 Prescriptions For Success Healthcare Conference,2016-11-30 12:30:00 +0000,http://finance.yahoo.com/news/mallinckrodt-present-bmo-capital-markets-123000310.html,"[PR Newswire] - CHESTERFIELD, United Kingdom, Nov. 30, 2016 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Wednesday, Dec. 14, 2016, at the ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt (MNK) Tops Q4 Earnings on Solid Sales Growth,2016-11-29 23:54:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Pu_ZAj3ROEs/mallinckrodt-mnk-tops-q4-earnings-on-solid-sales-growth-cm715420,Mallinckrodt Public Limited Company MNK reported adjusted earnings of 2 04 per share in the fourth quarter of fiscal 2016 ended Sep 30 2016 beating the Zacks Consensus Estimate of 1 98 Earnings were also up from the year ago figure of 2 02 Higher sales and profits in the Specialty
MNK,MNK:US,BBG002BHBHM1,"Why Mallinckrodt, Mechel PAO, and Newpark Resources Slumped Today",2016-11-29 23:54:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lenDyw7z6fo/why-mallinckrodt-mechel-pao-and-newpark-resources-slumped-today-cm715409,The stock market eased higher on Tuesday with major market benchmarks remaining below their all time record high levels but still advancing slightly Bond yields eased downward halting their recent rise and giving some nervous investors hope that an end to the big spike in interest
MNK,MNK:US,BBG002BHBHM1,"Why Mallinckrodt, Mechel PAO, and Newpark Resources Slumped Today",2016-11-29 22:41:05 +0000,http://www.fool.com/investing/2016/11/29/why-mallinckrodt-mechel-pao-and-newpark-resources.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Mallinckrodt, Mechel PAO, and Newpark Resources Slumped Today"
MNK,MNK:US,BBG002BHBHM1,Edited Transcript of MNK earnings conference call or presentation 29-Nov-16 1:30pm GMT,2016-11-29 22:36:33 +0000,http://finance.yahoo.com/news/edited-transcript-mnk-earnings-conference-223633153.html,Edited Transcript of MNK earnings conference call or presentation 29-Nov-16 1:30pm GMT
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt (MNK) Tops Q4 Earnings on Solid Sales Growth,2016-11-29 22:00:10 +0000,http://finance.yahoo.com/news/mallinckrodt-mnk-tops-q4-earnings-220010884.html,Mallinckrodt (MNK) Tops Q4 Earnings on Solid Sales Growth
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt plagued by 'production issues,' falls about 9%",2016-11-29 21:34:25 +0000,http://www.cnbc.com/id/104135344?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104135344,"Mallinckrodt plagued by 'production issues,' falls about 9%"
MNK,MNK:US,BBG002BHBHM1,The Biggest Loser: Mallinckrodt Tumbles 9%,2016-11-29 21:13:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/29/the-biggest-loser-mallinckrodt-tumbles-9/?mod=yahoobarrons&ru=yahoo,The Biggest Loser: Mallinckrodt Tumbles 9%
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Earnings Top, But Stock Dives On Guidance",2016-11-29 21:03:13 +0000,http://www.investors.com/news/technology/mallinckrodt-sales-beat-led-by-specialty-brands-acthar-up-19/,"Mallinckrodt Earnings Top, But Stock Dives On Guidance"
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Beats Estimates, Issues Downbeat Guidance",2016-11-29 20:22:00 +0000,http://www.thestreet.com/video/13908061/mallinckrodt-beats-estimates-issues-downbeat-guidance.html?puc=yahoov&cm_ven=YAHOOV,"Mallinckrodt Beats Estimates, Issues Downbeat Guidance"
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Shares Tank, Despite Better-Than-Expected Earnings",2016-11-29 19:30:00 +0000,https://www.thestreet.com/story/13908105/1/mallinckrodt-shares-tank-despite-better-than-expected-earnings.html?puc=yahoo&cm_ven=YAHOO,"Mallinckrodt Shares Tank, Despite Better-Than-Expected Earnings"
MNK,MNK:US,BBG002BHBHM1,"S&P 500 Movers: MNK, TIF",2016-11-29 16:54:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DfksUVX6Vak/sp-500-movers-mnk-tif-cm715119,In early trading on Tuesday shares of Tiffany amp Co TIF topped the list of the day s best performing components of the S amp P 500 index trading up 6 3 Year to date Tiffany amp Co registers a 8 9 gain And the worst performing S amp P 500 component thus far on the day
MNK,MNK:US,BBG002BHBHM1,What Do Analysts Have to Say about Mallinckrodt?,2016-11-29 16:05:12 +0000,http://marketrealist.com/2016/11/what-do-analysts-have-to-say-about-mallinckrodt/?utm_source=yahoo&utm_medium=feed,What Do Analysts Have to Say about Mallinckrodt?
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt: Wait, I Thought It Was Good News?!?!",2016-11-29 15:46:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/29/mallinckrodt-wait-i-thought-it-was-good-news/?mod=yahoobarrons&ru=yahoo,"Mallinckrodt: Wait, I Thought It Was Good News?!?!"
MNK,MNK:US,BBG002BHBHM1,What to Expect from Mallinckrodt in 2016,2016-11-29 15:05:38 +0000,http://marketrealist.com/2016/11/what-to-expect-from-mallinckrodt-in-2016/?utm_source=yahoo&utm_medium=feed,What to Expect from Mallinckrodt in 2016
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt (MNK) Tops on Earnings & Sales in Q4,2016-11-29 14:57:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r2mDXueBHwU/mallinckrodt-mnk-tops-on-earnings-sales-in-q4-cm715083,Ireland based Mallinckrodt Public Limited Company MNK focuses on developing treatments for autoimmune and rare diseases including neurology rheumatology nephrology and pulmonology as well as therapies for pain management The company develops manufactures markets and distributes
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt (MNK) Tops on Earnings & Sales in Q4,2016-11-29 13:34:01 +0000,http://finance.yahoo.com/news/mallinckrodt-mnk-tops-earnings-sales-133401242.html,Mallinckrodt (MNK) Tops on Earnings & Sales in Q4
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Plc Earnings Call scheduled for 8:30 am ET today,2016-11-29 13:30:00 +0000,http://biz.yahoo.com/cc/0/154320.html,Mallinckrodt Plc Earnings Call scheduled for 8:30 am ET today
MNK,MNK:US,BBG002BHBHM1,"Early movers: TIF, UNH, MNK, PFE, AAPL, T, TIVO, C, ALL & more",2016-11-29 13:17:13 +0000,http://www.cnbc.com/id/104134567?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104134567,"Early movers: TIF, UNH, MNK, PFE, AAPL, T, TIVO, C, ALL & more"
MNK,MNK:US,BBG002BHBHM1,Acthar’s Higher Exposure to Government-Oriented Franchise,2016-11-29 13:06:45 +0000,http://marketrealist.com/2016/11/acthars-higher-exposure-to-government-oriented-franchise/?utm_source=yahoo&utm_medium=feed,Acthar’s Higher Exposure to Government-Oriented Franchise
MNK,MNK:US,BBG002BHBHM1,Q4 2016 Mallinckrodt Plc Earnings Release - Before Market Open,2016-11-29 12:07:02 +0000,http://biz.yahoo.com/research/earncal/20161129.html?t=mnk,Q4 2016 Mallinckrodt Plc Earnings Release - Before Market Open
MNK,MNK:US,BBG002BHBHM1,"Earnings Reaction History: Mallinckrodt plc, 40.0% Follow-Through Indicator, 4.7% Sensitive",2016-11-29 11:53:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BJfjhlG8XBw/earnings-reaction-history-mallinckrodt-plc-400-follow-through-indicator-47-sensitive-cm714870,Expected Earnings Release 11 29 2016 PremarketExpected Earnings Release 11 29 2016 Premarket Avg Extended Hours Dollar Volume 1 994 275Avg Extended Hours Dollar Volume 1 994 275 Mallinckrodt plc MNK is due to issue its quarterly earnings report in the upcoming extended hours
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Under Pressure Despite Beating Q4 Estimates,2016-11-29 11:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/G3rvUFA7EOA/mallinckrodt-under-pressure-despite-beating-q4-estimates-20161129-00772,Mallinckrodt Under Pressure Despite Beating Q4 Estimates
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt tops Street 4Q forecasts,2016-11-29 11:25:29 +0000,http://sg.finance.yahoo.com/news/mallinckrodt-tops-street-4q-forecasts-112529049.html,Mallinckrodt tops Street 4Q forecasts
MNK,MNK:US,BBG002BHBHM1,"MALLINCKRODT PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits",2016-11-29 11:18:40 +0000,http://biz.yahoo.com/e/161129/mnk8-k.html,"MALLINCKRODT PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt plc Reports Fiscal 2016 Fourth Quarter and Full-Year Results,2016-11-29 11:00:00 +0000,http://finance.yahoo.com/news/mallinckrodt-plc-reports-fiscal-2016-110000336.html,"[PR Newswire] - CHESTERFIELD, United Kingdom, Nov. 29, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today reported results for the fourth quarter fiscal 2016 1 ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt’s Greater Dependence on Acthar and Generic Business,2016-11-28 23:25:02 +0000,http://marketrealist.com/2016/11/mallinckrodts-greater-dependence-on-acthar-and-generic-business/?utm_source=yahoo&utm_medium=feed,Mallinckrodt’s Greater Dependence on Acthar and Generic Business
MNK,MNK:US,BBG002BHBHM1,"Pre-Market Earnings Report for November 29, 2016 :  GASS, BERY, BNS, DLA, MNK, NORD, REX, SFL, SOL, TIF, TNP",2016-11-28 21:12:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nHjA9MyXris/pre-market-earnings-report-for-november-29-2016-gass-bery-bns-dla-mnk-nord-rex-sfl-sol-tif-tnp-cm714751,The following companies are expected to report earnings prior to market open on 11 29 2016 Visit our Earnings Calendar for a full list of expected earnings releases StealthGas Inc GASS is reporting for the quarter ending September 30 2016 The
MNK,MNK:US,BBG002BHBHM1,"Tiffany In Buy Zone Ahead Of Q3; Autodesk, Splunk Due: Investing Action Plan",2016-11-28 21:06:05 +0000,http://www.investors.com/news/tiffany-in-buy-zone-ahead-of-q3-autodesk-splunk-due-investing-action-plan/,"Tiffany In Buy Zone Ahead Of Q3; Autodesk, Splunk Due: Investing Action Plan"
MNK,MNK:US,BBG002BHBHM1,Intellipharmaceutics Submits NDA for Pain Treatment Rexista,2016-11-28 15:32:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dzfSWetryoU/intellipharmaceutics-submits-nda-for-pain-treatment-rexista-cm714422,Intellipharmaceutics International Inc IPCI announced that it has filed a new drug application NDA with the FDA for Rexista abuse deterrent oxycodone hydrochloride extended release tablets in the 10 mg 15 mg 20 mg 30 mg 40 mg 60 mg and 80 mg strengths The company is looking to
MNK,MNK:US,BBG002BHBHM1,Behind Mallinckrodt’s Performance Based on EV-to-EBITDA,2016-11-27 21:54:53 +0000,http://marketrealist.com/2016/03/behind-mallinckrodts-performance-based-ev-ebitda/?utm_source=yahoo&utm_medium=feed,Behind Mallinckrodt’s Performance Based on EV-to-EBITDA
MNK,MNK:US,BBG002BHBHM1,Why Mallinckrodt Is Trading at a Discount on PE Basis,2016-11-27 21:54:53 +0000,http://marketrealist.com/2016/03/mallinckrodt-trading-discount-pe-basis/?utm_source=yahoo&utm_medium=feed,Why Mallinckrodt Is Trading at a Discount on PE Basis
MNK,MNK:US,BBG002BHBHM1,Where Else Have We Seen Mallinckrodt’s ‘Acquire to Invest’ Strategy?,2016-11-27 21:54:53 +0000,http://marketrealist.com/2016/03/else-seen-mallinckrodts-acquire-invest-strategy/?utm_source=yahoo&utm_medium=feed,Where Else Have We Seen Mallinckrodt’s ‘Acquire to Invest’ Strategy?
MNK,MNK:US,BBG002BHBHM1,Has Mallinckrodt PLC (MNK) Turned the Corner?,2016-11-26 03:06:51 +0000,http://www.insidermonkey.com/blog/has-mallinckrodt-plc-mnk-turned-the-corner-491983/,Has Mallinckrodt PLC (MNK) Turned the Corner?
MNK,MNK:US,BBG002BHBHM1,Is Mallinckrodt (MNK) Poised for a Beat in Q4 Earnings?,2016-11-23 16:07:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MYx9k-cODgI/is-mallinckrodt-mnk-poised-for-a-beat-in-q4-earnings-cm713271,Mallinckrodt plc MNK is set to report fourth quarter fiscal 2016 results on Nov 29 The company s track has been impressive so far It has beaten estimates in each of the last four quarters with a positive average earnings surprise of 11 9 Let s see how things are shaping up for
MNK,MNK:US,BBG002BHBHM1,Is Mallinckrodt (MNK) Poised for a Beat in Q4 Earnings?,2016-11-23 13:42:01 +0000,http://finance.yahoo.com/news/mallinckrodt-mnk-poised-beat-q4-134201361.html,Is Mallinckrodt (MNK) Poised for a Beat in Q4 Earnings?
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Updated Statement on Extended-Release Methylphenidate Tablets,2016-11-23 13:21:07 +0000,http://www.publicnow.com/view/87B8CC78B5D38DC841C0F91645435E9D25AEEB35,[at noodls] - Mallinckrodt requested a 90-day extension of the deadline for submitting documentation supporting the necessity of a hearing on the U.S. Food and Drug Administration's (FDA's) proposal to withdraw the ...
MNK,MNK:US,BBG002BHBHM1,"Health Care Sector Update for 11/21/2016: MNK,OGEN,ACOR",2016-11-21 21:20:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ve-Znggb340/health-care-sector-update-for-11212016-mnkogenacor-cm712334,Top Health Care StocksTop Health Care Stocks JNJ 0 35 JNJ 0 35 PFE 0 05 PFE 0 05 MRK 0 26 MRK 0 26 ABT 0 57 ABT 0 57 AMGN 0 17 AMGN 0 17 Health care stocks were ending slightly higher today with the NYSE Health Care Index climbing just over 0 1 while shares of health care
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt: The Rebound Continues,2016-11-21 19:06:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/21/mallinckrodt-the-rebound-continues/?mod=yahoobarrons&ru=yahoo,Mallinckrodt: The Rebound Continues
MNK,MNK:US,BBG002BHBHM1,5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them,2016-11-21 18:19:33 +0000,http://www.fool.com/investing/2016/11/20/5-most-expensive-medicare-drugs-and-which-companie.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Will Initiate Company-Sponsored Clinical Trial of H.P. Acthar® Gel in Treatment of Amyotropic Lateral Sclerosis (ALS),2016-11-21 12:00:00 +0000,http://finance.yahoo.com/news/mallinckrodt-initiate-company-sponsored-clinical-120000642.html,"[PR Newswire] - CHESTERFIELD, United Kingdom, Nov. 21, 2016 /PRNewswire/ -- Mallinckrodt plc (MNK), a leading global specialty pharmaceutical company, today confirmed that it will initiate a company-sponsored, Phase 2 proof-of-concept clinical trial to assess the efficacy of H.P. Acthar® Gel (repository corticotropin injection) in patients with Amyotropic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease). Mallinckrodt also announced the U.S. Food and Drug Administration (FDA) has granted the company's request for a Fast Track designation for its Acthar Investigational New Drug (IND) application in patients with ALS. The company is working closely with the FDA as it establishes the Phase 2 study design."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt: The Biggest Loser No More,2016-11-18 16:38:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/18/mallinckrodt-the-biggest-loser-no-more/?mod=yahoobarrons&ru=yahoo,Mallinckrodt: The Biggest Loser No More
MNK,MNK:US,BBG002BHBHM1,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Mallinckrodt Public Limited Company (MNK)",2016-11-18 15:20:00 +0000,http://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-152000734.html,"[PR Newswire] - NEW YORK, Nov. 18, 2016 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Mallinckrodt Public Limited Company (""Mallinckrodt"" ..."
MNK,MNK:US,BBG002BHBHM1,Is Mallincrockdt Too Risky to Buy Right Now?,2016-11-18 14:52:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sfDkY_CQ-EI/is-mallincrockdt-too-risky-to-buy-right-now-cm711101,Shares of Mallinckrodt NYSE MNK have plunged 30 over the past three months The drugmaker s stock started to rebound after the U S election but that bounce is gone now What happened Another fiery attack from short seller Andrew Left took its toll Is Mallinckrodt just too
MNK,MNK:US,BBG002BHBHM1,Is Mallincrockdt Too Risky to Buy Right Now?,2016-11-18 13:29:38 +0000,http://www.fool.com/investing/2016/11/18/is-mallincrockdt-too-risky-to-buy-right-now.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Mallincrockdt Too Risky to Buy Right Now?
MNK,MNK:US,BBG002BHBHM1,Clinical Pharmacokinetic and Health Economic Data on OFIRMEV® (Acetaminophen) Injection Presented at 15th Annual Pain Medicine Meeting of ASRA,2016-11-18 12:30:00 +0000,http://finance.yahoo.com/news/clinical-pharmacokinetic-health-economic-data-123000937.html,"[PR Newswire] - CHESTERFIELD, United Kingdom, Nov. 18, 2016 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, today announced results from a clinical pharmacokinetic ..."
MNK,MNK:US,BBG002BHBHM1,The Biggest Loser: Mallinckrodt Slumps 7.3%,2016-11-17 22:52:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/17/the-biggest-loser-mallinckrodt-slumps-7-3/?mod=yahoobarrons&ru=yahoo,The Biggest Loser: Mallinckrodt Slumps 7.3%
MNK,MNK:US,BBG002BHBHM1,"Fallouts in big pharma: VRX, MNK & MYL",2016-11-17 22:14:00 +0000,http://finance.yahoo.com/video/fallouts-big-pharma-vrx-mnk-221400778.html,"Fallouts in big pharma: VRX, MNK & MYL"
MNK,MNK:US,BBG002BHBHM1,"Study Addresses Possible Impact of H.P. Acthar® Gel on Use of Corticosteroids Among Patients with Rheumatoid Arthritis, Lupus, and Dermatomyositis/Polymyositis",2016-11-17 21:30:00 +0000,http://finance.yahoo.com/news/study-addresses-possible-impact-h-213000456.html,"[PR Newswire] - CHESTERFIELD, United Kingdom, Nov. 17, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today presented results of a retrospective, claims-based analysis ..."
MNK,MNK:US,BBG002BHBHM1,Report of Mallinckrodt Fraud Raises Eyebrows (MNK),2016-11-17 18:00:00 +0000,http://www.investopedia.com/news/report-mallinckrodt-fraud-raises-eyebrows-mnk/?partner=YahooSA,Report of Mallinckrodt Fraud Raises Eyebrows (MNK)
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt: Time to Buy?,2016-11-17 16:33:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/17/mallinckrodt-time-to-buy/?mod=yahoobarrons&ru=yahoo,Mallinckrodt: Time to Buy?
MNK,MNK:US,BBG002BHBHM1,EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Mallinckrodt Public Limited Company - MNK,2016-11-17 16:28:00 +0000,http://finance.yahoo.com/news/equity-alert-rosen-law-firm-162800798.html,"[Business Wire] - Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Mallinckrodt Public Limited Company resulting from allegations that Mallinckrodt may have issued materially misleading business information to the investing public."
MNK,MNK:US,BBG002BHBHM1,5 Price-to-Book Value Picks to Buy Post Elections,2016-11-17 12:52:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oOQXr50lQMM/5-price-to-book-value-picks-to-buy-post-elections-cm710441,Equity markets generally gain stability post elections However though the U S markets rallied after Trump s win the momentum can fizzle anytime leading to volatility With such uncertainty about the direction of the market post elections it is prudent to pick value stocks In value
MNK,MNK:US,BBG002BHBHM1,5 Price-to-Book Value Picks to Buy Post Elections,2016-11-17 11:00:11 +0000,http://finance.yahoo.com/news/5-price-book-value-picks-110011906.html,5 Price-to-Book Value Picks to Buy Post Elections
MNK,MNK:US,BBG002BHBHM1,Andrew Left: Dump Mallinckrodt,2016-11-16 22:25:00 +0000,http://realmoney.thestreet.com/articles/11/16/2016/andrew-left-dump-mallinckrodt?puc=yahoo&cm_ven=YAHOO,Andrew Left: Dump Mallinckrodt
MNK,MNK:US,BBG002BHBHM1,Citron Research's Left Explains Allegation That Mallinckrodt CEO Committed Fraud,2016-11-16 21:37:00 +0000,https://www.thestreet.com/story/13896733/1/citron-research-s-left-explains-allegation-that-mallinckrodt-ceo-committed-fraud.html?puc=yahoo&cm_ven=YAHOO,Citron Research's Left Explains Allegation That Mallinckrodt CEO Committed Fraud
MNK,MNK:US,BBG002BHBHM1,Clinical Data Analysis on Terlipressin Presented at The Liver Meeting®,2016-11-16 21:30:00 +0000,http://finance.yahoo.com/news/clinical-data-analysis-terlipressin-presented-213000289.html,"[PR Newswire] - CHESTERFIELD, United Kingdom, Nov. 16, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced results of a post-hoc analysis of terlipressin ..."
MNK,MNK:US,BBG002BHBHM1,The Biggest Loser: Mallinckrodt Tumbles 12%,2016-11-16 21:11:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/16/why-mallinckrodt-is-tanking/?mod=yahoobarrons&ru=yahoo,The Biggest Loser: Mallinckrodt Tumbles 12%
MNK,MNK:US,BBG002BHBHM1,"Mizuho Defends Mallinckrodt Against Citron, Says Buy The Dip",2016-11-16 19:15:58 +0000,http://finance.yahoo.com/news/mizuho-defends-mallinckrodt-against-citron-191558466.html,"Mizuho Defends Mallinckrodt Against Citron, Says Buy The Dip"
MNK,MNK:US,BBG002BHBHM1,"MALLINCKRODT (MNK) ALERT: Johnson & Weaver, LLP Commences Investigation of Mallinckrodt Public Limited Company; Encourages all Investors to Contact the Firm for Information",2016-11-16 17:53:00 +0000,http://finance.yahoo.com/news/mallinckrodt-mnk-alert-johnson-weaver-175300289.html,"[PR Newswire] - SAN DIEGO, Nov. 16, 2016 /PRNewswire/ -- Shareholder rights law firm Johnson & Weaver, LLP has commenced an investigation into whether certain officers and directors of Mallinckrodt Public Limited Company ..."
MNK,MNK:US,BBG002BHBHM1,"S&P 500 Movers: MNK, TGT",2016-11-16 17:50:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6holAPQy3Hg/sp-500-movers-mnk-tgt-cm710106,In early trading on Wednesday shares of Target topped the list of the day s best performing components of the S amp P 500 index trading up 8 5 Year to date Target registers a 6 7 gain And the worst performing S amp P 500 component thus far on the day is Mallinckrodt trading down 5
MNK,MNK:US,BBG002BHBHM1,"ETFs with exposure to Mallinckrodt Plc : November 16, 2016",2016-11-16 17:01:27 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-mallinckrodt-plc-november-16-2016/,"ETFs with exposure to Mallinckrodt Plc : November 16, 2016"
MNK,MNK:US,BBG002BHBHM1,6 Things You Need to Know about Teva's (TEVA) Q3 Earnings,2016-11-16 16:53:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yUaQOZ1jNrg/6-things-you-need-to-know-about-tevas-teva-q3-earnings-cm710056,Israel based Teva Pharmaceutical Industries Limited TEVA reported third quarter results yesterday With the company missing revenue estimates and lowering its outlook for the year shares were down 8 4 Here is a look at some key points from the company s conference call
MNK,MNK:US,BBG002BHBHM1,6 Things You Need to Know about Teva's (TEVA) Q3 Earnings,2016-11-16 14:43:02 +0000,http://finance.yahoo.com/news/6-things-know-tevas-teva-144302626.html,6 Things You Need to Know about Teva's (TEVA) Q3 Earnings
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Plc breached its 50 day moving average in a Bullish Manner : MNK-US : November 15, 2016",2016-11-15 12:38:53 +0000,http://www.capitalcube.com/blog/index.php/mallinckrodt-plc-breached-its-50-day-moving-average-in-a-bullish-manner-mnk-us-november-15-2016/,"Mallinckrodt Plc breached its 50 day moving average in a Bullish Manner : MNK-US : November 15, 2016"
MNK,MNK:US,BBG002BHBHM1,First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar® Gel for Lupus,2016-11-14 21:47:04 +0000,http://www.publicnow.com/view/BA90D9802726A993276ED6B944EDE080386A1160,"[at noodls] - CHESTERFIELD, United Kingdom, Nov. 14, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty biopharmaceutical company, today confirmed enrollment of the first patients in the company's ..."
MNK,MNK:US,BBG002BHBHM1,How Did VRX’s US Diversified Business Perform in 3Q16?,2016-11-14 16:04:20 +0000,http://marketrealist.com/2016/11/how-did-vrxs-us-diversified-business-perform-in-3q16/?utm_source=yahoo&utm_medium=feed,How Did VRX’s US Diversified Business Perform in 3Q16?
MNK,MNK:US,BBG002BHBHM1,First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar® Gel for Rheumatoid Arthritis,2016-11-14 12:07:09 +0000,http://www.publicnow.com/view/097F478005A79B768CEE48BB9A7E33C2C33F67A7,"[at noodls] - CHESTERFIELD, United Kingdom, Nov. 14, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty biopharmaceutical company, today confirmed enrollment of the first patient in the company's ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Plc: Strong price momentum but will it sustain?,2016-11-11 20:32:36 +0000,http://www.capitalcube.com/blog/index.php/mallinckrodt-plc-strong-price-momentum-but-will-it-sustain-2/,Mallinckrodt Plc: Strong price momentum but will it sustain?
MNK,MNK:US,BBG002BHBHM1,MNK Makes Bullish Cross Above Critical Moving Average,2016-11-10 19:13:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tztaeuRay1E/mnk-makes-bullish-cross-above-critical-moving-average-cm707306,In trading on Thursday shares of Mallinckrodt plc Symbol MNK crossed above their 200 day moving average of 65 53 changing hands as high as 66 89 per share Mallinckrodt plc shares are currently trading up about 3 4 on the day The chart below shows the one year performance of MNK
MNK,MNK:US,BBG002BHBHM1,Valeant Pharmaceuticals: Why a Trump Presidency Can't Solve All Its Woes,2016-11-09 17:11:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/09/valeant-pharmaceuticals-why-a-trump-presidency-cant-solve-all-its-woes/?mod=yahoobarrons&ru=yahoo,Valeant Pharmaceuticals: Why a Trump Presidency Can't Solve All Its Woes
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Announces U.S. FDA Approval of OFIRMEV® IV Bag Presentation,2016-11-08 12:47:04 +0000,http://www.publicnow.com/view/69BC2FE616AC667FBCB0E1AD997C3E4CD28D0A4B,[at noodls] - Mallinckrodt Announces U.S. FDA Approval of OFIRMEV® IV Bag Presentation The text version of this document is not available at the moment. The original content was posted at original link . Mallinckrodt ...
MNK,MNK:US,BBG002BHBHM1,What Do Analysts Recommend for Valeant after Recent Happenings,2016-11-07 16:53:59 +0000,http://marketrealist.com/2016/11/what-do-analysts-recommend-for-valeant-after-recent-happenings/?utm_source=yahoo&utm_medium=feed,What Do Analysts Recommend for Valeant after Recent Happenings
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Statement on U.S. Department of Justice Generics Industry Investigation,2016-11-07 12:24:04 +0000,http://www.publicnow.com/view/90929D8C268D3B523BC61D95E150675E25E47A79,[at noodls] - Mallinckrodt has seen reports that the U.S. Department of Justice's Antitrust Division has been investigating generic drug manufacturers in connection with alleged price collusion involving approximately ...
MNK,MNK:US,BBG002BHBHM1,"Credit Suisse: Allergan Selloff 'Inappropriate,' Teva an 'Overreaction'",2016-11-04 17:57:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/04/credit-suisse-allergan-selloff-inappropriate-teva-an-overreaction/?mod=yahoobarrons&ru=yahoo,"Credit Suisse: Allergan Selloff 'Inappropriate,' Teva an 'Overreaction'"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt PLC (MNK) & Depomed Inc (DEPO) Helped Consonance Capital to Massive Q3 Returns,2016-11-04 05:17:09 +0000,http://www.insidermonkey.com/blog/mallinckrodt-plc-mnk-depomed-inc-depo-helped-consonance-capital-to-massive-q3-returns-484890/,Mallinckrodt PLC (MNK) & Depomed Inc (DEPO) Helped Consonance Capital to Massive Q3 Returns
MNK,MNK:US,BBG002BHBHM1,"The Biggest Loser: Endo International Tumbles 19%, Worst in the S&P 500",2016-11-03 20:41:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/11/03/the-biggest-loser-endo-international-tumbles-19-worst-in-the-sp-500/?mod=yahoobarrons&ru=yahoo,"The Biggest Loser: Endo International Tumbles 19%, Worst in the S&P 500"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt To Present At 28th Annual Piper Jaffray Healthcare Conference,2016-11-02 20:45:00 +0000,http://finance.yahoo.com/news/mallinckrodt-present-28th-annual-piper-204500295.html,"[PR Newswire] - CHESTERFIELD, United Kingdom, Nov. 2, 2016 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Wednesday, Nov. 30, 2016, at the ..."
MNK,MNK:US,BBG002BHBHM1,"'You Picked on the Wrong Company With Mylan (MYL),' Citron Research's Left Says",2016-10-28 20:19:00 +0000,https://www.thestreet.com/story/13872447/1/you-picked-on-the-wrong-company-with-mylan-myl-citron-research-s-left-says.html?puc=yahoo&cm_ven=YAHOO,"'You Picked on the Wrong Company With Mylan (MYL),' Citron Research's Left Says"
MNK,MNK:US,BBG002BHBHM1,Left: You picked on the wrong company with Mylan,2016-10-28 16:33:00 +0000,http://finance.yahoo.com/video/left-picked-wrong-company-mylan-163300216.html,Left: You picked on the wrong company with Mylan
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Builds UK Presence with New Global Corporate Headquarters in Staines-upon-Thames,2016-10-28 07:18:07 +0000,http://www.publicnow.com/view/87D562DDAF40C07959136F421BE485DE64EA4313,"[at noodls] - - Company announces £100,000 donation to local NHS Trust - STAINES-UPON-THAMES, United Kingdom, 27 October 2016 -- Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, has announced ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Builds UK Presence With New Global Corporate Headquarters in Staines-upon-Thames,2016-10-28 07:00:00 +0000,http://finance.yahoo.com/news/mallinckrodt-builds-uk-presence-global-070000797.html,"[PR Newswire] - Mallinckrodt plc (MNK), a leading specialty pharmaceutical company, has announced that it will be opening its new Global Corporate headquarters in Staines-upon-Thames outside London. The creation of this new Corporate Headquarters in the UK reflects the company's global focus and, in its first phase, will involve the creation of new positions and the movement of key roles from other jurisdictions to locate approximately 45 new jobs in Staines-upon-Thames. The new offices will house the company's corporate strategy functions under Gary Phillips, M.D., Executive Vice President and Chief Strategy Officer."
MNK,MNK:US,BBG002BHBHM1,"CIT Group Inc. (CIT), Mylan NV (MYL) & More: Five Stocks Recommended by David Einhorn",2016-10-27 15:36:23 +0000,http://www.insidermonkey.com/blog/cit-group-inc-cit-mylan-nv-myl-more-five-stocks-recommended-by-david-einhorn-482904/,"CIT Group Inc. (CIT), Mylan NV (MYL) & More: Five Stocks Recommended by David Einhorn"
MNK,MNK:US,BBG002BHBHM1,Johnson & Johnson (JNJ) Faces Competition From Mylan NV (MYL) Concerta Knockoff,2016-10-27 14:09:39 +0000,http://www.insidermonkey.com/blog/johnson-johnson-jnj-faces-competition-from-mylan-nv-myl-concerta-knockoff-483509/,Johnson & Johnson (JNJ) Faces Competition From Mylan NV (MYL) Concerta Knockoff
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt to present at Jefferies 2016 London Healthcare Conference,2016-10-26 20:45:00 +0000,http://finance.yahoo.com/news/mallinckrodt-present-jefferies-2016-london-204500817.html,"[PR Newswire] - CHESTERFIELD, England, Oct. 26, 2016 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Thursday, Nov. 17, 2016, at the Jefferies ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Pharmaceuticals Donates Drug Deactivation Pouches to Enable Safe Disposal of Prescription Drugs in West Virginia,2016-10-25 20:55:00 +0000,http://finance.yahoo.com/news/mallinckrodt-pharmaceuticals-donates-drug-deactivation-205500672.html,"[PR Newswire] - CHESTERFIELD, England, Oct. 25, 2016 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, today announced it will provide more than 60,000 drug ..."
MNK,MNK:US,BBG002BHBHM1,"MALLINCKRODT PLC Files SEC form 8-K, Regulation FD Disclosure",2016-10-24 20:48:09 +0000,http://biz.yahoo.com/e/161024/mnk8-k.html,"MALLINCKRODT PLC Files SEC form 8-K, Regulation FD Disclosure"
MNK,MNK:US,BBG002BHBHM1,"MALLINCKRODT PLC Files SEC form 8-K, Regulation FD Disclosure",2016-10-21 21:30:05 +0000,http://biz.yahoo.com/e/161021/mnk8-k.html,"MALLINCKRODT PLC Files SEC form 8-K, Regulation FD Disclosure"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt plc -- Moody's: FDA Proposal to withdraw generic Concerta from the market would be negative for Lannett and Mallinckrodt,2016-10-21 15:11:05 +0000,http://www.moodys.com/page/viewresearchdoc.aspx?docid=PR_356855&WT.mc_id=AM~WWFob29fRmluYW5jZV9TQl9SYXRpbmcgTmV3c19BbGxfRW5n~20161021_PR_356855,Mallinckrodt plc -- Moody's: FDA Proposal to withdraw generic Concerta from the market would be negative for Lannett and Mallinckrodt
MNK,MNK:US,BBG002BHBHM1,Surprising Analyst 12-Month Target For SPXN,2016-10-21 14:01:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Iopw396aPXk/surprising-analyst-12-month-target-for-spxn-cm696432,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
MNK,MNK:US,BBG002BHBHM1,"David Einhorn Speaks on Passive Investing, Mylan, His Cheapest Stock, the Fed",2016-10-20 22:48:26 +0000,http://finance.yahoo.com/news/david-einhorn-converses-range-topics-224510048.html,"David Einhorn Speaks on Passive Investing, Mylan, His Cheapest Stock, the Fed"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Pharmaceuticals Donates Drug Deactivation Pouches to Enable Safe Disposal of Prescription Drugs in Ohio,2016-10-20 11:30:00 +0000,http://finance.yahoo.com/news/mallinckrodt-pharmaceuticals-donates-drug-deactivation-113000895.html,"[PR Newswire] - CHESTERFIELD, United Kingdom, Oct. 20, 2016 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, today announced it will provide 160,000 drug deactivation ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Pharmaceuticals Donates Drug Deactivation Pouches to Enable Safe Disposal of Prescription Drugs in South Carolina,2016-10-20 11:30:00 +0000,http://finance.yahoo.com/news/mallinckrodt-pharmaceuticals-donates-drug-deactivation-113000391.html,"[PR Newswire] - CHESTERFIELD, United Kingdom, Oct. 20, 2016 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, today announced it will provide 160,000 drug deactivation ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Pharmaceuticals Donates Drug Deactivation Pouches to Enable Safe Disposal of Prescription Drugs in Tennessee,2016-10-20 11:30:00 +0000,http://finance.yahoo.com/news/mallinckrodt-pharmaceuticals-donates-drug-deactivation-113000341.html,"[PR Newswire] - CHESTERFIELD, United Kingdom, Oct. 20, 2016 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, today announced it will provide 160,000 drug deactivation ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Pharmaceuticals Donates Drug Deactivation Pouches to Enable Safe Disposal of Prescription Drugs in Kentucky,2016-10-20 11:30:00 +0000,http://finance.yahoo.com/news/mallinckrodt-pharmaceuticals-donates-drug-deactivation-113000127.html,"[PR Newswire] - CHESTERFIELD, United Kingdom, Oct. 20, 2016 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, today announced it will provide 160,000 drug deactivation ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Pharmaceuticals Donates Drug Deactivation Pouches to Enable Safe Disposal of Prescription Drugs in Indiana,2016-10-20 11:30:00 +0000,http://finance.yahoo.com/news/mallinckrodt-pharmaceuticals-donates-drug-deactivation-113000347.html,"[PR Newswire] - CHESTERFIELD, United Kingdom, Oct. 20, 2016 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, today announced it will provide 160,000 drug deactivation ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Pharmaceuticals Donates Drug Deactivation Pouches to Enable Safe Disposal of Prescription Drugs in Pennsylvania,2016-10-20 11:30:00 +0000,http://finance.yahoo.com/news/mallinckrodt-pharmaceuticals-donates-drug-deactivation-113000113.html,"[PR Newswire] - CHESTERFIELD, United Kingdom, Oct. 20, 2016 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, today announced it will provide 160,000 drug deactivation ..."
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt plc To Report Fourth Quarter And Full-Year Fiscal 2016 Results Nov. 29, 2016",2016-10-18 21:38:02 +0000,http://www.publicnow.com/view/5FA9D8739A0B281EA96B446A85A410716DB3E3B7,"[at noodls] - www.mallinckrodt.com. ... This is an abstract of the original noodl. To continue reading this document, click here for the original version."
MNK,MNK:US,BBG002BHBHM1,"ETF’s with exposure to Mallinckrodt Plc : October 18, 2016",2016-10-18 14:46:11 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-mallinckrodt-plc-october-18-2016/,"ETF’s with exposure to Mallinckrodt Plc : October 18, 2016"
MNK,MNK:US,BBG002BHBHM1,"Why Lannett Company, Inc. Shares Got Pummeled Today",2016-10-17 21:47:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ild-MKO2UV0/why-lannett-company-inc-shares-got-pummeled-today-cm694461,Image source Getty Images What happened Lannett Company Inc NYSE LCI ended the day down almost 13 after the Food and Drug Administration proposed withdrawing a generic version of Johnson amp Johnson s NYSE JNJ Concerta sold by Lannett s subsidiary Kremers
MNK,MNK:US,BBG002BHBHM1,"Why Lannett Company, Inc. Shares Got Pummeled Today",2016-10-17 20:33:55 +0000,http://www.fool.com/investing/2016/10/17/why-lannett-company-inc-shares-got-pummeled-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Lannett Company, Inc. Shares Got Pummeled Today"
MNK,MNK:US,BBG002BHBHM1,3 Incredibly Cheap Big Pharma Stocks,2016-10-15 12:41:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RIX-fVuGge0/3-incredibly-cheap-big-pharma-stocks-cm693771,Image source Getty Images Not everything about Big Pharma is big Some stocks of the largest drugmakers in the world actually trade at relatively low valuations Here s why Mallinckrodt NYSE MNK Bayer AG NASDAQOTH BAYRY and Bristol Myers Squibb NYSE BMY look
MNK,MNK:US,BBG002BHBHM1,3 Incredibly Cheap Big Pharma Stocks,2016-10-15 11:04:47 +0000,http://www.fool.com/investing/2016/10/15/3-incredibly-cheap-big-pharma-stocks.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Incredibly Cheap Big Pharma Stocks
MNK,MNK:US,BBG002BHBHM1,Valeant Thinks It Will Hit Its Financial Targets in 2016,2016-10-13 21:04:05 +0000,http://marketrealist.com/2016/10/valeant-pharmaceutical-expected-witness-year-year-revenue-decline-2016/?utm_source=yahoo&utm_medium=feed,Valeant Thinks It Will Hit Its Financial Targets in 2016
MNK,MNK:US,BBG002BHBHM1,Children's National Health System Granted $3 Million in Research Funding by Mallinckrodt Pharmaceuticals,2016-10-13 20:40:02 +0000,http://www.publicnow.com/view/297182D81D5E28D0C2F3DE2258D5AC4ABB160DDD,"[at noodls] - CHESTERFIELD, United Kingdom, Oct. 13, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced it has awarded a $3 million Healthcare Advancement ..."
MNK,MNK:US,BBG002BHBHM1,Close Update: Stocks End Mixed After FOMC Minutes,2016-10-12 21:00:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AqAADUwZWtY/close-update-stocks-end-mixed-after-fomc-minutes-cm692590,Stocks in the U S closed on a mixed note Wednesday with the Dow Jones Industrial Average and the S amp P 500 stronger but off the day s highs as the release of the Federal Open Market Committee s September meeting minutes seemed to firm up the view that a rate hike may be in the cards before
MNK,MNK:US,BBG002BHBHM1,"Health Care Sector Update for 10/12/2016: IPCI,MNK,HTGM,BSPM",2016-10-12 18:00:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ALY1WA_PUZk/health-care-sector-update-for-10122016-ipcimnkhtgmbspm-cm692526,Top Health Care StocksTop Health Care Stocks JNJ 0 53 JNJ 0 53 PFE 0 14 PFE 0 14 MRK 0 17 MRK 0 17 ABT 0 08 ABT 0 08 AMGN 0 11 AMGN 0 11 Health care stocks were turning lower again Wednesday afternoon with the NYSE Health Care Index slipping about 0 4 and shares of health
MNK,MNK:US,BBG002BHBHM1,Intellipharmaceutics (IPCI) Stock Climbs on Licensing Agreeement,2016-10-12 17:56:00 +0000,https://www.thestreet.com/story/13850874/1/intellipharmaceutics-ipci-stock-climbs-on-licensing-agreeement.html?puc=yahoo&cm_ven=YAHOO,Intellipharmaceutics (IPCI) Stock Climbs on Licensing Agreeement
MNK,MNK:US,BBG002BHBHM1,IntelliPharmaCeutics Inks New Licensing Deal With Mallinckrodt,2016-10-12 14:20:10 +0000,http://finance.yahoo.com/news/intellipharmaceutics-inks-licensing-deal-mallinckrodt-142010305.html,IntelliPharmaCeutics Inks New Licensing Deal With Mallinckrodt
MNK,MNK:US,BBG002BHBHM1,"IPCI Continues To Move Up, NBIX To Face FDA In April, Good Tidings From NYMX",2016-10-12 02:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p9xVzYcCTNE/ipci-continues-to-move-up-nbix-to-face-fda-in-april-good-tidings-from-nymx-20161012-00026,"IPCI Continues To Move Up, NBIX To Face FDA In April, Good Tidings From NYMX"
MNK,MNK:US,BBG002BHBHM1,Catabasis Presents Data from DMD study on Edasalonexent,2016-10-11 15:21:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CgJmOAeHPw4/catabasis-presents-data-from-dmd-study-on-edasalonexent-cm691773,Catabasis Pharmaceuticals Inc CATB announced that it has presented results from the part A of the MoveDMD study phase I II on edasalonexent at the congress of the World Muscle Society Edasalonexent a molecule that inhibits a protein called NF kB is being developed for the treatment
MNK,MNK:US,BBG002BHBHM1,"MALLINCKRODT PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits",2016-10-07 21:04:25 +0000,http://biz.yahoo.com/e/161007/mnk8-k.html,"MALLINCKRODT PLC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits"
MNK,MNK:US,BBG002BHBHM1,Specialty Pharma: Drug Pricing Controversies Just Won't Die!,2016-10-06 19:02:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/10/06/specialty-pharma-drug-pricing-controversies-just-wont-die/?mod=yahoobarrons&ru=yahoo,Specialty Pharma: Drug Pricing Controversies Just Won't Die!
MNK,MNK:US,BBG002BHBHM1,"S&P 500 Movers: MNK, CRM",2016-10-06 15:46:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lM2OpzQ280s/sp-500-movers-mnk-crm-cm689760,In early trading on Thursday shares of Salesforce com CRM topped the list of the day s best performing components of the S amp P 500 index trading up 3 8 Year to date Salesforce com has lost about 9 4 of its value And the worst performing S amp P 500 component thus far on the
MNK,MNK:US,BBG002BHBHM1,Ariad Pharmaceuticals Raises Cancer Drug Price For The 4th Time This Year,2016-10-05 18:41:09 +0000,http://finance.yahoo.com/news/ariad-pharmaceuticals-raises-cancer-drug-184109762.html,Ariad Pharmaceuticals Raises Cancer Drug Price For The 4th Time This Year
MNK,MNK:US,BBG002BHBHM1,What Are Analysts Saying about Mallinckrodt?,2016-09-30 18:04:22 +0000,http://marketrealist.com/2016/09/what-are-analysts-saying-about-mallinckrodt/?utm_source=yahoo&utm_medium=feed,What Are Analysts Saying about Mallinckrodt?
MNK,MNK:US,BBG002BHBHM1,How Much Revenue Can Mallinckrodt Bring In This Year?,2016-09-30 16:21:42 +0000,http://marketrealist.com/2016/09/how-much-revenue-can-mallinckrodt-bring-in-this-year/?utm_source=yahoo&utm_medium=feed,How Much Revenue Can Mallinckrodt Bring In This Year?
MNK,MNK:US,BBG002BHBHM1,Why Teva and Regeneron Entered Collaboration Agreement,2016-09-29 18:04:10 +0000,http://marketrealist.com/2016/09/teva-and-regenerons-global-collaboration-agreement-for-fasinumab/?utm_source=yahoo&utm_medium=feed,Why Teva and Regeneron Entered Collaboration Agreement
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt (MNK) Stock Price Target Lowered at Deutsche Bank,2016-09-28 20:01:00 +0000,https://www.thestreet.com/story/13755865/1/mallinckrodt-mnk-stock-price-target-lowered-at-deutsche-bank.html?puc=yahoo&cm_ven=YAHOO,Mallinckrodt (MNK) Stock Price Target Lowered at Deutsche Bank
MNK,MNK:US,BBG002BHBHM1,"MALLINCKRODT PLC Files SEC form 8-K, Change in Directors or Principal Officers",2016-09-28 12:59:28 +0000,http://biz.yahoo.com/e/160928/mnk8-k.html,"MALLINCKRODT PLC Files SEC form 8-K, Change in Directors or Principal Officers"
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Plc – Value Analysis (NYSE:MNK) : September 27, 2016",2016-09-27 14:49:35 +0000,http://www.capitalcube.com/blog/index.php/mallinckrodt-plc-value-analysis-nysemnk-september-27-2016/,"Mallinckrodt Plc – Value Analysis (NYSE:MNK) : September 27, 2016"
MNK,MNK:US,BBG002BHBHM1,"Clinton, Trump Share Big-Pharma Attack Goals, Andrew Left Says",2016-09-26 19:42:00 +0000,https://www.thestreet.com/story/13752208/1/clinton-trump-share-big-pharma-attack-goals-andrew-left-says.html?puc=yahoo&cm_ven=YAHOO,"Clinton, Trump Share Big-Pharma Attack Goals, Andrew Left Says"
MNK,MNK:US,BBG002BHBHM1,"S&P 500 Movers: MNK, RIG",2016-09-26 15:20:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-6BNGXQfMKY/sp-500-movers-mnk-rig-cm684428,In early trading on Monday shares of Transocean RIG topped the list of the day s best performing components of the S amp P 500 index trading up 2 4 Year to date Transocean has lost about 24 8 of its value And the worst performing S amp P 500 component thus far on the day
MNK,MNK:US,BBG002BHBHM1,How Mylan’s Profitability Has Changed,2016-09-26 15:05:05 +0000,http://marketrealist.com/2016/09/how-mylans-profitability-has-changed/?utm_source=yahoo&utm_medium=feed,How Mylan’s Profitability Has Changed
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Plc breached its 50 day moving average in a Bullish Manner : MNK-US : September 26, 2016",2016-09-26 12:13:29 +0000,http://www.capitalcube.com/blog/index.php/mallinckrodt-plc-breached-its-50-day-moving-average-in-a-bullish-manner-mnk-us-september-26-2016/,"Mallinckrodt Plc breached its 50 day moving average in a Bullish Manner : MNK-US : September 26, 2016"
MNK,MNK:US,BBG002BHBHM1,"Endo Int'l: New CEO ""Has His Work Cut Out For Him""",2016-09-23 17:11:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/09/23/endo-intl-new-ceo-has-his-work-cut-out-for-him/?mod=yahoobarrons&ru=yahoo,"Endo Int'l: New CEO ""Has His Work Cut Out For Him"""
MNK,MNK:US,BBG002BHBHM1,Validity of Mallinckrodt's INOMAX® Patent Claims Upheld,2016-09-23 12:42:06 +0000,http://www.publicnow.com/view/02BA1D5D2DF9691D6F4CCD214E598E809C9AE682,[at noodls] - Validity of Mallinckrodt's INOMAX® Patent Claims Upheld The text version of this document is not available at the moment. The original content was posted at original link . Mallinckrodt plc published this ...
MNK,MNK:US,BBG002BHBHM1,How Analysts See Horizon Compared to Its Peers,2016-09-21 15:05:03 +0000,http://marketrealist.com/2016/09/how-analysts-see-horizon-compared-to-its-peers/?utm_source=yahoo&utm_medium=feed,How Analysts See Horizon Compared to Its Peers
MNK,MNK:US,BBG002BHBHM1,What Is the Upside Potential for Valeant?,2016-09-21 12:04:25 +0000,http://marketrealist.com/2016/09/what-is-the-upside-potential-for-valeant/?utm_source=yahoo&utm_medium=feed,What Is the Upside Potential for Valeant?
MNK,MNK:US,BBG002BHBHM1,"Commit To Buy Mallinckrodt At $45, Earn 12.2% Using Options",2016-09-20 17:21:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vCRb6RVYwtk/commit-to-buy-mallinckrodt-at-45-earn-122-using-options-cm682130,Investors considering a purchase of Mallinckrodt plc Symbol MNK stock but tentative about paying the going market price of 74 91 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the
MNK,MNK:US,BBG002BHBHM1,How Will Valeant’s Profitability Pan Out over the Long Term?,2016-09-20 15:04:34 +0000,http://marketrealist.com/2016/09/how-will-valeants-profitability-pan-out-over-the-long-term/?utm_source=yahoo&utm_medium=feed,How Will Valeant’s Profitability Pan Out over the Long Term?
MNK,MNK:US,BBG002BHBHM1,We Did The Math VIXH Can Go To $26,2016-09-20 14:21:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VN9avp2hHTw/we-did-the-math-vixh-can-go-to-26-cm681929,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Grows Investment in Dublin College Business and Technology Park Site to €85 million,2016-09-19 10:48:07 +0000,http://www.publicnow.com/view/EF992EBEB0FAE1630B575D63B8A3DB63A1A9C3CB,"[at noodls] - - Announces new €10 million R&D facility to house global device engineering - - Creates 40 R&D jobs and grows total to 120 new roles at new site - Dublin, Monday, 19 September 2016 - Mallinckrodt plc (NYSE: ..."
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Completes Acquisition Of Stratatech Corporation, A Regenerative Medicine Company Focused On Proprietary Therapeutic Human Skin Substitute Products",2016-09-17 09:38:09 +0000,http://www.publicnow.com/view/A0BFA9B14B7BE3B5EE329740DDE921D0EFA4932C,"[at noodls] - CHESTERFIELD, United Kingdom, Aug. 31, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, today announced it closed the acquisition of Stratatech Corporation, ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt To Present At Morgan Stanley Global Conference; Webcast At 8:45 AM,2016-09-12 07:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PNZJuDyG8Jc/mallinckrodt-to-present-at-morgan-stanley-global-conference-webcast-at-845-am-20160912-00281,Mallinckrodt To Present At Morgan Stanley Global Conference; Webcast At 8:45 AM
MNK,MNK:US,BBG002BHBHM1,4 Low P/CF Stocks to Add More Value to Your Investment,2016-09-09 12:33:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hxgmVhpLtXs/4-low-pcf-stocks-to-add-more-value-to-your-investment-cm676672,Value style is considered one of the best practices when it comes to picking stocks There are different valuation metrics to determine a stock s inherent strength but a random selection of a ratio cannot serve your purpose if you want a realistic assessment of a company s financial position
MNK,MNK:US,BBG002BHBHM1,Drug Pricing Power Transcends Politics,2016-09-09 11:00:00 +0000,http://news.morningstar.com/articlenet/article.aspx?id=768713&SR=Yahoo,Drug Pricing Power Transcends Politics
MNK,MNK:US,BBG002BHBHM1,4 Low P/CF Stocks to Add More Value to Your Investment,2016-09-09 10:28:10 +0000,http://finance.yahoo.com/news/4-low-p-cf-stocks-102810989.html,4 Low P/CF Stocks to Add More Value to Your Investment
MNK,MNK:US,BBG002BHBHM1,Allergan Takes Over RetroSense; Boosts Eye Care Pipeline,2016-09-07 16:20:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Csb7PttCQ-0/allergan-takes-over-retrosense-boosts-eye-care-pipeline-cm675659,Allergan plc AGN has acquired RetroSense Therapeutics a privately held clinical stage biotechnology company which will add the latter s lead gene therapy development program RST 001 to its eye care pipeline RST 001 is being developed for the treatment of the eye disease retinitis
MNK,MNK:US,BBG002BHBHM1,Allergan Takes Over RetroSense; Boosts Eye Care Pipeline,2016-09-07 14:20:02 +0000,http://finance.yahoo.com/news/allergan-takes-over-retrosense-boosts-142002221.html,Allergan Takes Over RetroSense; Boosts Eye Care Pipeline
MNK,MNK:US,BBG002BHBHM1,Clinton Drug Plan No Threat to Innovators,2016-09-02 19:04:00 +0000,http://finance.yahoo.com/news/clinton-drug-plan-no-threat-190400507.html,Clinton Drug Plan No Threat to Innovators
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt completes purchase of regenerative medicine company,2016-09-01 12:30:11 +0000,http://www.bizjournals.com/stlouis/news/2016/09/01/malinckrodt-completes-purchase-of-regenerative.html?ana=yahoo,Mallinckrodt completes purchase of regenerative medicine company
MNK,MNK:US,BBG002BHBHM1,Health Economic Data Following Orthopedic Surgery for OFIRMEV® (Acetaminophen) Injection Published in Advances in Therapy,2016-09-01 12:23:06 +0000,http://www.publicnow.com/view/BB5F1CD9F8DF0CAC591263EF72404FDE7C8ABDC8,"[at noodls] - - Retrospective Health Economic Data Show Addition of OFIRMEV to Treat Post-Operative Pain Versus IV Opioids Alone Associated With Shorter Length of Stay, Decreased Hospital Costs - CHESTERFIELD, United ..."
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Completes Acquisition Of Stratatech Corporation, A Regenerative Medicine Company Focused On Proprietary Therapeutic Human Skin Substitute Products",2016-08-31 21:13:02 +0000,http://www.publicnow.com/view/178D5E8F1E9DD1732A38402BFF0326E04E77EDF4,"[at noodls] - CHESTERFIELD, United Kingdom, Aug. 31, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, today announced it closed the acquisition of Stratatech Corporation, ..."
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Completes Acquisition Of Stratatech Corporation, A Regenerative Medicine Company Focused On Proprietary Therapeutic Human Skin Substitute Products",2016-08-31 21:00:00 +0000,http://finance.yahoo.com/news/mallinckrodt-completes-acquisition-stratatech-corporation-210000043.html,"[PR Newswire] - CHESTERFIELD, United Kingdom, Aug. 31, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, today announced it closed the acquisition of Stratatech Corporation, ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt (MNK) Stock Price Target Reduced at Deutsche Bank,2016-08-31 14:10:00 +0000,https://www.thestreet.com/story/13690462/1/mallinckrodt-mnk-stock-price-target-reduced-at-deutsche-bank.html?puc=yahoo&cm_ven=YAHOO,Mallinckrodt (MNK) Stock Price Target Reduced at Deutsche Bank
MNK,MNK:US,BBG002BHBHM1,5 Health Care Stocks John Paulson Is Betting On in 2016,2016-08-31 12:33:00 +0000,https://www.thestreet.com/story/13285848/1/health-care-stocks-john-paulson-loves.html?puc=yahoo&cm_ven=YAHOO,5 Health Care Stocks John Paulson Is Betting On in 2016
MNK,MNK:US,BBG002BHBHM1,How StrataGraft Could Benefit Mallinckrodt’s Hospital Portfolio,2016-08-30 22:04:19 +0000,http://marketrealist.com/2016/08/how-stratagraft-could-benefit-mallinckrodts-hospital-portfolio/?utm_source=yahoo&utm_medium=feed,How StrataGraft Could Benefit Mallinckrodt’s Hospital Portfolio
MNK,MNK:US,BBG002BHBHM1,What’s behind Mallinckrodt’s Stratatech Acquisition?,2016-08-30 20:23:39 +0000,http://marketrealist.com/2016/08/whats-behind-mallinckrodts-stratatech-acquisition/?utm_source=yahoo&utm_medium=feed,What’s behind Mallinckrodt’s Stratatech Acquisition?
MNK,MNK:US,BBG002BHBHM1,"Top Research Reports for August 30, 2016",2016-08-30 15:17:03 +0000,http://finance.yahoo.com/news/top-research-reports-august-30-151703114.html,"Top Research Reports for August 30, 2016"
MNK,MNK:US,BBG002BHBHM1,"Billionaire John Paulson’s Favorite Healthcare Stocks Include The Latest Industry Punching Bag, Mylan",2016-08-27 08:17:36 +0000,http://www.insidermonkey.com/blog/billionaire-john-paulsons-favorite-healthcare-stocks-include-the-latest-industry-punching-bag-mylan-470472/,"Billionaire John Paulson’s Favorite Healthcare Stocks Include The Latest Industry Punching Bag, Mylan"
MNK,MNK:US,BBG002BHBHM1,6 More Pharma Companies Selling Overpriced Drugs,2016-08-26 17:30:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p4yb8i3lp6k/6-more-pharma-companies-selling-overpriced-drugs-cm670871,Kudos to Mylan NV (NASDAQ  MYL ) for offering discounts on the exorbitant price on EpiPen for patients with a high out of pocket
MNK,MNK:US,BBG002BHBHM1,"Stock Market News for August 26, 2016",2016-08-26 16:31:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Hq8RZlvfY0w/stock-market-news-for-august-26-2016-cm670818,"Benchmarks finished in the red on Thursday as investors refrained from making big bets ahead of Fed Chief Janet Yellen's speech at Jackson Hole, Wyoming today. Moreover, losses in healthcare and consumer discretionary stocks also weighed on"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt DMD Drug Gets Fast Track Status in the U.S.,2016-08-26 15:30:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bRd1jNkw7j4/mallinckrodt-dmd-drug-gets-fast-track-status-in-the-us-cm670703,Mallinckrodt Public Limited CompanyMNK announced that it has received Fast Track designation in the U.S. for its Investigational New Drug (IND) application for Synacthen Depot for the treatment of patients with Duchenne muscular dystrophy (DMD).  We
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt DMD Drug Gets Fast Track Status in the U.S.,2016-08-26 13:57:01 +0000,http://finance.yahoo.com/news/mallinckrodt-dmd-drug-gets-fast-135701200.html,Mallinckrodt DMD Drug Gets Fast Track Status in the U.S.
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Could Be Next in Spotlight Thanks to EpiPen Scrutiny,2016-08-25 14:39:00 +0000,https://www.thestreet.com/story/13685271/1/mallinckrodt-could-be-next-in-spotlight-thanks-to-epipen-scrutiny.html?puc=yahoo&cm_ven=YAHOO,Mallinckrodt Could Be Next in Spotlight Thanks to EpiPen Scrutiny
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Nuclear Biz Sale A Positive In BMO's View, Maintains Outperform",2016-08-25 14:33:46 +0000,http://finance.yahoo.com/news/mallinckrodt-nuclear-biz-sale-positive-143346889.html,"Mallinckrodt Nuclear Biz Sale A Positive In BMO's View, Maintains Outperform"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt to Divest Nuclear Imaging Business for $690M,2016-08-25 13:48:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ptM533U_DIQ/mallinckrodt-to-divest-nuclear-imaging-business-for-690m-cm670064,"Mallinckrodt plcMNK announced that it has entered into a definitive agreement to sell its Nuclear Imaging business to IBA Molecular for $690 million.  Of the total value of the deal, approximately $574 million comprises up front"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt's Top Drug Could Go the Way of EpiPen,2016-08-25 12:39:00 +0000,http://realmoney.thestreet.com/articles/08/25/2016/mallinckrodts-top-drug-could-go-way-epipen?puc=yahoo&cm_ven=YAHOO,Mallinckrodt's Top Drug Could Go the Way of EpiPen
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt to Divest Nuclear Imaging Business for $690M,2016-08-25 12:22:12 +0000,http://finance.yahoo.com/news/mallinckrodt-divest-nuclear-imaging-business-122212472.html,Mallinckrodt to Divest Nuclear Imaging Business for $690M
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Receives FDA Fast-Track Designation for Synacthen® Depot IND Application,2016-08-25 11:48:07 +0000,http://www.publicnow.com/view/0D0F7A7FA837640FFB49B18EB2D0DEAD7D723A00,"[at noodls] - CHESTERFIELD, United Kingdom, Aug. 25, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) ..."
MNK,MNK:US,BBG002BHBHM1,AstraZeneca Sells Antibiotics Business; Mallinckrodt Sheds Imaging Unit,2016-08-24 20:52:57 +0000,http://www.investors.com/news/technology/astrazeneca-sells-antibiotics-biz-mallinkcrodt-sheds-imaging-unit/,AstraZeneca Sells Antibiotics Business; Mallinckrodt Sheds Imaging Unit
MNK,MNK:US,BBG002BHBHM1,"S&P 500 Movers: INTU, MNK",2016-08-24 15:45:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BUBqSea7cNY/sp-500-movers-intu-mnk-cm669490,"In early trading on Wednesday, shares of Mallinckrodt topped the list of the day's best performing components of the S&P 500 index, trading up 3.1%. Year to date, Mallinckrodt registers a"
MNK,MNK:US,BBG002BHBHM1,Swiss approve reimbursement for Mallinckrodt treatment,2016-08-24 15:45:12 +0000,http://www.bizjournals.com/stlouis/news/2016/08/23/swiss-approve-reimbursement-for-mallinckrodt.html?ana=yahoo,Swiss approve reimbursement for Mallinckrodt treatment
MNK,MNK:US,BBG002BHBHM1,[$$] CapVest's IBA Molecular to Buy Mallinckrodt's Nuclear Imaging Unit for About $690 Million,2016-08-24 14:25:36 +0000,http://www.wsj.com/articles/capvests-iba-molecular-to-buy-mallinckrodts-nuclear-imaging-unit-for-about-690-million-1472048168?mod=yahoo_hs,[$$] CapVest's IBA Molecular to Buy Mallinckrodt's Nuclear Imaging Unit for About $690 Million
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt (MNK) Stock Climbs on Nuclear Imaging Business Sale,2016-08-24 13:52:00 +0000,https://www.thestreet.com/story/13683929/1/mallinckrodt-mnk-stock-climbs-on-nuclear-imaging-business-sale.html?puc=yahoo&cm_ven=YAHOO,Mallinckrodt (MNK) Stock Climbs on Nuclear Imaging Business Sale
MNK,MNK:US,BBG002BHBHM1,"Stocks to Watch: Express, Skullcandy, Mallinckrodt, La-Z-Boy",2016-08-24 13:34:18 +0000,http://blogs.wsj.com/moneybeat/2016/08/24/stocks-to-watch-express-skullcandy-mallinckrodt-la-z-boy/?mod=yahoo_hs,"Stocks to Watch: Express, Skullcandy, Mallinckrodt, La-Z-Boy"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt to sell nuclear imaging business for $690 million,2016-08-24 13:26:09 +0000,http://www.bizjournals.com/stlouis/news/2016/08/24/mallinckrodt-to-sell-nuclear-imaging-business-for.html?ana=yahoo,Mallinckrodt to sell nuclear imaging business for $690 million
MNK,MNK:US,BBG002BHBHM1,[$$] Mallinckrodt to Sell Nuclear-Imaging Operations,2016-08-24 13:15:22 +0000,http://www.wsj.com/articles/mallinckrodt-to-sell-nuclear-imaging-operations-1472044519?mod=yahoo_hs,[$$] Mallinckrodt to Sell Nuclear-Imaging Operations
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Enters Agreement To Sell Its Nuclear Imaging Business To IBA Molecular For Approximately $690 Million,2016-08-24 12:18:09 +0000,http://www.publicnow.com/view/44E532DD4CBBD9144936EA877530418D0FFE7583,"[at noodls] - CHESTERFIELD, United Kingdom, Aug. 24, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, announced today that it has entered into a definitive agreement under ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt sells nuclear imaging business for $690 million,2016-08-24 12:16:13 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=62F469BB-EDE0-4CCB-BE30-7116F0C082C5&siteid=yhoof2,Mallinckrodt sells nuclear imaging business for $690 million
MNK,MNK:US,BBG002BHBHM1,"MALLINCKRODT PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial",2016-08-24 12:11:56 +0000,http://biz.yahoo.com/e/160824/mnk8-k.html,"MALLINCKRODT PLC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Enters Agreement To Sell Its Nuclear Imaging Business To IBA Molecular For Approximately $690 Million,2016-08-24 12:00:00 +0000,http://finance.yahoo.com/news/mallinckrodt-enters-agreement-sell-nuclear-120000769.html,"[PR Newswire] - CHESTERFIELD, United Kingdom, Aug. 24, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading specialty pharmaceutical company, announced today that it has entered into a definitive agreement under ..."
MNK,MNK:US,BBG002BHBHM1,U.S. Hot Stocks: Hot Stocks to Watch,2016-08-24 09:24:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RUEpu57RS6c/us-hot-stocks-hot-stocks-to-watch-20160824-00363,U.S. Hot Stocks: Hot Stocks to Watch
MNK,MNK:US,BBG002BHBHM1,"Extracorporeal Photopheresis (ECP), Including Mallinckrodt's THERAKOS® ECP Immunomodulation, Receives Approval for Reimbursement by Swiss Federal Department of Home Affairs",2016-08-23 12:18:03 +0000,http://www.publicnow.com/view/42493362073790F6ABDE442C78DEDA4BCF190981,"[at noodls] - CHESTERFIELD, England, August 23, 2016 /PRNewswire/ -- - Approval granted for reimbursement of Extracorporeal Photopheresis (ECP) for Bronchiolitis Obliterans Syndrome (BOS) derived from lung transplantation. ..."
MNK,MNK:US,BBG002BHBHM1,"Extracorporeal Photopheresis (ECP), Including Mallinckrodt's THERAKOS® ECP Immunomodulation, Receives Approval for Reimbursement by Swiss Federal Department of Home Affairs",2016-08-23 12:00:00 +0000,http://finance.yahoo.com/news/extracorporeal-photopheresis-ecp-including-mallinckrodts-120000692.html,"[PR Newswire] - CHESTERFIELD, England, August 23, 2016 /PRNewswire/ -- - Approval granted for reimbursement of Extracorporeal Photopheresis (ECP) for Bronchiolitis Obliterans Syndrome (BOS) derived from lung transplantation. ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt To Present At Morgan Stanley Global Healthcare Conference,2016-08-22 11:48:03 +0000,http://www.publicnow.com/view/09270C93E0A195FE7A37E349CF105FE1466810B5,"[at noodls] - CHESTERFIELD, United Kingdom, Aug. 22, 2016 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present on Monday, Sept. 12, 2016, at the Morgan ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt To Present At Wells Fargo Securities Healthcare Conference,2016-08-19 11:51:05 +0000,http://www.publicnow.com/view/D838BF971449379DDBE2E5EC423C3CD05A9971F2,"[at noodls] - CHESTERFIELD, United Kingdom, Aug. 19, 2016 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty pharmaceutical company, will present at the Wells Fargo Securities Healthcare ..."
MNK,MNK:US,BBG002BHBHM1,Behind Horizon’s Price-to-Sales Valuation,2016-08-18 15:10:14 +0000,http://marketrealist.com/2016/08/behind-horizons-price-to-sales-valuation/?utm_source=yahoo&utm_medium=feed,Behind Horizon’s Price-to-Sales Valuation
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt consolidating specialty brands to New Jersey,2016-08-18 14:00:12 +0000,http://www.bizjournals.com/stlouis/news/2016/08/18/mallinckrodt-consolidating-specialty-brands-to-new.html?ana=yahoo,Mallinckrodt consolidating specialty brands to New Jersey
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Locates Growing Specialty Brands Businesses In Bedminster, N.J.; Continues Significant St. Louis Reinvestment",2016-08-18 12:11:08 +0000,http://www.publicnow.com/view/7341EE22399923EB5F5A53B5E88C9547F0235159,"[at noodls] - CHESTERFIELD, United Kingdom, Aug. 18, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, announced today it will build out a new campus for its fast-growing ..."
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Locates Growing Specialty Brands Businesses In Bedminster, N.J.; Continues Significant St. Louis Reinvestment",2016-08-18 11:55:00 +0000,http://finance.yahoo.com/news/mallinckrodt-locates-growing-specialty-brands-115500798.html,"[PR Newswire] - CHESTERFIELD, United Kingdom, Aug. 18, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, announced today it will build out a new campus for its fast-growing ..."
MNK,MNK:US,BBG002BHBHM1,Look Under The Hood: HCRF Has 11% Upside,2016-08-17 21:58:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iKvhhYyxHxE/look-under-the-hood-hcrf-has-11-upside-cm666386,"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12 month forward target price, and computed the weighted average"
MNK,MNK:US,BBG002BHBHM1,How Did Valeant Manage Its Operating Expenses in 2Q16?,2016-08-17 15:04:30 +0000,http://marketrealist.com/2016/08/how-did-valeant-manage-its-operating-expenses-in-2q16/?utm_source=yahoo&utm_medium=feed,How Did Valeant Manage Its Operating Expenses in 2Q16?
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt (MNK) to Buy Stratatech for Undisclosed Value,2016-08-12 18:49:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rTDr8tVuNEg/mallinckrodt-mnk-to-buy-stratatech-for-undisclosed-value-cm664814,"Mallinckrodt plcMNK announced that it will acquire privately held regenerative medicine company, Stratatech Corporation. However, financial terms of the transaction were not disclosed. The transaction will close in the second half of the year. Assets Acquired through the Deal"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt (MNK) to Buy Stratatech for Undisclosed Value,2016-08-12 16:24:04 +0000,http://finance.yahoo.com/news/mallinckrodt-mnk-buy-stratatech-undisclosed-162404386.html,Mallinckrodt (MNK) to Buy Stratatech for Undisclosed Value
MNK,MNK:US,BBG002BHBHM1,What Are Valeant’s New Segments?,2016-08-12 15:05:25 +0000,http://marketrealist.com/2016/08/what-are-valeants-new-segments/?utm_source=yahoo&utm_medium=feed,What Are Valeant’s New Segments?
MNK,MNK:US,BBG002BHBHM1,Blog Coverage Mallinckrodt Acquires Privately Held Regenerative Skin Technology Firm,2016-08-12 13:16:50 +0000,http://news.investornetwork.com/2016/08/12/blog-coverage-mallinckrodt-acquires-privately-held-regenerative-skin-technology-firm/?1=1&1471007810,Blog Coverage Mallinckrodt Acquires Privately Held Regenerative Skin Technology Firm
MNK,MNK:US,BBG002BHBHM1,"MNK Opens Wallet, CYNA Awaits Parkinson''s Drug Data, 3rd Time''s A Charm For HRTX",2016-08-11 06:03:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oiK81xlGoX0/mnk-opens-wallet-cyna-awaits-parkinsons-drug-data-3rd-times-a-charm-for-hrtx-20160811-00126,"MNK Opens Wallet, CYNA Awaits Parkinson''s Drug Data, 3rd Time''s A Charm For HRTX"
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt To Acquire Stratatech Corporation, A Regenerative Medicine Company Focused On Proprietary Therapeutic Human Skin Substitute Products",2016-08-10 22:01:07 +0000,http://www.publicnow.com/view/5DC5B60B751BF9F7C9E8FFDF965B0B6CE0F0885E,"[at noodls] - CHESTERFIELD, United Kingdom, Aug. 10, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced that it has entered into a merger agreement ..."
MNK,MNK:US,BBG002BHBHM1,S&P 500 Analyst Moves: MNK,2016-08-09 17:35:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PPWJDNFHHkA/sp-500-analyst-moves-mnk-cm662621,"The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Mallinckrodt ( MNK ) is now the #5 analyst pick, moving up by 5 spots. This rank is"
MNK,MNK:US,BBG002BHBHM1,An ETF to Track Companies That Invest Toward Their Future,2016-08-08 20:18:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/78_0iCeEeIA/an-etf-to-track-companies-that-invest-toward-their-future-cm660679,"Corporate America has fueled years of stock repurchases, and investors have finally had enough, opting for companies that have employed cash toward high capital expenditures and bolstering a capex themed exchange traded fund.  The extended low"
MNK,MNK:US,BBG002BHBHM1,The death of short sellers?,2016-08-08 17:47:00 +0000,http://finance.yahoo.com/video/death-short-sellers-174700147.html,The death of short sellers?
MNK,MNK:US,BBG002BHBHM1,"Noteworthy ETF Outflows: XPH, MNK, AKRX, HZNP",2016-08-08 16:12:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F2mUlrbye_Q/noteworthy-etf-outflows-xph-mnk-akrx-hznp-cm661845,"Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P Pharmaceuticals ETF (Symbol XPH) where we have detected an approximate $32.8 million dollar outflow"
MNK,MNK:US,BBG002BHBHM1,An Update on Analysts’ Recommendations for Mallinckrodt,2016-08-05 15:04:51 +0000,http://marketrealist.com/2016/08/update-analysts-recommendations-mallinckrodt/?utm_source=yahoo&utm_medium=feed,An Update on Analysts’ Recommendations for Mallinckrodt
MNK,MNK:US,BBG002BHBHM1,Falls Continue in Specialty Generics and Nuclear Imaging,2016-08-05 13:05:09 +0000,http://marketrealist.com/2016/08/falls-continue-specialty-generics-nuclear-imaging/?utm_source=yahoo&utm_medium=feed,Falls Continue in Specialty Generics and Nuclear Imaging
MNK,MNK:US,BBG002BHBHM1,An ETF to Track Companies That Invest Toward Their Future,2016-08-04 19:24:43 +0000,http://finance.yahoo.com/news/etf-track-companies-invest-toward-192443256.html,An ETF to Track Companies That Invest Toward Their Future
MNK,MNK:US,BBG002BHBHM1,"ETF’s with exposure to Mallinckrodt Plc : August 4, 2016",2016-08-04 19:04:41 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-mallinckrodt-plc-august-4-2016/,"ETF’s with exposure to Mallinckrodt Plc : August 4, 2016"
MNK,MNK:US,BBG002BHBHM1,Strong Growth for Acthar in Fiscal 3Q16,2016-08-04 15:05:38 +0000,http://marketrealist.com/2016/08/strong-growth-acthar-fiscal-3q16/?utm_source=yahoo&utm_medium=feed,Strong Growth for Acthar in Fiscal 3Q16
MNK,MNK:US,BBG002BHBHM1,How Did Mallinckrodt’s Specialty Brands Perform in Fiscal 3Q16?,2016-08-04 13:07:22 +0000,http://marketrealist.com/2016/08/mallinckrodts-specialty-brands-perform-fiscal-3q16/?utm_source=yahoo&utm_medium=feed,How Did Mallinckrodt’s Specialty Brands Perform in Fiscal 3Q16?
MNK,MNK:US,BBG002BHBHM1,Sizzling S&P sectors for summer,2016-08-04 09:35:00 +0000,http://finance.yahoo.com/video/sizzling-p-sectors-summer-093500841.html,Sizzling S&P sectors for summer
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Plc: Strong price momentum but will it sustain?,2016-08-03 20:17:39 +0000,http://www.capitalcube.com/blog/index.php/mallinckrodt-plc-strong-price-momentum-but-will-it-sustain/,Mallinckrodt Plc: Strong price momentum but will it sustain?
MNK,MNK:US,BBG002BHBHM1,A Look at Mallinckrodt’s Operating Segments,2016-08-03 19:39:05 +0000,http://marketrealist.com/2016/08/look-mallinckrodts-operating-segments/?utm_source=yahoo&utm_medium=feed,A Look at Mallinckrodt’s Operating Segments
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt’s Strong Fiscal 3Q16 Impressed Wall Street,2016-08-03 19:39:00 +0000,http://marketrealist.com/2016/08/mallinckrodts-strong-fiscal-3q16-impressed-wall-street/?utm_source=yahoo&utm_medium=feed,Mallinckrodt’s Strong Fiscal 3Q16 Impressed Wall Street
MNK,MNK:US,BBG002BHBHM1,How Analysts Are Rating Valeant before Its Q216 Earnings,2016-08-03 19:08:13 +0000,http://marketrealist.com/2016/08/analysts-rating-valeant-q216-earnings/?utm_source=yahoo&utm_medium=feed,How Analysts Are Rating Valeant before Its Q216 Earnings
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Plc :MNK-US: Earnings Analysis: Q3, 2016 By the Numbers : August 3, 2016",2016-08-03 16:08:07 +0000,http://www.capitalcube.com/blog/index.php/mallinckrodt-plc-mnk-us-earnings-analysis-q3-2016-by-the-numbers-august-3-2016/,"Mallinckrodt Plc :MNK-US: Earnings Analysis: Q3, 2016 By the Numbers : August 3, 2016"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt (MNK) Tops Q3 Earnings on Solid Sales Growth,2016-08-02 22:56:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y54amJmGB3k/mallinckrodt-mnk-tops-q3-earnings-on-solid-sales-growth-cm659216,"Mallinckrodt plcMNK reported adjusted earnings of $2.20 per share in the third quarter of fiscal 2016 (ended Jun 24, 2016), beating the Zacks Consensus Estimate of $2.01. Earnings were also up from the year ago figure of $2.02. Net"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt leads S&P after second-quarter results beat the Street,2016-08-02 21:04:17 +0000,http://www.cnbc.com/id/103838129?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=103838129,Mallinckrodt leads S&P after second-quarter results beat the Street
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt (MNK) Tops Q3 Earnings on Solid Sales Growth,2016-08-02 20:51:08 +0000,http://finance.yahoo.com/news/mallinckrodt-mnk-tops-q3-earnings-205108816.html,Mallinckrodt (MNK) Tops Q3 Earnings on Solid Sales Growth
MNK,MNK:US,BBG002BHBHM1,Edited Transcript of MNK earnings conference call or presentation 2-Aug-16 12:30pm GMT,2016-08-02 20:28:06 +0000,http://finance.yahoo.com/news/edited-transcript-mnk-earnings-conference-202806932.html,Edited Transcript of MNK earnings conference call or presentation 2-Aug-16 12:30pm GMT
MNK,MNK:US,BBG002BHBHM1,"S&P 500 Movers: RCL, MNK",2016-08-02 15:55:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/LZWRUwUdma8/sp-500-movers-rcl-mnk-cm658809,"In early trading on Tuesday, shares of Mallinckrodt ( MNK ) topped the list of the day's best performing components of the S&P 500 index, trading up 9.9%. Year to date, Mallinckrodt has lost about 0.8% of its value."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt (MNK) Tops on Earnings & Sales in Q3,2016-08-02 12:57:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZskpZon5LsQ/mallinckrodt-mnk-tops-on-earnings-sales-in-q3-cm658586,"Ireland based MallinckrodtMNK focuses on developing treatments for autoimmune and rare diseases (including neurology, rheumatology, nephrology and pulmonology) as well as therapies for pain management. The company develops, manufactures, markets and distributes both branded and specialty generic pharmaceuticals. During"
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt Posting Strong Gain On Upbeat Q3 Results, Guidance",2016-08-02 12:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RZ2Z_fRkYVY/mallinckrodt-posting-strong-gain-on-upbeat-q3-results-guidance-20160802-01025,"Mallinckrodt Posting Strong Gain On Upbeat Q3 Results, Guidance"
MNK,MNK:US,BBG002BHBHM1,"Earnings Reaction History: Mallinckrodt plc, 33.3% Follow-Through Indicator, 3.9% Sensitive",2016-08-02 10:52:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c4lia05aP3E/earnings-reaction-history-mallinckrodt-plc-333-follow-through-indicator-39-sensitive-cm658559,"Expected Earnings Release 08 02 2016, Premarket Avg. Extended Hours Dollar Volume $2,009,638 Mallinckrodt plc ( MNK ) is due to issue its quarterly earnings report in the upcoming extended hours session. Given its history, traders can expect light"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt plc Reports Fiscal 2016 Third Quarter Results and Provides Guidance for Calendar Year 2016,2016-08-02 10:21:05 +0000,http://www.publicnow.com/view/99CAB4E74E1AF07BFF2C218914837E5F03119850,"[at noodls] - CHESTERFIELD, United Kingdom, Aug. 2, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today reported results for the third quarter of fiscal 2016. ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt beats Street 3Q forecasts,2016-08-02 10:16:50 +0000,http://sg.finance.yahoo.com/news/mallinckrodt-beats-street-3q-forecasts-101650397.html,Mallinckrodt beats Street 3Q forecasts
MNK,MNK:US,BBG002BHBHM1,First Patient Enrolled in Mallinckrodt Phase 3 Terlipressin Trial,2016-07-28 20:58:12 +0000,http://www.publicnow.com/view/D9D6849F5510DBDA5A8375E216B8523B87C4FFC5,"[at noodls] - CHESTERFIELD, United Kingdom, July 28, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today confirmed enrollment of the first patient in the company's ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt (MNK) Q3 Earnings: Will the Stock Surprise?,2016-07-28 01:22:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QtCyMgBqWJo/mallinckrodt-mnk-q3-earnings-will-the-stock-surprise-cm656136,"Mallinckrodt plcMNK is set to report third quarter fiscal 2016 results on Aug 2. The company's track record has been impressive so far. It has beaten estimates in all of the last four quarters, with a positive average earnings"
MNK,MNK:US,BBG002BHBHM1,5 Low Price-to-Book Stocks with Great Growth Prospects,2016-07-26 14:28:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CNwVaNkBBTk/5-low-price-to-book-stocks-with-great-growth-prospects-cm654846,"Given the rally in stocks in the past one month, value analysis is the best approach to identify great bargains. Though price to earnings (P E) and price to sales (P S) valuation tools are more commonly used for"
MNK,MNK:US,BBG002BHBHM1,4 Low P/CF Stocks to Improve Your Value Investing,2016-07-22 13:13:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F0fvmtKQTxQ/4-low-pcf-stocks-to-improve-your-value-investing-cm653197,Value style is generally considered one of the best practices when it comes to picking stocks. There are different valuation metrics to determine a stock's inherent strength but a random selection of a ratio cannot serve your purpose if
MNK,MNK:US,BBG002BHBHM1,Bullish Two Hundred Day Moving Average Cross - MNK,2016-07-20 17:08:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IFTVXpHYPvg/bullish-two-hundred-day-moving-average-cross-mnk-cm652028,"In trading on Wednesday, shares of Mallinckrodt plc (Symbol MNK) crossed above their 200 day moving average of $64.01, changing hands as high as $64.84 per share. Mallinckrodt plc shares are currently trading up about 4.2% on the day."
MNK,MNK:US,BBG002BHBHM1,"Research Reports for Amazon, IBM, Cisco & others",2016-07-19 22:13:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jVR8OovgJIk/research-reports-for-amazon-ibm-cisco-others-cm651629,"Tuesday, July 19, 2016 We have hand picked 16 research reports in today's Research Daily, out of the roughly 80 research reports issued by our team of analysts, including the 7 featured below about Amazon.com (AMZN), Visa (V), Mallinckrodt"
MNK,MNK:US,BBG002BHBHM1,Looking for Bargain Stocks? Pick These 5 with Low P/B Ratio,2016-07-11 16:51:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3XY2gk6Z8bg/looking-for-bargain-stocks-pick-these-5-with-low-pb-ratio-cm647230,"It's not easy to find value stocks. Being aware of a company's key financial numbers like earnings per share and sales growth can help investors identify stocks that are trading for less than they're worth. However, a proper analysis"
MNK,MNK:US,BBG002BHBHM1,Progenics Pharmaceuticals (PGNX) Jumps: Stock Up 9.3%,2016-07-07 14:47:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tEj3qX59j40/progenics-pharmaceuticals-pgnx-jumps-stock-up-93-cm645764,"Progenics Pharmaceuticals, Inc.PGNX was a big mover last session, as its shares rose over 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. Yesterday's rally breaks"
MNK,MNK:US,BBG002BHBHM1,Businesses Say Tax Proposal Goes Too Far,2016-07-06 14:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jP3aEJbbM4o/businesses-say-tax-proposal-goes-too-far-20160706-00767,Businesses Say Tax Proposal Goes Too Far
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt plc To Report Third Quarter Fiscal 2016 Results On Aug. 2, 2016",2016-06-21 11:19:03 +0000,http://www.publicnow.com/view/F016DBD4BFAB0444B085975534A326967EC46F1C,"[at noodls] - CHESTERFIELD, United Kingdom, June 21, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty biopharmaceutical company, will report third quarter fiscal 2016 results on Tuesday, ..."
MNK,MNK:US,BBG002BHBHM1,Perrigo Says FDA Oks Generic Version Of Ofirmev Acetaminophen Injection,2016-06-16 23:10:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mS8bpsQDeZc/perrigo-says-fda-oks-generic-version-of-ofirmev-acetaminophen-injection-20160616-01114,Perrigo Says FDA Oks Generic Version Of Ofirmev Acetaminophen Injection
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Submits Investigational New Drug Application for Synacthen® Depot,2016-06-13 11:19:02 +0000,http://www.publicnow.com/view/7318B8452690241A122559502A7B86E623414ABD,"[at noodls] - CHESTERFIELD, United Kingdom, June 13, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty biopharmaceutical company, today announced it has submitted an Investigational New Drug ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt Presents New Data from 44-Week Open Label Extension Of Company-Sponsored H.P. Acthar® Gel Trial in Lupus,2016-06-09 21:19:05 +0000,http://www.publicnow.com/view/A070ECEE298883F577DFC7A24998C54EB1212D5F,"[at noodls] - CHESTERFIELD, United Kingdom, June 9, 2016 /PRNewswire/ -- Researchers for Mallinckrodt plc (NYSE: MNK), a leading specialty biopharmaceutical company, today presented results from the 44-week open label ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt plc to Change Fiscal Year,2016-05-18 21:12:08 +0000,http://www.publicnow.com/view/1EA3BF9D334D2674E3C149022A547663A2640C8C,"[at noodls] - CHESTERFIELD, United Kingdom, May 18, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty biopharmaceutical company, today announced that its Board of Directors has approved a ..."
MNK,MNK:US,BBG002BHBHM1,First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar® Gel for Rare Cause of Nephrotic Syndrome,2016-05-17 20:42:12 +0000,http://www.publicnow.com/view/89190B7F385DD1E4D3E39A59304A677FC9341BC4,"[at noodls] - CHESTERFIELD, United Kingdom, May 17, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty biopharmaceutical company, today confirmed enrollment of the first patient in the company's ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt plc Reports Fiscal 2016 Second Quarter Results,2016-05-03 10:30:06 +0000,http://www.publicnow.com/view/147C581037766FBE4A9BAF60DD5DE7F8F27D5602,"[at noodls] - CHESTERFIELD, United Kingdom, May 3, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty biopharmaceutical company, today reported results for the second quarter of fiscal 2016. ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt tops Street 2Q forecasts,2016-05-03 10:15:34 +0000,http://sg.finance.yahoo.com/news/mallinckrodt-tops-street-2q-forecasts-101534233.html,Mallinckrodt tops Street 2Q forecasts
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt to Present at UBS Global Healthcare Conference,2016-04-27 11:21:26 +0000,http://www.publicnow.com/view/3CC5765DD58C25AEE8C896F3C8F29789FCFBC935,"[at noodls] - CHESTERFIELD, United Kingdom, April 27, 2016 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty biopharmaceutical company, will present on Tuesday, May 24, 2016, at the ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt To Present At Bank Of America Merrill Lynch 2016 Healthcare Conference,2016-04-11 20:51:20 +0000,http://www.publicnow.com/view/74E1959D382D387CAC8A13C1E4DBCDF69FDDA4E2,"[at noodls] - CHESTERFIELD, United Kingdom, April 11, 2016 /PRNewswire/ -- Mallinckrodt Pharmaceuticals (NYSE: MNK), a leading global specialty biopharmaceutical company, today announced it will present on Tuesday, ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt To Present At Deutsche Bank 41st Annual Healthcare Conference,2016-04-04 20:49:22 +0000,http://www.publicnow.com/view/0756F4B7C08C2922860EB29DA84646D541E22CF8,"[at noodls] - CHESTERFIELD, United Kingdom, April 4, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty biopharmaceutical company, will present on Thursday, May 5, 2016, at the Deutsche Bank ..."
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt plc To Report Second Quarter Fiscal 2016 Results On May 3, 2016",2016-03-22 21:28:00 +0000,http://www.publicnow.com/view/0D77E1F409B0ECCE4500EF2ADF3531671DBFDA79,"[at noodls] - CHESTERFIELD, United Kingdom, March 22, 2016 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty biopharmaceutical company, will report second quarter fiscal 2016 results on Tuesday, ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt beats Street 1Q forecasts,2016-02-02 11:09:32 +0000,http://sg.finance.yahoo.com/news/mallinckrodt-beats-street-1q-forecasts-110932946.html,Mallinckrodt beats Street 1Q forecasts
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt To Present At Leerink Partners Global Healthcare Conference,2016-01-28 22:27:13 +0000,http://www.publicnow.com/view/167BC6E541CC1E784281CD21CAE0312CE129F01F,"[at noodls] - , /PRNewswire/ -- (NYSE: MNK), a leading global specialty biopharmaceutical company, will present on , at the at the Waldorf Astoria New York, in . , Senior Vice President and Chief Financial Officer, ..."
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt plc To Report First Quarter Fiscal 2016 Results On Feb. 2, 2016",2016-01-12 22:25:24 +0000,http://www.noodls.com/view/B040BCDD905D06AB08B78FA902206021A2C45644,"[at noodls] - , /PRNewswire/ -- plc (NYSE: MNK), a leading global specialty biopharmaceutical company, will report first quarter fiscal 2016 results on . A conference call for investors will begin at U.S. Eastern time. ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt CEO Mark Trudeau Nominated To TE Connectivity Board Of Directors,2015-12-18 00:14:05 +0000,http://www.noodls.com/view/16E24EB8A78E6B14A54B6D5EFEB8EA276A78FA54,"[at noodls] - , /PRNewswire/ -- (NYSE: MNK), a leading global specialty biopharmaceuticals company, today announced that its President and Chief Executive Officer, , has been nominated to the Board of Directors for ..."
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt To Present At J.P. Morgan 34th Annual Healthcare Conference,2015-12-15 22:25:10 +0000,http://www.noodls.com/view/A4D4E3F8B252B9ECE0CBEEBE68F9718F35A16DC7,"[at noodls] - , /PRNewswire/ -- (NYSE: MNK), a leading global specialty biopharmaceutical company, will present on , at the J.P. Morgan 34 Annual Healthcare Conference at The Westin St. Francis on , , in . The conference ..."
MNK,MNK:US,BBG002BHBHM1,"Mallinckrodt plc Discusses R&D Initiatives, Company Outlook at Investor Briefing",2015-12-07 18:08:16 +0000,http://www.noodls.com/view/16845A61B09B909B642DDFD485DB1C1F2F8E42A9,"[at noodls] - Mallinckrodt plc Discusses R&D Initiatives, Company Outlook at Investor Briefing"
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt beats Street 4Q forecasts,2015-11-23 11:40:47 +0000,http://sg.finance.yahoo.com/news/mallinckrodt-beats-street-4q-forecasts-112339276.html,Mallinckrodt beats Street 4Q forecasts
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt plc Reports Financial Results For Fiscal 2015 Fourth Quarter and Full Year,2015-11-23 11:31:13 +0000,http://www.noodls.com/view/FCFD8B44E2CF6CDE09FB61780D71123523523FE7,[at noodls] - Mallinckrodt plc Reports Financial Results For Fiscal 2015 Fourth Quarter and Full Year
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt plc Board Adds $500 Million To Company's Existing Share Repurchase Program,2015-11-19 14:30:13 +0000,http://www.noodls.com/view/780310B944F4FF6DC659989DF167198EFB294522,[at noodls] - Mallinckrodt plc Board Adds $500 Million To Company's Existing Share Repurchase Program
MNK,MNK:US,BBG002BHBHM1,Judge orders mercury cleanup plan for Penobscot River,2015-09-03 16:43:17 +0000,http://sg.finance.yahoo.com/news/judge-orders-mercury-cleanup-plan-164317881.html,Judge orders mercury cleanup plan for Penobscot River
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt will buy immune cell therapy company for $1.33B,2015-08-10 22:53:21 +0000,http://sg.finance.yahoo.com/news/mallinckrodt-buy-immune-cell-therapy-225321336.html,Mallinckrodt will buy immune cell therapy company for $1.33B
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt buys immunotherapy maker Therakos in $1.33 billion deal,2015-08-10 19:24:13 +0000,http://in.finance.yahoo.com/news/mallinckrodt-buys-immunotherapy-maker-therakos-192413188.html,Mallinckrodt buys immunotherapy maker Therakos in $1.33 billion deal
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt buys immunotherapy maker Therakos in $1.33 billion deal,2015-08-10 19:24:13 +0000,http://sg.finance.yahoo.com/news/mallinckrodt-buys-immunotherapy-maker-therakos-192413598.html,Mallinckrodt buys immunotherapy maker Therakos in $1.33 billion deal
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt slumps after trimming sales forecast for Acthar,2015-08-04 17:43:13 +0000,http://sg.finance.yahoo.com/news/mallinckrodt-slumps-trimming-sales-forecast-174313586.html,Mallinckrodt slumps after trimming sales forecast for Acthar
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt beats 3Q profit forecasts,2015-08-04 11:06:47 +0000,http://sg.finance.yahoo.com/news/mallinckrodt-beats-3q-profit-forecasts-110647536.html,Mallinckrodt beats 3Q profit forecasts
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt beats Street 2Q forecasts,2015-05-05 11:12:49 +0000,http://sg.finance.yahoo.com/news/mallinckrodt-beats-street-2q-forecasts-111249616.html,Mallinckrodt beats Street 2Q forecasts
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt beats 1Q profit forecasts,2015-02-03 12:39:31 +0000,http://sg.finance.yahoo.com/news/mallinckrodt-beats-1q-profit-forecasts-123931548.html,Mallinckrodt beats 1Q profit forecasts
MNK,MNK:US,BBG002BHBHM1,Wal-Mart and Viacom are big market movers,2014-11-13 21:41:40 +0000,http://sg.finance.yahoo.com/news/smucker-susquehanna-big-market-movers-213031003--finance.html,Wal-Mart and Viacom are big market movers
MNK,MNK:US,BBG002BHBHM1,Mallinckrodt shares rise on earnings outlook,2014-10-14 14:07:43 +0000,http://sg.finance.yahoo.com/news/mallinckrodt-shares-rise-earnings-outlook-140743260--finance.html,Mallinckrodt shares rise on earnings outlook
